activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2470340	CHEMBL995019	Inhibition of RIPK1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5464	Homo sapiens	INH	%	10.0
	2470340	CHEMBL995019	Inhibition of RIPK1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5464	Homo sapiens	INH	%	10.0
Not Active	2483305	CHEMBL985318	Inhibition of GST-tagged human recombinant RIP1 kinase expressed in Sf9 cells	B	N=C1S/C(=C\c2c[nH]nc2-c2ccc(S(=O)(=O)c3ccccc3)cc2)C(=O)N1c1nccs1		CHEMBL490788		Activity			CHEMBL5464	Homo sapiens	Activity		
	2906699	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	2800.0	CHEMBL5464	Homo sapiens	Kd	nM	2800.0
	2906700	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2906701	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	210.0	CHEMBL5464	Homo sapiens	Kd	nM	210.0
	2906702	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2906703	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2906704	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2906705	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	320.0	CHEMBL5464	Homo sapiens	Kd	nM	320.0
	2906706	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2906707	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2906708	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2906709	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2906710	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2906711	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2906712	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2906713	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2906714	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2906715	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2906716	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	260.0	CHEMBL5464	Homo sapiens	Kd	nM	260.0
	2906717	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2906718	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	1800.0	CHEMBL5464	Homo sapiens	Kd	nM	1800.0
	2906719	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2907496	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2907497	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2907498	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2907499	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2907500	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2907501	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2907502	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2907503	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2907504	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2907505	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2907506	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2907507	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2907508	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1200.0	CHEMBL5464	Homo sapiens	Kd	nM	1200.0
	2907509	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	370.0	CHEMBL5464	Homo sapiens	Kd	nM	370.0
	2907510	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	20.0	CHEMBL5464	Homo sapiens	Kd	nM	20.0
	2907511	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2907512	CHEMBL1062869	Binding constant for RIPK1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	2921979	CHEMBL1052947	Inhibition of RIPK1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	92.0	CHEMBL5464	Homo sapiens	Activity	%	92.0
	3332132	CHEMBL1166843	Inhibition of RIPK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5464	Homo sapiens	INH	%	50.0
	3333547	CHEMBL1166843	Inhibition of RIPK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5464	Homo sapiens	INH	%	50.0
	3334952	CHEMBL1166843	Inhibition of RIPK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5464	Homo sapiens	INH	%	50.0
	3336372	CHEMBL1166843	Inhibition of RIPK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5464	Homo sapiens	INH	%	50.0
	3337639	CHEMBL1166843	Inhibition of RIPK1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL5464	Homo sapiens	INH	%	50.0
	3338970	CHEMBL1166843	Inhibition of RIPK1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL5464	Homo sapiens	INH	%	50.0
	3339224	CHEMBL1166843	Inhibition of RIPK1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5464	Homo sapiens	INH	%	50.0
	3340527	CHEMBL1166843	Inhibition of RIPK1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL5464	Homo sapiens	INH	%	50.0
	3341914	CHEMBL1166843	Inhibition of RIPK1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5464	Homo sapiens	INH	%	50.0
	3343361	CHEMBL1166843	Inhibition of RIPK1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5464	Homo sapiens	INH	%	50.0
	3358787	CHEMBL1175253	Inhibition of RIPK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.05	CHEMBL5464	Homo sapiens	INH	%	0.05
	3359229	CHEMBL1175253	Inhibition of RIPK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.0	CHEMBL5464	Homo sapiens	INH	%	0.0
Dose-dependent effect	3395877	CHEMBL1221001	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in HEK293T cells	B	CN1C(=O)C(Cc2c[nH]c3ccccc23)NC1=S		CHEMBL195008		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Not Active	3395878	CHEMBL1221001	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in HEK293T cells	B	O=C1NC(=S)NC1Cc1c[nH]c2ccccc12		CHEMBL366011		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Not Active	3395879	CHEMBL1221002	Inhibition of endogenous RIP1 autophosphorylation in human Jurkat cells	B	O=C1NC(=S)NC1Cc1c[nH]c2ccccc12		CHEMBL366011		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
	3395880	CHEMBL1221002	Inhibition of endogenous RIP1 autophosphorylation in human Jurkat cells	B	CN1C(=O)C(Cc2c[nH]c3ccccc23)NC1=S		CHEMBL195008	=	EC50	nM	182.0	CHEMBL5464	Homo sapiens	EC50	nM	182.0
	3395881	CHEMBL1221002	Inhibition of endogenous RIP1 autophosphorylation in human Jurkat cells	B	CN1C(=O)N[C@H](Cc2c[nH]c3c(Cl)cccc23)C1=O		CHEMBL370438	=	EC50	nM	18.0	CHEMBL5464	Homo sapiens	EC50	nM	18.0
Not Active	3395883	CHEMBL1221001	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in HEK293T cells	B	CN1C(=O)C(C)(Cc2c[nH]c3ccccc23)NC1=S		CHEMBL1213272		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Not Active	3395885	CHEMBL1221001	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in HEK293T cells	B	CN1C(=O)C(Cc2c[nH]c3ccccc23)N(C)C1=S		CHEMBL1213273		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Not Active	3395887	CHEMBL1221001	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in HEK293T cells	B	CN1C(=O)C(Cc2cn(C)c3ccccc23)NC1=S		CHEMBL365948		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	3395889	CHEMBL1221001	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in HEK293T cells	B	CN1C(=O)NC(Cc2c[nH]c3ccccc23)C1=O		CHEMBL196317		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	3395891	CHEMBL1221001	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in HEK293T cells	B	CN1C(=O)C(Cc2c[nH]c3c(Cl)cccc23)NC1=S		CHEMBL382085		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	3395892	CHEMBL1221001	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in HEK293T cells	B	COc1ccc(-n2c(SCC#N)nc3sc4c(c3c2=O)CCCC4)cc1		CHEMBL396100		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	3395893	CHEMBL1221004	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in Sf9 cells	B	CN1C(=O)C(Cc2c[nH]c3ccccc23)NC1=S		CHEMBL195008		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Not Active	3395894	CHEMBL1221004	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in Sf9 cells	B	O=C1NC(=S)NC1Cc1c[nH]c2ccccc12		CHEMBL366011		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Not Active	3395895	CHEMBL1221005	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in FADD deficient human Jurkat cells in presence of increasing concentration of ATP	B	CN1C(=O)C(Cc2c[nH]c3ccccc23)NC1=S		CHEMBL195008		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Not Active	3395900	CHEMBL1221008	Inhibition of human RIP1 S161E mutant autophosphorylation expressed in HEK293T cells at 100 uM	B	CN1C(=O)C(Cc2c[nH]c3ccccc23)NC1=S		CHEMBL195008		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	3395901	CHEMBL1221001	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in HEK293T cells	B	COc1ccc([C@H]2[C@H]3CCc4ccccc4C3=NN2C(C)=O)cc1		CHEMBL222155		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Not Active	3395904	CHEMBL1221001	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in HEK293T cells	B	COc1ccc([C@H]2[C@H]3CCc4c(OC)cccc4C3=NN2C(C)=O)cc1		CHEMBL376241		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Not Active	3395906	CHEMBL1221001	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in HEK293T cells	B	N#CCSc1nc2sc3c(c2c(=O)n1-c1ccccc1)CCCC3		CHEMBL428047		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	3395908	CHEMBL1221012	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in FADD deficient human Jurkat cells at 10 to 30 uM	B	COc1ccc([C@H]2[C@H]3CCc4ccccc4C3=NN2C(C)=O)cc1		CHEMBL222155		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	3395909	CHEMBL1221012	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in FADD deficient human Jurkat cells at 10 to 30 uM	B	COc1ccc(-n2c(SCC#N)nc3sc4c(c3c2=O)CCCC4)cc1		CHEMBL396100		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Not Active	3395910	CHEMBL1221004	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in Sf9 cells	B	COc1ccc(-n2c(SCC#N)nc3sc4c(c3c2=O)CCCC4)cc1		CHEMBL396100		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	3395911	CHEMBL1221004	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in Sf9 cells	B	COc1ccc([C@H]2[C@H]3CCc4ccccc4C3=NN2C(C)=O)cc1		CHEMBL222155		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	3395912	CHEMBL1221013	Inhibition of human RIP1 S161E mutant autophosphorylation expressed in HEK293T cells at 10 to 30 uM	B	COc1ccc([C@H]2[C@H]3CCc4ccccc4C3=NN2C(C)=O)cc1		CHEMBL222155		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Not Active	3395925	CHEMBL1221012	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in FADD deficient human Jurkat cells at 10 to 30 uM	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Not Active	3395926	CHEMBL1221014	Inhibition of human RIP1 K45M mutant autophosphorylation expressed in Sf9 cells at 10 to 30 uM	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
	3448605	CHEMBL1244958	Binding affinity to RIPK1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	3449330	CHEMBL1244958	Binding affinity to RIPK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	370.0	CHEMBL5464	Homo sapiens	Kd	nM	370.0
	3449832	CHEMBL1244958	Binding affinity to RIPK1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	3449957	CHEMBL1244958	Binding affinity to RIPK1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	3450225	CHEMBL1244958	Binding affinity to RIPK1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	3450857	CHEMBL1244958	Binding affinity to RIPK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	3451133	CHEMBL1244958	Binding affinity to RIPK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	uM	10.0
	6218844	CHEMBL1787148	Binding affinity to human RIPK1 at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075	=	Activity	%	3.5	CHEMBL5464	Homo sapiens	Activity	%	3.5
Not Determined	6218870	CHEMBL1787533	Binding affinity to human RIPK1 incubated for 1 hr by kinase binding assay	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075		Kd			CHEMBL5464	Homo sapiens	Kd		
	6219048	CHEMBL1787148	Binding affinity to human RIPK1 at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	CCc1cnc(N2CCN(C(=O)c3ccc(CNc4ncnc5ccccc45)cc3)CC2)nc1		CHEMBL1783929	>	Activity	%	50.0	CHEMBL5464	Homo sapiens	Activity	%	50.0
	6220397	CHEMBL1787148	Binding affinity to human RIPK1 at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	O=C(c1cccc(Nc2ncnc3ccccc23)c1)N1CCN(c2ncc(Cc3ccccc3)cn2)CC1		CHEMBL1783930	=	Activity	%	19.0	CHEMBL5464	Homo sapiens	Activity	%	19.0
	6340003	CHEMBL1827241	Activity of RIPK1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	86.0	CHEMBL5464	Homo sapiens	Activity	%	86.0
	7567321	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7567780	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7568277	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	3500.0	CHEMBL5464	Homo sapiens	Kd	nM	3500.0
	7568709	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1200.0	CHEMBL5464	Homo sapiens	Kd	nM	1200.0
	7569294	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7569754	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	1600.0	CHEMBL5464	Homo sapiens	Kd	nM	1600.0
	7569784	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7570247	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	1500.0	CHEMBL5464	Homo sapiens	Kd	nM	1500.0
	7570674	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	370.0	CHEMBL5464	Homo sapiens	Kd	nM	370.0
	7571270	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7571761	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7572224	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7572640	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7573266	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7573742	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	240.0	CHEMBL5464	Homo sapiens	Kd	nM	240.0
	7574211	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7574619	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7574787	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	240.0	CHEMBL5464	Homo sapiens	Kd	nM	240.0
	7575248	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7575719	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7576184	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	5100.0	CHEMBL5464	Homo sapiens	Kd	nM	5100.0
	7576592	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	5300.0	CHEMBL5464	Homo sapiens	Kd	nM	5300.0
	7576761	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7577220	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	850.0	CHEMBL5464	Homo sapiens	Kd	nM	850.0
	7577698	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	64.0	CHEMBL5464	Homo sapiens	Kd	nM	64.0
	7578168	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7578573	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7578769	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7579143	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7579593	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7580067	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7581127	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7581512	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7581957	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7582428	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7582450	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7582850	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	20.0	CHEMBL5464	Homo sapiens	Kd	nM	20.0
	7583473	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	2800.0	CHEMBL5464	Homo sapiens	Kd	nM	2800.0
	7583870	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7584315	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7584806	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7585210	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7585803	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	890.0	CHEMBL5464	Homo sapiens	Kd	nM	890.0
	7586211	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7586686	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7587140	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7587764	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	2500.0	CHEMBL5464	Homo sapiens	Kd	nM	2500.0
	7588194	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7588665	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7589116	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7589711	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7590178	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7590652	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7591103	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7591260	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7591682	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	320.0	CHEMBL5464	Homo sapiens	Kd	nM	320.0
	7592154	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7592627	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7593080	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7593227	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	210.0	CHEMBL5464	Homo sapiens	Kd	nM	210.0
	7593662	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	5400.0	CHEMBL5464	Homo sapiens	Kd	nM	5400.0
	7594134	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7594607	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7595059	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7595195	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7595639	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7596113	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7596584	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	260.0	CHEMBL5464	Homo sapiens	Kd	nM	260.0
	7597167	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7597620	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7598093	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	7598563	CHEMBL1908621	Binding constant for RIPK1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL5464	Homo sapiens	Kd	nM	10000.0
	8004468	CHEMBL1943613	Inhibition of human RIPK1 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL5464	Homo sapiens	INH	%	35.0
	8004469	CHEMBL1943613	Inhibition of human RIPK1 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL5464	Homo sapiens	INH	%	35.0
	8004470	CHEMBL1943613	Inhibition of human RIPK1 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL5464	Homo sapiens	INH	%	35.0
	8004471	CHEMBL1943613	Inhibition of human RIPK1 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL5464	Homo sapiens	INH	%	35.0
	12172230	CHEMBL2212010	Inhibition of RIPK1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL5464	Homo sapiens	Activity	%	100.0
	13439761	CHEMBL2429002	Competitive binding affinity to RIPK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5464	Homo sapiens	INH	%	50.0
	13445594	CHEMBL2429002	Competitive binding affinity to RIPK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL5464	Homo sapiens	INH	%	50.0
	13451581	CHEMBL2429002	Competitive binding affinity to RIPK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL5464	Homo sapiens	INH	%	50.0
	13889994	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)no1		CHEMBL3109221	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13889995	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13889996	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4ccc5ccccc5c4)cc3)c12		CHEMBL436806	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13889997	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL3109220	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13889998	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	CCc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL3109219	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13889999	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4Cl)cc3)c12		CHEMBL437369	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890000	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)c12		CHEMBL3109218	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890001	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4F)cc3)c12		CHEMBL3109217	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890002	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890003	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL3109216	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890004	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)c12		CHEMBL3109215	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890005	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890006	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4cn[nH]c4)cc23)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3109214	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890007	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1ccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)cc1		CHEMBL3109213	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890008	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1cccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)c1		CHEMBL3109212	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890009	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	CS(=O)(=O)c1cccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)c1		CHEMBL3109211	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890010	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)c1		CHEMBL3109210	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890011	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4cccnc4)cc23)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3109209	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890012	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	CCS(=O)(=O)c1ccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)cc1		CHEMBL3109194	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890013	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)NC1CCCC1		CHEMBL3109208	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890014	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3109207	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890015	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	CC(=O)c1cccc(NC(=O)Nc2cccc(-c3c[nH]c4ncc(-c5ccccc5)cc34)c2)c1		CHEMBL3109206	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890016	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	COc1cccc(NC(=O)Nc2cccc(-c3c[nH]c4ncc(-c5ccccc5)cc34)c2)c1		CHEMBL3109205	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890017	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL3109204	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890018	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)Nc1cccc([N+](=O)[O-])c1		CHEMBL3109203	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890019	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Cc1cccc(NC(=O)Nc2cccc(-c3c[nH]c4ncc(-c5ccccc5)cc34)c2)c1		CHEMBL3108785	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890020	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	O=C(Nc1ccccc1)Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1		CHEMBL550273	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890021	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cccc4c(N)nccc34)cc2)no1		CHEMBL3109202	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890022	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4Cl)cc3)cccc12		CHEMBL3109201	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890023	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109200	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890024	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4F)cc3)cccc12		CHEMBL3109199	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890025	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109198	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890026	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cc(F)cc(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109197	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890027	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cccc12		CHEMBL3109196	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890028	CHEMBL3110726	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by ADP-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109195	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890029	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)no1		CHEMBL3109221	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890030	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890031	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4ccc5ccccc5c4)cc3)c12		CHEMBL436806	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890032	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL3109220	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890033	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	CCc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL3109219	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890034	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4Cl)cc3)c12		CHEMBL437369	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890035	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)c12		CHEMBL3109218	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890036	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4F)cc3)c12		CHEMBL3109217	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890037	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890038	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL3109216	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890039	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)c12		CHEMBL3109215	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890040	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890041	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4cn[nH]c4)cc23)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3109214	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890042	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1ccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)cc1		CHEMBL3109213	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890043	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1cccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)c1		CHEMBL3109212	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890044	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	CS(=O)(=O)c1cccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)c1		CHEMBL3109211	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890045	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)c1		CHEMBL3109210	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890046	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4cccnc4)cc23)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3109209	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890047	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	CCS(=O)(=O)c1ccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)cc1		CHEMBL3109194	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890048	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)NC1CCCC1		CHEMBL3109208	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890049	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3109207	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890050	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	CC(=O)c1cccc(NC(=O)Nc2cccc(-c3c[nH]c4ncc(-c5ccccc5)cc34)c2)c1		CHEMBL3109206	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890051	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	COc1cccc(NC(=O)Nc2cccc(-c3c[nH]c4ncc(-c5ccccc5)cc34)c2)c1		CHEMBL3109205	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890052	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL3109204	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890053	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)Nc1cccc([N+](=O)[O-])c1		CHEMBL3109203	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890054	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Cc1cccc(NC(=O)Nc2cccc(-c3c[nH]c4ncc(-c5ccccc5)cc34)c2)c1		CHEMBL3108785	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890055	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	O=C(Nc1ccccc1)Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1		CHEMBL550273	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890056	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cccc4c(N)nccc34)cc2)no1		CHEMBL3109202	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890057	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4Cl)cc3)cccc12		CHEMBL3109201	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890058	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109200	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890059	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4F)cc3)cccc12		CHEMBL3109199	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890060	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109198	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890061	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cc(F)cc(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109197	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890062	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cccc12		CHEMBL3109196	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890063	CHEMBL3110727	Ratio of IC50 for RIP1 in TNFalpha/zVAD.fmk-stimulated human U937 cells by Cell Titer-Glo luminescence assay to IC50 for human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells by fluorescence polarization assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109195	=	Ratio IC50		10.0	CHEMBL5464	Homo sapiens	Ratio IC50		10.0
	13890064	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)no1		CHEMBL3109221	=	IC50	nM	200.0	CHEMBL5464	Homo sapiens	IC50	uM	0.2
	13890065	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	IC50	nM	7900.0	CHEMBL5464	Homo sapiens	IC50	uM	7.9
	13890066	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4ccc5ccccc5c4)cc3)c12		CHEMBL436806	=	IC50	nM	790.0	CHEMBL5464	Homo sapiens	IC50	uM	0.79
	13890067	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL3109220	=	IC50	nM	7900.0	CHEMBL5464	Homo sapiens	IC50	uM	7.9
	13890068	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	CCc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL3109219	=	IC50	nM	250.0	CHEMBL5464	Homo sapiens	IC50	uM	0.25
	13890069	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4Cl)cc3)c12		CHEMBL437369	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	uM	10.0
	13890070	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)c12		CHEMBL3109218	=	IC50	nM	1300.0	CHEMBL5464	Homo sapiens	IC50	uM	1.3
	13890071	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4F)cc3)c12		CHEMBL3109217	=	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	uM	10.0
	13890072	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	IC50	nM	250.0	CHEMBL5464	Homo sapiens	IC50	uM	0.25
	13890073	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL3109216	=	IC50	nM	5000.0	CHEMBL5464	Homo sapiens	IC50	uM	5.0
	13890074	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)c12		CHEMBL3109215	=	IC50	nM	1300.0	CHEMBL5464	Homo sapiens	IC50	uM	1.3
	13890075	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	IC50	nM	1000.0	CHEMBL5464	Homo sapiens	IC50	uM	1.0
	13890076	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4cn[nH]c4)cc23)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3109214	=	IC50	nM	63.0	CHEMBL5464	Homo sapiens	IC50	uM	0.063
	13890077	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1ccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)cc1		CHEMBL3109213	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	uM	0.016
	13890078	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1cccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)c1		CHEMBL3109212	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	uM	0.016
	13890079	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	CS(=O)(=O)c1cccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)c1		CHEMBL3109211	=	IC50	nM	50.0	CHEMBL5464	Homo sapiens	IC50	uM	0.05
	13890080	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)c1		CHEMBL3109210	=	IC50	nM	63.0	CHEMBL5464	Homo sapiens	IC50	uM	0.063
	13890081	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4cccnc4)cc23)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3109209	=	IC50	nM	6.3	CHEMBL5464	Homo sapiens	IC50	uM	0.0063
	13890082	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	CCS(=O)(=O)c1ccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)cc1		CHEMBL3109194	=	IC50	nM	25.0	CHEMBL5464	Homo sapiens	IC50	uM	0.025
	13890083	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)NC1CCCC1		CHEMBL3109208	=	IC50	nM	7900.0	CHEMBL5464	Homo sapiens	IC50	uM	7.9
	13890084	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3109207	=	IC50	nM	160.0	CHEMBL5464	Homo sapiens	IC50	uM	0.16
	13890085	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	CC(=O)c1cccc(NC(=O)Nc2cccc(-c3c[nH]c4ncc(-c5ccccc5)cc34)c2)c1		CHEMBL3109206	=	IC50	nM	320.0	CHEMBL5464	Homo sapiens	IC50	uM	0.32
	13890086	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	COc1cccc(NC(=O)Nc2cccc(-c3c[nH]c4ncc(-c5ccccc5)cc34)c2)c1		CHEMBL3109205	=	IC50	nM	400.0	CHEMBL5464	Homo sapiens	IC50	uM	0.4
	13890087	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL3109204	=	IC50	nM	79.0	CHEMBL5464	Homo sapiens	IC50	uM	0.079
	13890088	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)Nc1cccc([N+](=O)[O-])c1		CHEMBL3109203	=	IC50	nM	320.0	CHEMBL5464	Homo sapiens	IC50	uM	0.32
	13890089	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Cc1cccc(NC(=O)Nc2cccc(-c3c[nH]c4ncc(-c5ccccc5)cc34)c2)c1		CHEMBL3108785	=	IC50	nM	160.0	CHEMBL5464	Homo sapiens	IC50	uM	0.16
	13890090	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	O=C(Nc1ccccc1)Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1		CHEMBL550273	=	IC50	nM	600.0	CHEMBL5464	Homo sapiens	IC50	uM	0.6
	13890091	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cccc4c(N)nccc34)cc2)no1		CHEMBL3109202	=	IC50	nM	630.0	CHEMBL5464	Homo sapiens	IC50	uM	0.63
	13890092	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4Cl)cc3)cccc12		CHEMBL3109201	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	uM	10.0
	13890093	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109200	=	IC50	nM	2000.0	CHEMBL5464	Homo sapiens	IC50	uM	2.0
	13890094	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4F)cc3)cccc12		CHEMBL3109199	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	uM	10.0
	13890095	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109198	=	IC50	nM	2500.0	CHEMBL5464	Homo sapiens	IC50	uM	2.5
	13890096	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cc(F)cc(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109197	=	IC50	nM	2500.0	CHEMBL5464	Homo sapiens	IC50	uM	2.5
	13890097	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cccc12		CHEMBL3109196	=	IC50	nM	630.0	CHEMBL5464	Homo sapiens	IC50	uM	0.63
	13890098	CHEMBL3110728	Inhibition of RIP1 in human U937 cells assessed as prevention of TNFalpha/zVAD.fmk-induced necrotic cell death preincubated for 30 to 60 mins followed by TNF-alpha induction measured after overnight incubation by Cell Titer-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109195	=	IC50	nM	630.0	CHEMBL5464	Homo sapiens	IC50	uM	0.63
	13890099	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)no1		CHEMBL3109221	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	uM	0.016
	13890100	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	IC50	nM	32.0	CHEMBL5464	Homo sapiens	IC50	uM	0.032
	13890101	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL3109220	=	IC50	nM	200.0	CHEMBL5464	Homo sapiens	IC50	uM	0.2
	13890102	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	CCc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL3109219	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	uM	0.01
	13890103	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4Cl)cc3)c12		CHEMBL437369	=	IC50	nM	2500.0	CHEMBL5464	Homo sapiens	IC50	uM	2.5
	13890104	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)c12		CHEMBL3109218	=	IC50	nM	32.0	CHEMBL5464	Homo sapiens	IC50	uM	0.032
	13890105	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4F)cc3)c12		CHEMBL3109217	=	IC50	nM	200.0	CHEMBL5464	Homo sapiens	IC50	uM	0.2
	13890106	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	IC50	nM	13.0	CHEMBL5464	Homo sapiens	IC50	uM	0.013
	13890107	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL3109216	=	IC50	nM	63.0	CHEMBL5464	Homo sapiens	IC50	uM	0.063
	13890108	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)c12		CHEMBL3109215	=	IC50	nM	500.0	CHEMBL5464	Homo sapiens	IC50	uM	0.5
	13890109	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	uM	0.01
	13890110	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4cn[nH]c4)cc23)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3109214	=	IC50	nM	6.0	CHEMBL5464	Homo sapiens	IC50	uM	0.006
	13890111	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1ccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)cc1		CHEMBL3109213	=	IC50	nM	50.0	CHEMBL5464	Homo sapiens	IC50	uM	0.05
	13890112	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1cccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)c1		CHEMBL3109212	=	IC50	nM	32.0	CHEMBL5464	Homo sapiens	IC50	uM	0.032
	13890113	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	CS(=O)(=O)c1cccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)c1		CHEMBL3109211	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	uM	0.01
	13890114	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)c1		CHEMBL3109210	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	uM	0.01
	13890115	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4cccnc4)cc23)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3109209	=	IC50	nM	4.0	CHEMBL5464	Homo sapiens	IC50	uM	0.004
	13890116	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	CCS(=O)(=O)c1ccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)cc1		CHEMBL3109194	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	uM	0.01
	13890117	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)NC1CCCC1		CHEMBL3109208	=	IC50	nM	500.0	CHEMBL5464	Homo sapiens	IC50	uM	0.5
	13890118	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3109207	=	IC50	nM	80.0	CHEMBL5464	Homo sapiens	IC50	uM	0.08
	13890119	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	CC(=O)c1cccc(NC(=O)Nc2cccc(-c3c[nH]c4ncc(-c5ccccc5)cc34)c2)c1		CHEMBL3109206	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	uM	0.01
	13890120	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	COc1cccc(NC(=O)Nc2cccc(-c3c[nH]c4ncc(-c5ccccc5)cc34)c2)c1		CHEMBL3109205	=	IC50	nM	6.3	CHEMBL5464	Homo sapiens	IC50	uM	0.0063
	13890121	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL3109204	=	IC50	nM	32.0	CHEMBL5464	Homo sapiens	IC50	uM	0.032
	13890122	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)Nc1cccc([N+](=O)[O-])c1		CHEMBL3109203	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	uM	0.016
	13890123	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Cc1cccc(NC(=O)Nc2cccc(-c3c[nH]c4ncc(-c5ccccc5)cc34)c2)c1		CHEMBL3108785	=	IC50	nM	13.0	CHEMBL5464	Homo sapiens	IC50	uM	0.013
	13890124	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1ccccc1)Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1		CHEMBL550273	=	IC50	nM	400.0	CHEMBL5464	Homo sapiens	IC50	uM	0.4
	13890125	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cccc4c(N)nccc34)cc2)no1		CHEMBL3109202	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	uM	0.01
	13890126	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4Cl)cc3)cccc12		CHEMBL3109201	=	IC50	nM	630.0	CHEMBL5464	Homo sapiens	IC50	uM	0.63
	13890127	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109200	=	IC50	nM	160.0	CHEMBL5464	Homo sapiens	IC50	uM	0.16
	13890128	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4F)cc3)cccc12		CHEMBL3109199	=	IC50	nM	4000.0	CHEMBL5464	Homo sapiens	IC50	uM	4.0
	13890129	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109198	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	uM	0.01
	13890130	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cc(F)cc(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109197	=	IC50	nM	25.0	CHEMBL5464	Homo sapiens	IC50	uM	0.025
	13890131	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cccc12		CHEMBL3109196	=	IC50	nM	130.0	CHEMBL5464	Homo sapiens	IC50	uM	0.13
	13890132	CHEMBL3110729	Inhibition of human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) autophosphorylation expressed in baculovirus infected insect Sf9 cells after 4 hrs by ADP-Glo luminescence assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109195	=	IC50	nM	25.0	CHEMBL5464	Homo sapiens	IC50	uM	0.025
	13890133	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)no1		CHEMBL3109221	=	IC50	nM	32.0	CHEMBL5464	Homo sapiens	IC50	uM	0.032
	13890134	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	IC50	nM	320.0	CHEMBL5464	Homo sapiens	IC50	uM	0.32
	13890135	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4ccc5ccccc5c4)cc3)c12		CHEMBL436806	=	IC50	nM	100.0	CHEMBL5464	Homo sapiens	IC50	uM	0.1
	13890136	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL3109220	=	IC50	nM	160.0	CHEMBL5464	Homo sapiens	IC50	uM	0.16
	13890137	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	CCc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL3109219	=	IC50	nM	25.0	CHEMBL5464	Homo sapiens	IC50	uM	0.025
	13890138	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4Cl)cc3)c12		CHEMBL437369	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	uM	10.0
	13890139	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)c12		CHEMBL3109218	=	IC50	nM	160.0	CHEMBL5464	Homo sapiens	IC50	uM	0.16
	13890140	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4F)cc3)c12		CHEMBL3109217	=	IC50	nM	250.0	CHEMBL5464	Homo sapiens	IC50	uM	0.25
	13890141	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	IC50	nM	63.0	CHEMBL5464	Homo sapiens	IC50	uM	0.063
	13890142	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL3109216	=	IC50	nM	130.0	CHEMBL5464	Homo sapiens	IC50	uM	0.13
	13890143	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)c12		CHEMBL3109215	=	IC50	nM	160.0	CHEMBL5464	Homo sapiens	IC50	uM	0.16
	13890144	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	IC50	nM	20.0	CHEMBL5464	Homo sapiens	IC50	uM	0.02
	13890145	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4cn[nH]c4)cc23)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3109214	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	uM	0.016
	13890146	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1ccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)cc1		CHEMBL3109213	=	IC50	nM	32.0	CHEMBL5464	Homo sapiens	IC50	uM	0.032
	13890147	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1cccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)c1		CHEMBL3109212	=	IC50	nM	1.3	CHEMBL5464	Homo sapiens	IC50	uM	0.0013
	13890148	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	CS(=O)(=O)c1cccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)c1		CHEMBL3109211	=	IC50	nM	63.0	CHEMBL5464	Homo sapiens	IC50	uM	0.063
	13890149	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)c1		CHEMBL3109210	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	uM	0.016
	13890150	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4cccnc4)cc23)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3109209	=	IC50	nM	7.9	CHEMBL5464	Homo sapiens	IC50	uM	0.0079
	13890151	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	CCS(=O)(=O)c1ccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c4)c3c2)cc1		CHEMBL3109194	=	IC50	nM	3.2	CHEMBL5464	Homo sapiens	IC50	uM	0.0032
	13890152	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)NC1CCCC1		CHEMBL3109208	=	IC50	nM	2000.0	CHEMBL5464	Homo sapiens	IC50	uM	2.0
	13890153	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3109207	=	IC50	nM	200.0	CHEMBL5464	Homo sapiens	IC50	uM	0.2
	13890154	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	CC(=O)c1cccc(NC(=O)Nc2cccc(-c3c[nH]c4ncc(-c5ccccc5)cc34)c2)c1		CHEMBL3109206	=	IC50	nM	13.0	CHEMBL5464	Homo sapiens	IC50	uM	0.013
	13890155	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	COc1cccc(NC(=O)Nc2cccc(-c3c[nH]c4ncc(-c5ccccc5)cc34)c2)c1		CHEMBL3109205	=	IC50	nM	32.0	CHEMBL5464	Homo sapiens	IC50	uM	0.032
	13890156	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL3109204	=	IC50	nM	32.0	CHEMBL5464	Homo sapiens	IC50	uM	0.032
	13890157	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	O=C(Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1)Nc1cccc([N+](=O)[O-])c1		CHEMBL3109203	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	uM	0.016
	13890158	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Cc1cccc(NC(=O)Nc2cccc(-c3c[nH]c4ncc(-c5ccccc5)cc34)c2)c1		CHEMBL3108785	=	IC50	nM	20.0	CHEMBL5464	Homo sapiens	IC50	uM	0.02
	13890159	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	O=C(Nc1ccccc1)Nc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1		CHEMBL550273	=	IC50	nM	1300.0	CHEMBL5464	Homo sapiens	IC50	uM	1.3
	13890160	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cccc4c(N)nccc34)cc2)no1		CHEMBL3109202	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	uM	0.016
	13890161	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4Cl)cc3)cccc12		CHEMBL3109201	=	IC50	nM	3200.0	CHEMBL5464	Homo sapiens	IC50	uM	3.2
	13890162	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109200	=	IC50	nM	40.0	CHEMBL5464	Homo sapiens	IC50	uM	0.04
	13890163	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4F)cc3)cccc12		CHEMBL3109199	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	uM	10.0
	13890164	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109198	=	IC50	nM	320.0	CHEMBL5464	Homo sapiens	IC50	uM	0.32
	13890165	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cc(F)cc(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109197	=	IC50	nM	160.0	CHEMBL5464	Homo sapiens	IC50	uM	0.16
	13890166	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cccc12		CHEMBL3109196	=	IC50	nM	13.0	CHEMBL5464	Homo sapiens	IC50	uM	0.013
	13890473	CHEMBL3110730	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human N-terminal His-GST-TEV-fused RIP1 kinase domain (1 to 375) expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by fluorescent ligand addition measured after 15 mins by fluorescence polarization assay	B	Nc1nccc2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cccc12		CHEMBL3109195	=	IC50	nM	20.0	CHEMBL5464	Homo sapiens	IC50	uM	0.02
	13895007	CHEMBL3111939	Inhibition of RIPK1 (unknown origin) assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	O=C(Nc1ccc(CO)cc1)Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1		CHEMBL3109142	=	Activity	%	78.0	CHEMBL5464	Homo sapiens	Activity	%	78.0
	15756830	CHEMBL3631112	Inhibition of RIP (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	53.21	CHEMBL5464	Homo sapiens	INH	%	53.21
	15757893	CHEMBL3631112	Inhibition of RIP (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	54.38	CHEMBL5464	Homo sapiens	INH	%	54.38
	15758872	CHEMBL3631112	Inhibition of RIP (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	33.15	CHEMBL5464	Homo sapiens	INH	%	33.15
	16538084	CHEMBL3789110	Inhibition of human RIP1 at 10 uM	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc21		CHEMBL3785703	=	Inhibition	%	100.0	CHEMBL5464	Homo sapiens	INH	%	100.0
	16538085	CHEMBL3789111	Competitive inhibition of human RIP1 (1 to 375 residues) in presence of increasing ATP by ADP-Glo reagent based assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc21		CHEMBL3785703	=	Ki	nM	0.8	CHEMBL5464	Homo sapiens	Ki	nM	0.8
Not Active	16538086	CHEMBL3789112	Inhibition of human RIP1 in human HT-29 cells assessed as reduction in of TNF/SMAC-mimetic/zVAD.fmk induced RIP1 autophosphorylation at Ser166 at 10 times IC90 concentration pre-incubated for 1 hr measured after 2.5 hrs by ELISA	B	CN1C(=O)N[C@H](Cc2c[nH]c3c(Cl)cccc23)C1=O		CHEMBL370438		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	16538087	CHEMBL3789112	Inhibition of human RIP1 in human HT-29 cells assessed as reduction in of TNF/SMAC-mimetic/zVAD.fmk induced RIP1 autophosphorylation at Ser166 at 10 times IC90 concentration pre-incubated for 1 hr measured after 2.5 hrs by ELISA	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc21		CHEMBL3785703		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
	16538088	CHEMBL3789113	Binding affinity to Flag-tagged human RIP1 (1 to 324 residues) at 10 uM after 30 mins by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3cccc(C4(C(F)(F)F)N=N4)c3)[nH]n2)COc2ccccc21		CHEMBL3786660	=	IC50	nM	35.0	CHEMBL5464	Homo sapiens	IC50	nM	35.0
	16538089	CHEMBL3789113	Binding affinity to Flag-tagged human RIP1 (1 to 324 residues) at 10 uM after 30 mins by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)CCc2cc(C3(C(F)(F)F)N=N3)ccc21		CHEMBL3787617	=	IC50	nM	210.0	CHEMBL5464	Homo sapiens	IC50	nM	210.0
	16538090	CHEMBL3789114	Inhibition of Flag-tagged human RIP1 (1 to 324 residues) after 30 mins by ADP-Glo reagent based assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)[nH]n2)COc2ccccc21		CHEMBL3785482	=	IC50	nM	0.4	CHEMBL5464	Homo sapiens	IC50	nM	0.4
	16538091	CHEMBL3789114	Inhibition of Flag-tagged human RIP1 (1 to 324 residues) after 30 mins by ADP-Glo reagent based assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)CCc2ccccc21		CHEMBL3786997	=	IC50	nM	0.2	CHEMBL5464	Homo sapiens	IC50	nM	0.2
	16538109	CHEMBL3789354	Inhibition of human WT RIP1 infected in HEK293T cells assessed as reduction in S166 phosphorylation by ELISA	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc21		CHEMBL3785703	=	IC50	nM	2.8	CHEMBL5464	Homo sapiens	IC50	nM	2.8
	16538128	CHEMBL3789106	Inhibition of human RIP1 in human U937 cells assessed as inhibition of TNF/zVAD.fmk induced necroptosis after 24 hrs by Cell titer-Glo luminescence assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cccc4c(N)nccc34)cc2)no1		CHEMBL3109202	=	IC50	nM	500.0	CHEMBL5464	Homo sapiens	IC50	uM	0.5
	16538129	CHEMBL3789106	Inhibition of human RIP1 in human U937 cells assessed as inhibition of TNF/zVAD.fmk induced necroptosis after 24 hrs by Cell titer-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc21		CHEMBL3785703	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	16538130	CHEMBL3789106	Inhibition of human RIP1 in human U937 cells assessed as inhibition of TNF/zVAD.fmk induced necroptosis after 24 hrs by Cell titer-Glo luminescence assay	B	O=C(N[C@@H]1COc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3787216	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	16538131	CHEMBL3789106	Inhibition of human RIP1 in human U937 cells assessed as inhibition of TNF/zVAD.fmk induced necroptosis after 24 hrs by Cell titer-Glo luminescence assay	B	CCCCCc1cc(C(=O)N[C@H]2COc3ccccc3NC2=O)n[nH]1		CHEMBL3786778	=	IC50	nM	1600.0	CHEMBL5464	Homo sapiens	IC50	nM	1600.0
	16538132	CHEMBL3789106	Inhibition of human RIP1 in human U937 cells assessed as inhibition of TNF/zVAD.fmk induced necroptosis after 24 hrs by Cell titer-Glo luminescence assay	B	O=C(N[C@H]1COc2ccccc2NC1=O)c1cccc(Oc2ccccc2)c1		CHEMBL3786162	=	IC50	nM	400.0	CHEMBL5464	Homo sapiens	IC50	nM	400.0
	16538133	CHEMBL3789106	Inhibition of human RIP1 in human U937 cells assessed as inhibition of TNF/zVAD.fmk induced necroptosis after 24 hrs by Cell titer-Glo luminescence assay	B	O=C(N[C@H]1COc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3786293	=	IC50	nM	200.0	CHEMBL5464	Homo sapiens	IC50	nM	200.0
	16538134	CHEMBL3789106	Inhibition of human RIP1 in human U937 cells assessed as inhibition of TNF/zVAD.fmk induced necroptosis after 24 hrs by Cell titer-Glo luminescence assay	B	CN1C(=O)N[C@H](Cc2c[nH]c3c(Cl)cccc23)C1=O		CHEMBL370438	=	IC50	nM	320.0	CHEMBL5464	Homo sapiens	IC50	nM	320.0
	16538135	CHEMBL3789105	Inhibition of human RIP1 (1 to 375 residues) after 4 hrs by ADP-Glo reagent based assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)CNc2ccccc21		CHEMBL3786078	=	IC50	nM	0.79	CHEMBL5464	Homo sapiens	IC50	nM	0.79
	16538136	CHEMBL3789105	Inhibition of human RIP1 (1 to 375 residues) after 4 hrs by ADP-Glo reagent based assay	B	O=C(N[C@H]1CNc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3787689	=	IC50	nM	3.2	CHEMBL5464	Homo sapiens	IC50	nM	3.2
	16538137	CHEMBL3789105	Inhibition of human RIP1 (1 to 375 residues) after 4 hrs by ADP-Glo reagent based assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)CSc2ccccc21		CHEMBL3785745	=	IC50	nM	0.94	CHEMBL5464	Homo sapiens	IC50	nM	0.94
	16538138	CHEMBL3789105	Inhibition of human RIP1 (1 to 375 residues) after 4 hrs by ADP-Glo reagent based assay	B	O=C(N[C@H]1CS(=O)(=O)c2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3785838	=	IC50	nM	79.0	CHEMBL5464	Homo sapiens	IC50	nM	79.0
	16538139	CHEMBL3789105	Inhibition of human RIP1 (1 to 375 residues) after 4 hrs by ADP-Glo reagent based assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc21		CHEMBL3785703	=	IC50	nM	1.6	CHEMBL5464	Homo sapiens	IC50	nM	1.6
	16538140	CHEMBL3789105	Inhibition of human RIP1 (1 to 375 residues) after 4 hrs by ADP-Glo reagent based assay	B	O=C(N[C@H]1COc2ccccc2NC1=O)c1cccc(Oc2ccccc2)c1		CHEMBL3786162	=	IC50	nM	7.9	CHEMBL5464	Homo sapiens	IC50	nM	7.9
	16538141	CHEMBL3789105	Inhibition of human RIP1 (1 to 375 residues) after 4 hrs by ADP-Glo reagent based assay	B	O=C(N[C@H]1COc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3786293	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	nM	16.0
	16538142	CHEMBL3789105	Inhibition of human RIP1 (1 to 375 residues) after 4 hrs by ADP-Glo reagent based assay	B	CN1C(=O)N[C@H](Cc2c[nH]c3c(Cl)cccc23)C1=O		CHEMBL370438	=	IC50	nM	200.0	CHEMBL5464	Homo sapiens	IC50	nM	200.0
	16538143	CHEMBL3789104	Binding affinity to human RIP1 (1 to 375 residues) preincubated for 10 mins measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cccc4c(N)nccc34)cc2)no1		CHEMBL3109202	=	IC50	nM	25.0	CHEMBL5464	Homo sapiens	IC50	uM	0.025
	16538144	CHEMBL3789104	Binding affinity to human RIP1 (1 to 375 residues) preincubated for 10 mins measured after 20 mins by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc21		CHEMBL3785703	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	16538145	CHEMBL3789104	Binding affinity to human RIP1 (1 to 375 residues) preincubated for 10 mins measured after 20 mins by fluorescence polarization assay	B	O=C(N[C@@H]1COc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3787216	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	16538146	CHEMBL3789104	Binding affinity to human RIP1 (1 to 375 residues) preincubated for 10 mins measured after 20 mins by fluorescence polarization assay	B	CCCCCc1cc(C(=O)N[C@H]2COc3ccccc3NC2=O)n[nH]1		CHEMBL3786778	=	IC50	nM	320.0	CHEMBL5464	Homo sapiens	IC50	nM	320.0
	16538147	CHEMBL3789104	Binding affinity to human RIP1 (1 to 375 residues) preincubated for 10 mins measured after 20 mins by fluorescence polarization assay	B	O=C(N[C@H]1COc2ccccc2NC1=O)c1cccc(Oc2ccccc2)c1		CHEMBL3786162	=	IC50	nM	40.0	CHEMBL5464	Homo sapiens	IC50	nM	40.0
	16538148	CHEMBL3789104	Binding affinity to human RIP1 (1 to 375 residues) preincubated for 10 mins measured after 20 mins by fluorescence polarization assay	B	O=C(N[C@H]1COc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3786293	=	IC50	nM	32.0	CHEMBL5464	Homo sapiens	IC50	nM	32.0
	16538149	CHEMBL3789104	Binding affinity to human RIP1 (1 to 375 residues) preincubated for 10 mins measured after 20 mins by fluorescence polarization assay	B	CN1C(=O)N[C@H](Cc2c[nH]c3c(Cl)cccc23)C1=O		CHEMBL370438	=	IC50	nM	630.0	CHEMBL5464	Homo sapiens	IC50	nM	630.0
	16538154	CHEMBL3791406	Binding affinity to human RIP1 (1 to 375 residues) assessed as half life preincubated for 10 mins measured after 20 mins by fluorescence polarization assay	B	CN1C(=O)N[C@H](Cc2c[nH]c3c(Cl)cccc23)C1=O		CHEMBL370438	<	T1/2	hr	0.08333	CHEMBL5464	Homo sapiens	t1/2	min	5.0
	16538155	CHEMBL3791406	Binding affinity to human RIP1 (1 to 375 residues) assessed as half life preincubated for 10 mins measured after 20 mins by fluorescence polarization assay	B	O=C(N[C@H]1COc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3786293	<	T1/2	hr	0.08333	CHEMBL5464	Homo sapiens	t1/2	min	5.0
	16538156	CHEMBL3791406	Binding affinity to human RIP1 (1 to 375 residues) assessed as half life preincubated for 10 mins measured after 20 mins by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc21		CHEMBL3785703	=	T1/2	hr	1.067	CHEMBL5464	Homo sapiens	t1/2	min	64.0
	16538157	CHEMBL3791406	Binding affinity to human RIP1 (1 to 375 residues) assessed as half life preincubated for 10 mins measured after 20 mins by fluorescence polarization assay	B	O=C(N[C@H]1CS(=O)(=O)c2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3785838	<	T1/2	hr	0.08333	CHEMBL5464	Homo sapiens	t1/2	min	5.0
	16538158	CHEMBL3791406	Binding affinity to human RIP1 (1 to 375 residues) assessed as half life preincubated for 10 mins measured after 20 mins by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)CSc2ccccc21		CHEMBL3785745	=	T1/2	hr	0.5	CHEMBL5464	Homo sapiens	t1/2	min	30.0
	16538159	CHEMBL3791406	Binding affinity to human RIP1 (1 to 375 residues) assessed as half life preincubated for 10 mins measured after 20 mins by fluorescence polarization assay	B	O=C(N[C@H]1CNc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3787689	=	T1/2	hr	0.5	CHEMBL5464	Homo sapiens	t1/2	min	30.0
	16538160	CHEMBL3791406	Binding affinity to human RIP1 (1 to 375 residues) assessed as half life preincubated for 10 mins measured after 20 mins by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)CNc2ccccc21		CHEMBL3786078	>	T1/2	hr	0.8333	CHEMBL5464	Homo sapiens	t1/2	min	50.0
	16538161	CHEMBL3791407	Binding affinity to human RIP1 (1 to 375 residues) by stopped flow kinetic study	B	CN1C(=O)N[C@H](Cc2c[nH]c3c(Cl)cccc23)C1=O	Non standard unit for type	CHEMBL370438	=	K	/uM/s	1.1	CHEMBL5464	Homo sapiens	K	/uM/s	1.1
	16538162	CHEMBL3791407	Binding affinity to human RIP1 (1 to 375 residues) by stopped flow kinetic study	B	O=C(N[C@H]1COc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1	Non standard unit for type	CHEMBL3786293	=	K	/uM/s	1.1	CHEMBL5464	Homo sapiens	K	/uM/s	1.1
	16538163	CHEMBL3791407	Binding affinity to human RIP1 (1 to 375 residues) by stopped flow kinetic study	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc21	Non standard unit for type	CHEMBL3785703	=	K	/uM/s	0.66	CHEMBL5464	Homo sapiens	K	/uM/s	0.66
	16538164	CHEMBL3791407	Binding affinity to human RIP1 (1 to 375 residues) by stopped flow kinetic study	B	O=C(N[C@H]1CS(=O)(=O)c2ccccc2NC1=O)c1cc(Cc2ccccc2)on1	Non standard unit for type	CHEMBL3785838	=	K	/uM/s	0.41	CHEMBL5464	Homo sapiens	K	/uM/s	0.41
	16538165	CHEMBL3791407	Binding affinity to human RIP1 (1 to 375 residues) by stopped flow kinetic study	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)CSc2ccccc21	Non standard unit for type	CHEMBL3785745	=	K	/uM/s	1.0	CHEMBL5464	Homo sapiens	K	/uM/s	1.0
	16538166	CHEMBL3791407	Binding affinity to human RIP1 (1 to 375 residues) by stopped flow kinetic study	B	O=C(N[C@H]1CNc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1	Non standard unit for type	CHEMBL3787689	=	K	/uM/s	0.78	CHEMBL5464	Homo sapiens	K	/uM/s	0.78
	16538167	CHEMBL3791407	Binding affinity to human RIP1 (1 to 375 residues) by stopped flow kinetic study	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)CNc2ccccc21	Non standard unit for type	CHEMBL3786078	=	K	/uM/s	0.35	CHEMBL5464	Homo sapiens	K	/uM/s	0.35
Active	16538168	CHEMBL3791408	Binding affinity to Flag-tagged human RIP1 (1 to 324 residues) assessed as photo-labeling of Ser161 residue after photoactivation by enzymatic digestion based MS/MS method	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3cccc(C4(C(F)(F)F)N=N4)c3)[nH]n2)COc2ccccc21		CHEMBL3786660		Activity			CHEMBL5464	Homo sapiens	Activity		
Active	16538169	CHEMBL3791409	Binding affinity to Flag-tagged human RIP1 (1 to 324 residues) assessed as photo-labeling of Phe28 residue after photoactivation by enzymatic digestion based MS/MS method	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)CCc2cc(C3(C(F)(F)F)N=N3)ccc21		CHEMBL3787617		Activity			CHEMBL5464	Homo sapiens	Activity		
	16578322	CHEMBL3804376	Inhibition of partial length wild type human RIPK2 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	40.0	CHEMBL5464	Homo sapiens	Activity	%	40.0
	16844193	CHEMBL3877216	Inhibition of recombinant human GST-fused RIPK1 (1 to 497 residues) expressed in baculovirus infected insect Sf9 cells in presence of 32P-gamma-ATP after 30 mins by autoradiogram-based Western blot method	B	CN1C(=O)C(Cc2c[nH]c3ccccc23)NC1=S		CHEMBL195008	=	IC50	nM	182.0	CHEMBL5464	Homo sapiens	IC50	nM	182.0
	17953082	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(O)Cc1cc(F)cc(F)c1F		CHEMBL4061192	=	EC50	nM	74.0	CHEMBL5464	Homo sapiens	EC50	nM	74.0
	17953083	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(O)Cc1cc(F)c(F)c(F)c1		CHEMBL4083065	=	EC50	nM	49.0	CHEMBL5464	Homo sapiens	EC50	nM	49.0
	17953084	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(O)Cc1ccc(F)c(F)c1F		CHEMBL4099502	=	EC50	nM	262.0	CHEMBL5464	Homo sapiens	EC50	nM	262.0
	17953085	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(O)Cc1ccc(F)c(F)c1		CHEMBL4072591	=	EC50	nM	56.0	CHEMBL5464	Homo sapiens	EC50	nM	56.0
	17953086	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(O)Cc1ccc(F)cc1F		CHEMBL4091760	=	EC50	nM	198.0	CHEMBL5464	Homo sapiens	EC50	nM	198.0
	17953087	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(O)Cc1ccc(F)cc1		CHEMBL4063996	=	EC50	nM	64.0	CHEMBL5464	Homo sapiens	EC50	nM	64.0
	17953088	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(O)Cc1ccccc1		CHEMBL4092421	=	EC50	nM	28.0	CHEMBL5464	Homo sapiens	EC50	nM	28.0
	17953089	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)C(C)(C)c1ccccc1		CHEMBL4071625	>	EC50	nM	10000.0	CHEMBL5464	Homo sapiens	EC50	nM	10000.0
	17953090	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)NC1(c2ccccc2)CC1		CHEMBL4095808	>	EC50	nM	5000.0	CHEMBL5464	Homo sapiens	EC50	nM	5000.0
	17953091	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)C(CO)c1ccccc1		CHEMBL4077776	>	EC50	nM	10000.0	CHEMBL5464	Homo sapiens	EC50	nM	10000.0
	17953092	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)NC(C)(C)c1ccccc1		CHEMBL4088080	>	EC50	nM	10000.0	CHEMBL5464	Homo sapiens	EC50	nM	10000.0
	17953093	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)NC(CO)c1ccccc1		CHEMBL4066793	=	EC50	nM	1077.0	CHEMBL5464	Homo sapiens	EC50	nM	1077.0
	17953094	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)C(C)c1ccccc1		CHEMBL4065759	>	EC50	nM	10000.0	CHEMBL5464	Homo sapiens	EC50	nM	10000.0
	17953095	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)NC(C)c1ccccc1		CHEMBL4093372	>	EC50	nM	10000.0	CHEMBL5464	Homo sapiens	EC50	nM	10000.0
	17953096	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CC1CCCC(C)N1C(=O)N(C)Cc1cc(F)cc(F)c1F		CHEMBL4103563	=	EC50	nM	1526.0	CHEMBL5464	Homo sapiens	EC50	nM	1526.0
	17953097	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CC1CCCCN1C(=O)N(C)Cc1cc(F)cc(F)c1F		CHEMBL4085631	>	EC50	nM	3000.0	CHEMBL5464	Homo sapiens	EC50	nM	3000.0
	17953098	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CC(C)N(C(=O)N(C)Cc1cc(F)cc(F)c1F)C(C)C		CHEMBL4096996	>	EC50	nM	3000.0	CHEMBL5464	Homo sapiens	EC50	nM	3000.0
	17953099	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CC(C)N(C)C(=O)N(C)Cc1cc(F)cc(F)c1F		CHEMBL4069797	>	EC50	nM	3000.0	CHEMBL5464	Homo sapiens	EC50	nM	3000.0
	17953100	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN(Cc1cc(F)cc(F)c1F)C(=O)C1(C)CCCCC1		CHEMBL4084908	=	EC50	nM	490.0	CHEMBL5464	Homo sapiens	EC50	nM	490.0
	17953101	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN(Cc1cc(F)cc(F)c1F)C(=O)C1(C(F)(F)F)CCCC1		CHEMBL4102856	=	EC50	nM	1234.0	CHEMBL5464	Homo sapiens	EC50	nM	1234.0
	17953102	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN(Cc1cc(F)cc(F)c1F)C(=O)C1(C(F)(F)F)CCC1		CHEMBL4092663	=	EC50	nM	656.0	CHEMBL5464	Homo sapiens	EC50	nM	656.0
	17953103	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN(Cc1cc(F)cc(F)c1F)C(=O)C1CCC1		CHEMBL4064968	=	EC50	nM	8237.0	CHEMBL5464	Homo sapiens	EC50	nM	8237.0
	17953104	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN(Cc1cc(F)cc(F)c1F)C(=O)C1(C)CC1		CHEMBL4100395	>	EC50	nM	10000.0	CHEMBL5464	Homo sapiens	EC50	nM	10000.0
	17953105	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN(Cc1cc(F)cc(F)c1F)C(=O)C(C)(C)CO		CHEMBL4073564	>	EC50	nM	3000.0	CHEMBL5464	Homo sapiens	EC50	nM	3000.0
	17953106	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	COC(C)(C)C(=O)N(C)Cc1cc(F)cc(F)c1F		CHEMBL4062217	>	EC50	nM	10000.0	CHEMBL5464	Homo sapiens	EC50	nM	10000.0
	17953107	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN(Cc1cc(F)cc(F)c1F)C(=O)C(C)(C)C		CHEMBL4083937	=	EC50	nM	98.0	CHEMBL5464	Homo sapiens	EC50	nM	98.0
	17953108	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1ccn(C)n1		CHEMBL4092903	>	EC50	nM	10000.0	CHEMBL5464	Homo sapiens	EC50	nM	10000.0
	17953109	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1cnc(C)s1		CHEMBL4067499	>	EC50	nM	10000.0	CHEMBL5464	Homo sapiens	EC50	nM	10000.0
	17953110	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1ccco1		CHEMBL4076266	=	EC50	nM	628.0	CHEMBL5464	Homo sapiens	EC50	nM	628.0
	17953111	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1cc(C)c(C)s1		CHEMBL4073983	=	EC50	nM	1308.0	CHEMBL5464	Homo sapiens	EC50	nM	1308.0
	17953112	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1ccc(C)s1		CHEMBL4068805	=	EC50	nM	378.0	CHEMBL5464	Homo sapiens	EC50	nM	378.0
	17953113	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1sccc1C		CHEMBL4095053	=	EC50	nM	2527.0	CHEMBL5464	Homo sapiens	EC50	nM	2527.0
	17953114	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1cccs1		CHEMBL4096270	=	EC50	nM	221.0	CHEMBL5464	Homo sapiens	EC50	nM	221.0
	17953115	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1ccncc1F		CHEMBL4078215	>	EC50	nM	10000.0	CHEMBL5464	Homo sapiens	EC50	nM	10000.0
	17953116	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1cccnc1		CHEMBL4095647	=	EC50	nM	1735.0	CHEMBL5464	Homo sapiens	EC50	nM	1735.0
	17953117	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1ccncc1		CHEMBL4086110	>	EC50	nM	10000.0	CHEMBL5464	Homo sapiens	EC50	nM	10000.0
	17953118	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1c(F)cc(F)cc1F		CHEMBL4063537	=	EC50	nM	1254.0	CHEMBL5464	Homo sapiens	EC50	nM	1254.0
	17953119	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1cc(F)cc(F)c1F		CHEMBL4085167	=	EC50	nM	12.0	CHEMBL5464	Homo sapiens	EC50	nM	12.0
	17953120	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1cc(F)ccc1F		CHEMBL4076443	=	EC50	nM	36.0	CHEMBL5464	Homo sapiens	EC50	nM	36.0
	17953121	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1ccc(F)cc1F		CHEMBL4087013	=	EC50	nM	627.0	CHEMBL5464	Homo sapiens	EC50	nM	627.0
	17953122	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1cccc(F)c1F		CHEMBL4101314	=	EC50	nM	58.0	CHEMBL5464	Homo sapiens	EC50	nM	58.0
	17953123	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1ccc(F)cc1		CHEMBL4080685	=	EC50	nM	815.0	CHEMBL5464	Homo sapiens	EC50	nM	815.0
	17953124	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1cccc(O)c1		CHEMBL4086116	>	EC50	nM	3000.0	CHEMBL5464	Homo sapiens	EC50	nM	3000.0
	17953125	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1cccc(Br)c1		CHEMBL4104038	=	EC50	nM	1233.0	CHEMBL5464	Homo sapiens	EC50	nM	1233.0
	17953126	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1cccc(Cl)c1		CHEMBL4078224	=	EC50	nM	628.0	CHEMBL5464	Homo sapiens	EC50	nM	628.0
	17953127	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1cccc(F)c1		CHEMBL4096278	=	EC50	nM	72.0	CHEMBL5464	Homo sapiens	EC50	nM	72.0
	17953128	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1ccccc1Cl		CHEMBL4073019	>	EC50	nM	10000.0	CHEMBL5464	Homo sapiens	EC50	nM	10000.0
	17953129	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCN(Cc1ccccc1F)C(=O)C(C)(C)CC		CHEMBL4073022	>	EC50	nM	10000.0	CHEMBL5464	Homo sapiens	EC50	nM	10000.0
	17953130	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1ccccc1F		CHEMBL4059584	=	EC50	nM	125.0	CHEMBL5464	Homo sapiens	EC50	nM	125.0
	17953131	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)N(C)Cc1ccccc1		CHEMBL4082828	=	EC50	nM	457.0	CHEMBL5464	Homo sapiens	EC50	nM	457.0
	17953132	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)NCc1cccc(Br)c1		CHEMBL4098042	>	EC50	nM	10000.0	CHEMBL5464	Homo sapiens	EC50	nM	10000.0
	17953133	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)NCc1ccccc1Br		CHEMBL4080015	=	EC50	nM	8562.0	CHEMBL5464	Homo sapiens	EC50	nM	8562.0
	17953134	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)NCc1ccccc1F		CHEMBL4090332	=	EC50	nM	898.0	CHEMBL5464	Homo sapiens	EC50	nM	898.0
	17953135	CHEMBL3993115	Inhibition of RIP1 in human HT-29 cells assessed as reduction in TNFalpha/z-VAD-FMK-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCC(C)(C)C(=O)NCc1ccccc1		CHEMBL4069288	=	EC50	nM	4100.0	CHEMBL5464	Homo sapiens	EC50	uM	4.1
Active	17953141	CHEMBL3993122	Inhibition of TNFalpha/z-VAD-FMK-induced RIP1 phosphorylation in human HT-29 cells by Western blot method	B	CCC(C)(C)C(=O)N(O)Cc1ccccc1		CHEMBL4092421		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
	17953143	CHEMBL3993114	Inhibition of RIP1 (unknown origin) using MBP as substrate preincubated for 15 mins followed by MBP/ATP mixture addition measured after 90 mins by ADP-Glo kinase assay	B	CCC(C)(C)C(=O)N(O)Cc1ccccc1		CHEMBL4092421	=	IC50	nM	13.0	CHEMBL5464	Homo sapiens	IC50	nM	13.0
	17953144	CHEMBL3993113	Inhibition of recombinant GST-tagged RIP1 (unknown origin) after 4 hrs by ADP-Glo kinase assay	B	CN1C(=O)C(Cc2c[nH]c3ccccc23)NC1=S		CHEMBL195008	=	IC50	nM	760.0	CHEMBL5464	Homo sapiens	IC50	nM	760.0
	17953145	CHEMBL3993112	Potency index, ratio of Nec-1 IC50 to compound IC50 for RIP1 (unknown origin)	B	CCC(C)(C)C(=O)N(O)Cc1ccccc1		CHEMBL4092421	=	Ratio IC50		57.0	CHEMBL5464	Homo sapiens	Ratio IC50		57.0
Not Active	17953146	CHEMBL3993111	Inhibition of RIP1 (unknown origin) at 2 uM using MBP as substrate preincubated for 15 mins followed by MBP/ATP mixture addition measured after 90 mins by ADP-Glo kinase assay	B	CCC(C)(C)C(=O)N(O)Cc1ccccc1		CHEMBL4092421		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
	17964948	CHEMBL3995058	Inhibition of human RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	52.0	CHEMBL5464	Homo sapiens	Activity	%	52.0
Not Active	17986119	CHEMBL3999328	Inhibition of RIP1 in human intestine mucosal explants derived from inflammatory bowel disease patient assessed as reduction in IL6 production at 300 nM after 24 hrs by sandwich ELISA	B	CN1C(=O)[C@H](NC(=O)c2nnc(Cc3ccccc3)[nH]2)COc2ccccc21		CHEMBL4090420		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Not Active	17986120	CHEMBL3999327	Inhibition of RIP1 in human intestine mucosal explants derived from inflammatory bowel disease patient assessed as reduction in IL1beta production at 300 nM after 24 hrs by sandwich ELISA	B	CN1C(=O)[C@H](NC(=O)c2nnc(Cc3ccccc3)[nH]2)COc2ccccc21		CHEMBL4090420		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
	17986121	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(CN3CCCCC3)on2)COc2ccccc21		CHEMBL4091956	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986122	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(CC3CCCCC3)on2)COc2ccccc21		CHEMBL4071135	=	IC50	nM	501.0	CHEMBL5464	Homo sapiens	IC50	nM	501.0
	17986123	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CC(C)Cc1cc(C(=O)N[C@H]2COc3ccccc3N(C)C2=O)no1		CHEMBL4084200	=	IC50	nM	6310.0	CHEMBL5464	Homo sapiens	IC50	nM	6310.0
	17986124	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCCCCc1cc(C(=O)N[C@H]2COc3ccccc3N(C)C2=O)no1		CHEMBL4062496	=	IC50	nM	126.0	CHEMBL5464	Homo sapiens	IC50	nM	126.0
	17986125	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(CN3CCCCC3)on2)COc2ccccc21		CHEMBL4091956	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986126	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(CC3CCCCC3)on2)COc2ccccc21		CHEMBL4071135	=	IC50	nM	251.0	CHEMBL5464	Homo sapiens	IC50	nM	251.0
	17986127	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	CC(C)Cc1cc(C(=O)N[C@H]2COc3ccccc3N(C)C2=O)no1		CHEMBL4084200	=	IC50	nM	1600.0	CHEMBL5464	Homo sapiens	IC50	nM	1600.0
	17986128	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	CCCCCc1cc(C(=O)N[C@H]2COc3ccccc3N(C)C2=O)no1		CHEMBL4062496	=	IC50	nM	100.0	CHEMBL5464	Homo sapiens	IC50	nM	100.0
	17986129	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	Cc1cc(C(=O)N[C@H]2COc3ccccc3N(C)C2=O)no1		CHEMBL4061414	=	IC50	nM	12600.0	CHEMBL5464	Homo sapiens	IC50	nM	12600.0
	17986130	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CC(=O)Nc1ccc2c(c1)N(C)C(=O)[C@@H](NC(=O)c1cc(Cc3ccccc3)on1)CO2		CHEMBL4068954	=	IC50	nM	0.32	CHEMBL5464	Homo sapiens	IC50	nM	0.32
	17986131	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C[C@H](NC(=O)c2cc(Cc3ccccc3)on2)C(=O)N(C)c2ccccc21		CHEMBL4069959	=	IC50	nM	5.0	CHEMBL5464	Homo sapiens	IC50	nM	5.0
	17986132	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)CNc2ccccc21		CHEMBL3786078	=	IC50	nM	0.79	CHEMBL5464	Homo sapiens	IC50	nM	0.79
	17986133	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)CCc2ccccc21		CHEMBL3786997	=	IC50	nM	0.2	CHEMBL5464	Homo sapiens	IC50	nM	0.2
	17986134	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)CSc2ccccc21		CHEMBL3785745	=	IC50	nM	0.063	CHEMBL5464	Homo sapiens	IC50	nM	0.063
	17986135	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	O=C(N[C@H]1COc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3786293	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	nM	16.0
	17986136	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4071864	=	IC50	nM	1.0	CHEMBL5464	Homo sapiens	IC50	nM	1.0
	17986137	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2cccc(Cc3ccccc3)c2)COc2ccccc21		CHEMBL4098139	=	IC50	nM	251.0	CHEMBL5464	Homo sapiens	IC50	nM	251.0
	17986138	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	COC(=O)Nc1ccc2c(c1)N(C)C(=O)[C@@H](NC(=O)c1cc(Cc3ccccc3)on1)CO2		CHEMBL4096224	=	IC50	nM	0.32	CHEMBL5464	Homo sapiens	IC50	nM	0.32
	17986139	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccc(NS(C)(=O)=O)cc21		CHEMBL4081685	=	IC50	nM	0.63	CHEMBL5464	Homo sapiens	IC50	nM	0.63
	17986140	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccc(-c3cc[nH]n3)cc21		CHEMBL4099698	=	IC50	nM	1.0	CHEMBL5464	Homo sapiens	IC50	nM	1.0
	17986141	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccc(-c3n[nH]c(=O)o3)cc21		CHEMBL4089558	=	IC50	nM	0.5	CHEMBL5464	Homo sapiens	IC50	nM	0.5
	17986142	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2ncc(Cc3ccccc3)o2)COc2ccccc21		CHEMBL4067372	=	IC50	nM	0.05	CHEMBL5464	Homo sapiens	IC50	nM	0.05
	17986143	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2cn(Cc3ccccc3)cn2)COc2ccccc21		CHEMBL4069318	=	IC50	nM	0.4	CHEMBL5464	Homo sapiens	IC50	nM	0.4
	17986144	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)n(C)n2)COc2ccccc21		CHEMBL4060644	=	IC50	nM	0.4	CHEMBL5464	Homo sapiens	IC50	nM	0.4
	17986145	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2nnc(Cc3ccccc3)o2)COc2ccccc21		CHEMBL4088857	=	IC50	nM	0.79	CHEMBL5464	Homo sapiens	IC50	nM	0.79
	17986146	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2noc(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4099004	=	IC50	nM	0.5	CHEMBL5464	Homo sapiens	IC50	nM	0.5
	17986147	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2cn(Cc3ccccc3)nn2)COc2ccccc21		CHEMBL4080978	=	IC50	nM	1.0	CHEMBL5464	Homo sapiens	IC50	nM	1.0
	17986148	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2cnn(Cc3ccccc3)c2)COc2ccccc21		CHEMBL4096551	=	IC50	nM	63.0	CHEMBL5464	Homo sapiens	IC50	nM	63.0
	17986149	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2c[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4104281	=	IC50	nM	1259.0	CHEMBL5464	Homo sapiens	IC50	nM	1259.0
	17986150	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2coc(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4080047	=	IC50	nM	794.0	CHEMBL5464	Homo sapiens	IC50	nM	794.0
	17986151	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2ncc(Cc3ccccc3)s2)COc2ccccc21		CHEMBL4088627	=	IC50	nM	631.0	CHEMBL5464	Homo sapiens	IC50	nM	631.0
	17986152	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	O=C(N[C@H]1CO[C@@H]2CCCC[C@H]2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL4088502	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986153	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	O=C(N[C@H]1COCCNC1=O)c1cc(Cc2ccccc2)on1		CHEMBL4060280	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986154	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	O=C(NC1Cc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL4080634	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986155	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	O=C(N[C@H]1CCOc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL4098676	=	IC50	nM	200.0	CHEMBL5464	Homo sapiens	IC50	nM	200.0
	17986156	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	O=C(N[C@@H]1CNc2ccccc2OC1)c1cc(Cc2ccccc2)on1		CHEMBL4065985	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986157	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	CN(C(=O)c1cc(Cc2ccccc2)on1)[C@H]1COc2ccccc2NC1=O		CHEMBL4093587	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986158	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	C[C@]1(NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc2NC1=O		CHEMBL4074616	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986159	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	O=C(N[C@@H]1COc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3787216	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986160	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	O=C(N[C@H]1COc2ccccc2N(C2CC2)C1=O)c1cc(Cc2ccccc2)on1		CHEMBL4084884	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986161	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	CCN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc21		CHEMBL4063232	=	IC50	nM	3162.0	CHEMBL5464	Homo sapiens	IC50	nM	3162.0
	17986162	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	O=C(N[C@H]1COc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3786293	=	IC50	nM	32.0	CHEMBL5464	Homo sapiens	IC50	nM	32.0
	17986163	CHEMBL3999295	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells measured for 50 mins by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4071864	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	uM	0.016
	17986164	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2ncn(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4065561	=	IC50	nM	0.63	CHEMBL5464	Homo sapiens	IC50	nM	0.63
	17986165	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2nnn(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4093220	=	IC50	nM	0.079	CHEMBL5464	Homo sapiens	IC50	nM	0.079
	17986166	CHEMBL3999296	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated for 1 hr followed by ATP addition measured after 5 hrs by ADP-Glo luminescence assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)ccn2)COc2ccccc21		CHEMBL4071080	=	IC50	nM	2.0	CHEMBL5464	Homo sapiens	IC50	nM	2.0
	17986167	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4071864	=	IC50	nM	6.3	CHEMBL5464	Homo sapiens	IC50	uM	0.0063
	17986168	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	O=C(N[C@H]1COc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3786293	=	IC50	nM	200.0	CHEMBL5464	Homo sapiens	IC50	nM	200.0
	17986169	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CCN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc21		CHEMBL4063232	=	IC50	nM	7943.0	CHEMBL5464	Homo sapiens	IC50	nM	7943.0
	17986170	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	O=C(N[C@H]1COc2ccccc2N(C2CC2)C1=O)c1cc(Cc2ccccc2)on1		CHEMBL4084884	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986171	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	O=C(N[C@@H]1COc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3787216	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986172	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	C[C@]1(NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc2NC1=O		CHEMBL4074616	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986173	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN(C(=O)c1cc(Cc2ccccc2)on1)[C@H]1COc2ccccc2NC1=O		CHEMBL4093587	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986174	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	O=C(N[C@@H]1CNc2ccccc2OC1)c1cc(Cc2ccccc2)on1		CHEMBL4065985	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986175	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)CSc2ccccc21		CHEMBL3785745	=	IC50	nM	2.0	CHEMBL5464	Homo sapiens	IC50	nM	2.0
	17986176	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)CCc2ccccc21		CHEMBL3786997	=	IC50	nM	6.3	CHEMBL5464	Homo sapiens	IC50	nM	6.3
	17986177	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)CNc2ccccc21		CHEMBL3786078	=	IC50	nM	40.0	CHEMBL5464	Homo sapiens	IC50	nM	40.0
	17986178	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C[C@H](NC(=O)c2cc(Cc3ccccc3)on2)C(=O)N(C)c2ccccc21		CHEMBL4069959	=	IC50	nM	20.0	CHEMBL5464	Homo sapiens	IC50	nM	20.0
	17986179	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	O=C(N[C@H]1CCOc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL4098676	=	IC50	nM	631.0	CHEMBL5464	Homo sapiens	IC50	nM	631.0
	17986180	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	O=C(NC1Cc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL4080634	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986181	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	O=C(N[C@H]1COCCNC1=O)c1cc(Cc2ccccc2)on1		CHEMBL4060280	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	17986182	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CC(=O)Nc1ccc2c(c1)N(C)C(=O)[C@@H](NC(=O)c1cc(Cc3ccccc3)on1)CO2		CHEMBL4068954	=	IC50	nM	7.9	CHEMBL5464	Homo sapiens	IC50	nM	7.9
	17986183	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	COC(=O)Nc1ccc2c(c1)N(C)C(=O)[C@@H](NC(=O)c1cc(Cc3ccccc3)on1)CO2		CHEMBL4096224	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	17986184	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccc(NS(C)(=O)=O)cc21		CHEMBL4081685	=	IC50	nM	13.0	CHEMBL5464	Homo sapiens	IC50	nM	13.0
	17986185	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccc(-c3cc[nH]n3)cc21		CHEMBL4099698	=	IC50	nM	6.3	CHEMBL5464	Homo sapiens	IC50	nM	6.3
	17986186	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccc(-c3n[nH]c(=O)o3)cc21		CHEMBL4089558	=	IC50	nM	3.2	CHEMBL5464	Homo sapiens	IC50	nM	3.2
	17986187	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2ncc(Cc3ccccc3)o2)COc2ccccc21		CHEMBL4067372	=	IC50	nM	1.0	CHEMBL5464	Homo sapiens	IC50	nM	1.0
	17986188	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2ncc(Cc3ccccc3)s2)COc2ccccc21		CHEMBL4088627	=	IC50	nM	794.0	CHEMBL5464	Homo sapiens	IC50	nM	794.0
	17986189	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2coc(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4080047	=	IC50	nM	2512.0	CHEMBL5464	Homo sapiens	IC50	nM	2512.0
	17986190	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2c[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4104281	=	IC50	nM	1995.0	CHEMBL5464	Homo sapiens	IC50	nM	1995.0
	17986191	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2cn(Cc3ccccc3)cn2)COc2ccccc21		CHEMBL4069318	=	IC50	nM	6.3	CHEMBL5464	Homo sapiens	IC50	nM	6.3
	17986192	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2cnn(Cc3ccccc3)c2)COc2ccccc21		CHEMBL4096551	=	IC50	nM	631.0	CHEMBL5464	Homo sapiens	IC50	nM	631.0
	17986193	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)n(C)n2)COc2ccccc21		CHEMBL4060644	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	17986194	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2nnc(Cc3ccccc3)o2)COc2ccccc21		CHEMBL4088857	=	IC50	nM	7.9	CHEMBL5464	Homo sapiens	IC50	nM	7.9
	17986195	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2noc(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4099004	=	IC50	nM	5.0	CHEMBL5464	Homo sapiens	IC50	nM	5.0
	17986196	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2cn(Cc3ccccc3)nn2)COc2ccccc21		CHEMBL4080978	=	IC50	nM	25.0	CHEMBL5464	Homo sapiens	IC50	nM	25.0
	17986197	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2ncn(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4065561	=	IC50	nM	1.6	CHEMBL5464	Homo sapiens	IC50	nM	1.6
	17986198	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2nnn(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4093220	=	IC50	nM	2.5	CHEMBL5464	Homo sapiens	IC50	nM	2.5
	17986199	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2cccc(Cc3ccccc3)c2)COc2ccccc21		CHEMBL4098139	=	IC50	nM	398.0	CHEMBL5464	Homo sapiens	IC50	nM	398.0
	17986200	CHEMBL3999297	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necrosis after 24 hrs by Cell Titer-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)ccn2)COc2ccccc21		CHEMBL4071080	=	IC50	nM	40.0	CHEMBL5464	Homo sapiens	IC50	nM	40.0
	17986249	CHEMBL3999303	Inhibition of RIP1 in human primary neutrophils assessed as reduction in TNFalpha/QCD-OPh/SMAC mimetic RMT 5265-induced necroptosis by measuring cellular ATP level at 21 hrs post-stimulation by CellTiter-Glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4071864	=	IC50	nM	1.6	CHEMBL5464	Homo sapiens	IC50	nM	1.6
	17986250	CHEMBL3999304	Inhibition of RIP1 in human primary neutrophils assessed as reduction in TNFalpha/QCD-OPh/SMAC mimetic RMT 5265-induced necroptosis at 21 hrs post-stimulation by LDH release assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4071864	=	IC50	nM	0.4	CHEMBL5464	Homo sapiens	IC50	nM	0.4
	17986251	CHEMBL3999305	Inhibition of RIP1 in human primary neutrophils assessed as reduction in TNFalpha/QCD-OPh/SMAC mimetic RMT 5265-MIP-1beta production at 21 hrs post-stimulation by sandwich ELISA	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4071864	=	IC50	nM	0.5	CHEMBL5464	Homo sapiens	IC50	nM	0.5
	17986252	CHEMBL3999306	Inhibition of RIP1 in human whole blood assessed as reduction in TNFalpha/QCD-OPh/zVAD FMK/SMAC mimetic RMT 5265-MIP-1beta production after 6 hrs by sandwich ELISA	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4071864	=	IC50	nM	2.0	CHEMBL5464	Homo sapiens	IC50	nM	2.0
Dose-dependent effect	17986254	CHEMBL3999308	Inhibition of RIP1 in human intestine mucosal explants derived from inflammatory bowel disease patient assessed as reduction in IL1beta production after 24 hrs by sandwich ELISA	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4071864		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Dose-dependent effect	17986255	CHEMBL3999309	Inhibition of RIP1 in human intestine mucosal explants derived from inflammatory bowel disease patient assessed as reduction in IL6 production after 24 hrs by sandwich ELISA	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4071864		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
	17986335	CHEMBL3999352	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells assessed as slow off rate constant measured for 50 mins by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21	Non standard unit for type	CHEMBL4071864	=	K	/hr	0.37	CHEMBL5464	Homo sapiens	K	/hr	0.37
	17986336	CHEMBL3999353	Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells assessed as on rate constant by stopped-flow tryptophan fluorescence assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21	Non standard unit for type	CHEMBL4071864	=	K	/uM/s	0.045	CHEMBL5464	Homo sapiens	K	/uM/s	0.045
	17986337	CHEMBL3999354	Displacement of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)-amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2'',3'']indolizino-[8'',7'':5',6']pyrano[3',2':3,4]pyrido[1,2-a]indol-5-ium-2-sulfonate from human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells assessed as dissociation half life by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4071864	=	T1/2	hr	1.867	CHEMBL5464	Homo sapiens	t1/2	min	112.0
	18111055	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	O=[N+]([O-])c1ccc2[nH]c(Cc3ccccc3)nc2c1		CHEMBL4077039	=	Ki	nM	63.1	CHEMBL5464	Homo sapiens	pKi		7.2
	18111056	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4071864	=	Ki	nM	0.9772	CHEMBL5464	Homo sapiens	pKi		9.01
	18111057	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3[nH]c(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4082291	=	Ki	nM	117.49	CHEMBL5464	Homo sapiens	pKi		6.93
	18111058	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCn3nc(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4100309	=	Ki	nM	54.95	CHEMBL5464	Homo sapiens	pKi		7.26
	18111059	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCn3cc(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4066941	=	Ki	nM	107.15	CHEMBL5464	Homo sapiens	pKi		6.97
	18111060	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216	=	Ki	nM	3.89	CHEMBL5464	Homo sapiens	pKi		8.41
	18111061	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3nn(Cc4ccccc4)cc3C2=O)COc2ccccc21		CHEMBL4063075	=	Ki	nM	251.19	CHEMBL5464	Homo sapiens	pKi		6.6
	18111062	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4F)nc3C2=O)COc2ccccc21		CHEMBL4090975	=	Ki	nM	1.738	CHEMBL5464	Homo sapiens	pKi		8.76
	18111063	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4cccc(F)c4)nc3C2=O)COc2ccccc21		CHEMBL4071690	=	Ki	nM	5.129	CHEMBL5464	Homo sapiens	pKi		8.29
	18111064	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccc(F)cc4)nc3C2=O)COc2ccccc21		CHEMBL4098708	=	Ki	nM	7.943	CHEMBL5464	Homo sapiens	pKi		8.1
	18111065	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4c(F)cccc4F)nc3C2=O)COc2ccccc21		CHEMBL4082215	=	Ki	nM	1.148	CHEMBL5464	Homo sapiens	pKi		8.94
	18111066	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCC4)nc3C2=O)COc2ccccc21		CHEMBL4060308	=	Ki	nM	13.8	CHEMBL5464	Homo sapiens	pKi		7.86
	18111067	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4cccnc4)nc3C2=O)COc2ccccc21		CHEMBL4090065	=	Ki	nM	33.88	CHEMBL5464	Homo sapiens	pKi		7.47
	18111068	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccn4)nc3C2=O)COc2ccccc21		CHEMBL4076592	=	Ki	nM	38.02	CHEMBL5464	Homo sapiens	pKi		7.42
	18111069	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778	=	Ki	nM	6918.31	CHEMBL5464	Homo sapiens	pKi		5.16
	18111070	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)C4)nc3C2=O)COc2ccccc21		CHEMBL4079755	=	Ki	nM	4265.8	CHEMBL5464	Homo sapiens	pKi		5.37
	18111071	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	Cc1c2c(nn1Cc1ccccc1)C(=O)N([C@H]1COc3ccccc3N(C)C1=O)CC2		CHEMBL4064701	=	Ki	nM	2.57	CHEMBL5464	Homo sapiens	pKi		8.59
	18111072	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Cl)C2=O)COc2ccccc21		CHEMBL4075976	=	Ki	nM	0.4074	CHEMBL5464	Homo sapiens	pKi		9.39
	18111073	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3C#N)C2=O)COc2ccccc21		CHEMBL4084681	=	Ki	nM	1.148	CHEMBL5464	Homo sapiens	pKi		8.94
	18111074	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3C(N)=O)C2=O)COc2ccccc21		CHEMBL4102622	=	Ki	nM	2.512	CHEMBL5464	Homo sapiens	pKi		8.6
	18111075	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Cl)C2=O)COc2ccc(C#N)cc21		CHEMBL4061975	=	Ki	nM	0.8511	CHEMBL5464	Homo sapiens	pKi		9.07
	18111076	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Cl)C2=O)COc2cc(C#N)ccc21		CHEMBL4100398	=	Ki	nM	0.912	CHEMBL5464	Homo sapiens	pKi		9.04
	18111077	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CNC(=O)c1ccc2c(c1)OC[C@H](N1CCc3c(nn(Cc4ccccc4)c3Cl)C1=O)C(=O)N2C		CHEMBL4069537	=	Ki	nM	0.912	CHEMBL5464	Homo sapiens	pKi		9.04
	18111078	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN(C)C(=O)c1ccc2c(c1)OC[C@H](N1CCc3c(nn(Cc4ccccc4)c3Cl)C1=O)C(=O)N2C		CHEMBL4073321	=	Ki	nM	3.467	CHEMBL5464	Homo sapiens	pKi		8.46
	18111079	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4F)nc3C2=O)COc2cc(C#N)ccc21		CHEMBL4085728	=	Ki	nM	2.951	CHEMBL5464	Homo sapiens	pKi		8.53
	18111080	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4c(F)cccc4F)nc3C2=O)COc2cc(C#N)ccc21		CHEMBL4075705	=	Ki	nM	1.778	CHEMBL5464	Homo sapiens	pKi		8.75
	18111081	CHEMBL4023993	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system by TR-FRET assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Ki	nM	2.042	CHEMBL5464	Homo sapiens	pKi		8.69
	18111094	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4071864	=	log K		6.79	CHEMBL5464	Homo sapiens	log K		6.79
Not Determined	18111095	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3[nH]c(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4082291		log K			CHEMBL5464	Homo sapiens	log K		
	18111096	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCn3nc(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4100309	=	log K		6.27	CHEMBL5464	Homo sapiens	log K		6.27
	18111097	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCn3cc(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4066941	=	log K		5.85	CHEMBL5464	Homo sapiens	log K		5.85
	18111098	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216	=	log K		6.48	CHEMBL5464	Homo sapiens	log K		6.48
Not Determined	18111099	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3nn(Cc4ccccc4)cc3C2=O)COc2ccccc21		CHEMBL4063075		log K			CHEMBL5464	Homo sapiens	log K		
	18111100	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4F)nc3C2=O)COc2ccccc21		CHEMBL4090975	=	log K		6.54	CHEMBL5464	Homo sapiens	log K		6.54
	18111101	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4cccc(F)c4)nc3C2=O)COc2ccccc21		CHEMBL4071690	=	log K		6.48	CHEMBL5464	Homo sapiens	log K		6.48
	18111102	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccc(F)cc4)nc3C2=O)COc2ccccc21		CHEMBL4098708	=	log K		6.65	CHEMBL5464	Homo sapiens	log K		6.65
	18111103	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4c(F)cccc4F)nc3C2=O)COc2ccccc21		CHEMBL4082215	=	log K		6.58	CHEMBL5464	Homo sapiens	log K		6.58
	18111104	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCC4)nc3C2=O)COc2ccccc21		CHEMBL4060308	=	log K		6.49	CHEMBL5464	Homo sapiens	log K		6.49
	18111105	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4cccnc4)nc3C2=O)COc2ccccc21		CHEMBL4090065	=	log K		5.9	CHEMBL5464	Homo sapiens	log K		5.9
	18111106	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccn4)nc3C2=O)COc2ccccc21		CHEMBL4076592	=	log K		5.98	CHEMBL5464	Homo sapiens	log K		5.98
Not Determined	18111107	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		log K			CHEMBL5464	Homo sapiens	log K		
Not Determined	18111108	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)C4)nc3C2=O)COc2ccccc21		CHEMBL4079755		log K			CHEMBL5464	Homo sapiens	log K		
	18111109	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	Cc1c2c(nn1Cc1ccccc1)C(=O)N([C@H]1COc3ccccc3N(C)C1=O)CC2		CHEMBL4064701	=	log K		6.3	CHEMBL5464	Homo sapiens	log K		6.3
	18111110	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Cl)C2=O)COc2ccccc21		CHEMBL4075976	=	log K		6.91	CHEMBL5464	Homo sapiens	log K		6.91
	18111111	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3C#N)C2=O)COc2ccccc21		CHEMBL4084681	=	log K		6.52	CHEMBL5464	Homo sapiens	log K		6.52
	18111112	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3C(N)=O)C2=O)COc2ccccc21		CHEMBL4102622	=	log K		6.27	CHEMBL5464	Homo sapiens	log K		6.27
	18111113	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Cl)C2=O)COc2ccc(C#N)cc21		CHEMBL4061975	=	log K		6.58	CHEMBL5464	Homo sapiens	log K		6.58
	18111114	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Cl)C2=O)COc2cc(C#N)ccc21		CHEMBL4100398	=	log K		6.55	CHEMBL5464	Homo sapiens	log K		6.55
	18111115	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CNC(=O)c1ccc2c(c1)OC[C@H](N1CCc3c(nn(Cc4ccccc4)c3Cl)C1=O)C(=O)N2C		CHEMBL4069537	=	log K		6.52	CHEMBL5464	Homo sapiens	log K		6.52
	18111116	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN(C)C(=O)c1ccc2c(c1)OC[C@H](N1CCc3c(nn(Cc4ccccc4)c3Cl)C1=O)C(=O)N2C		CHEMBL4073321	=	log K		6.13	CHEMBL5464	Homo sapiens	log K		6.13
	18111117	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4F)nc3C2=O)COc2cc(C#N)ccc21		CHEMBL4085728	=	log K		6.19	CHEMBL5464	Homo sapiens	log K		6.19
	18111118	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4c(F)cccc4F)nc3C2=O)COc2cc(C#N)ccc21		CHEMBL4075705	=	log K		6.29	CHEMBL5464	Homo sapiens	log K		6.29
	18111119	CHEMBL4023995	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as association rate constant by TR-FRET assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	log K		7.63	CHEMBL5464	Homo sapiens	log K		7.63
	18111120	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4071864	=	pK		2.22	CHEMBL5464	Homo sapiens	pK		2.22
Not Determined	18111121	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3[nH]c(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4082291		pK			CHEMBL5464	Homo sapiens	pK		
	18111122	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCn3nc(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4100309	=	pK		0.984	CHEMBL5464	Homo sapiens	pK		0.984
	18111123	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCn3cc(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4066941	=	pK		1.13	CHEMBL5464	Homo sapiens	pK		1.13
	18111124	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216	=	pK		1.93	CHEMBL5464	Homo sapiens	pK		1.93
Not Determined	18111125	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3nn(Cc4ccccc4)cc3C2=O)COc2ccccc21		CHEMBL4063075		pK			CHEMBL5464	Homo sapiens	pK		
	18111126	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4F)nc3C2=O)COc2ccccc21		CHEMBL4090975	=	pK		2.21	CHEMBL5464	Homo sapiens	pK		2.21
	18111127	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4cccc(F)c4)nc3C2=O)COc2ccccc21		CHEMBL4071690	=	pK		1.82	CHEMBL5464	Homo sapiens	pK		1.82
	18111128	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccc(F)cc4)nc3C2=O)COc2ccccc21		CHEMBL4098708	=	pK		1.45	CHEMBL5464	Homo sapiens	pK		1.45
	18111129	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4c(F)cccc4F)nc3C2=O)COc2ccccc21		CHEMBL4082215	=	pK		2.36	CHEMBL5464	Homo sapiens	pK		2.36
	18111130	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCC4)nc3C2=O)COc2ccccc21		CHEMBL4060308	=	pK		1.37	CHEMBL5464	Homo sapiens	pK		1.37
	18111131	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4cccnc4)nc3C2=O)COc2ccccc21		CHEMBL4090065	=	pK		1.58	CHEMBL5464	Homo sapiens	pK		1.58
	18111132	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccn4)nc3C2=O)COc2ccccc21		CHEMBL4076592	=	pK		1.44	CHEMBL5464	Homo sapiens	pK		1.44
Not Determined	18111133	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		pK			CHEMBL5464	Homo sapiens	pK		
Not Determined	18111134	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)C4)nc3C2=O)COc2ccccc21		CHEMBL4079755		pK			CHEMBL5464	Homo sapiens	pK		
	18111135	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	Cc1c2c(nn1Cc1ccccc1)C(=O)N([C@H]1COc3ccccc3N(C)C1=O)CC2		CHEMBL4064701	=	pK		2.29	CHEMBL5464	Homo sapiens	pK		2.29
	18111136	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Cl)C2=O)COc2ccccc21		CHEMBL4075976	=	pK		2.48	CHEMBL5464	Homo sapiens	pK		2.48
	18111137	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3C#N)C2=O)COc2ccccc21		CHEMBL4084681	=	pK		2.42	CHEMBL5464	Homo sapiens	pK		2.42
	18111138	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3C(N)=O)C2=O)COc2ccccc21		CHEMBL4102622	=	pK		2.33	CHEMBL5464	Homo sapiens	pK		2.33
	18111139	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Cl)C2=O)COc2ccc(C#N)cc21		CHEMBL4061975	=	pK		2.49	CHEMBL5464	Homo sapiens	pK		2.49
	18111140	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Cl)C2=O)COc2cc(C#N)ccc21		CHEMBL4100398	=	pK		2.49	CHEMBL5464	Homo sapiens	pK		2.49
	18111141	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CNC(=O)c1ccc2c(c1)OC[C@H](N1CCc3c(nn(Cc4ccccc4)c3Cl)C1=O)C(=O)N2C		CHEMBL4069537	=	pK		2.52	CHEMBL5464	Homo sapiens	pK		2.52
	18111142	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN(C)C(=O)c1ccc2c(c1)OC[C@H](N1CCc3c(nn(Cc4ccccc4)c3Cl)C1=O)C(=O)N2C		CHEMBL4073321	=	pK		2.32	CHEMBL5464	Homo sapiens	pK		2.32
	18111143	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4F)nc3C2=O)COc2cc(C#N)ccc21		CHEMBL4085728	=	pK		2.33	CHEMBL5464	Homo sapiens	pK		2.33
	18111144	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4c(F)cccc4F)nc3C2=O)COc2cc(C#N)ccc21		CHEMBL4075705	=	pK		2.47	CHEMBL5464	Homo sapiens	pK		2.47
	18111145	CHEMBL4023996	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation rate constant by TR-FRET assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	pK		1.06	CHEMBL5464	Homo sapiens	pK		1.06
	18111146	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4071864	=	T1/2	hr	1.917	CHEMBL5464	Homo sapiens	t1/2	min	115.0
	18111147	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3[nH]c(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4082291	<	T1/2	hr	0.08333	CHEMBL5464	Homo sapiens	t1/2	min	5.0
	18111148	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCn3nc(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4100309	=	T1/2	hr	0.1117	CHEMBL5464	Homo sapiens	t1/2	min	6.7
	18111149	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCn3cc(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4066941	=	T1/2	hr	0.155	CHEMBL5464	Homo sapiens	t1/2	min	9.3
	18111150	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216	=	T1/2	hr	0.9833	CHEMBL5464	Homo sapiens	t1/2	min	59.0
	18111151	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3nn(Cc4ccccc4)cc3C2=O)COc2ccccc21		CHEMBL4063075	<	T1/2	hr	0.08333	CHEMBL5464	Homo sapiens	t1/2	min	5.0
	18111152	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4F)nc3C2=O)COc2ccccc21		CHEMBL4090975	=	T1/2	hr	1.833	CHEMBL5464	Homo sapiens	t1/2	min	110.0
	18111153	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4cccc(F)c4)nc3C2=O)COc2ccccc21		CHEMBL4071690	=	T1/2	hr	0.7667	CHEMBL5464	Homo sapiens	t1/2	min	46.0
	18111154	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccc(F)cc4)nc3C2=O)COc2ccccc21		CHEMBL4098708	=	T1/2	hr	0.3333	CHEMBL5464	Homo sapiens	t1/2	min	20.0
	18111155	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4c(F)cccc4F)nc3C2=O)COc2ccccc21		CHEMBL4082215	=	T1/2	hr	2.667	CHEMBL5464	Homo sapiens	t1/2	min	160.0
	18111156	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCC4)nc3C2=O)COc2ccccc21		CHEMBL4060308	=	T1/2	hr	0.2667	CHEMBL5464	Homo sapiens	t1/2	min	16.0
	18111157	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4cccnc4)nc3C2=O)COc2ccccc21		CHEMBL4090065	=	T1/2	hr	0.4333	CHEMBL5464	Homo sapiens	t1/2	min	26.0
	18111158	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccn4)nc3C2=O)COc2ccccc21		CHEMBL4076592	=	T1/2	hr	0.3167	CHEMBL5464	Homo sapiens	t1/2	min	19.0
	18111159	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778	<	T1/2	hr	0.08333	CHEMBL5464	Homo sapiens	t1/2	min	5.0
	18111160	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)C4)nc3C2=O)COc2ccccc21		CHEMBL4079755	<	T1/2	hr	0.08333	CHEMBL5464	Homo sapiens	t1/2	min	5.0
	18111161	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	Cc1c2c(nn1Cc1ccccc1)C(=O)N([C@H]1COc3ccccc3N(C)C1=O)CC2		CHEMBL4064701	=	T1/2	hr	2.167	CHEMBL5464	Homo sapiens	t1/2	min	130.0
	18111162	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Cl)C2=O)COc2ccccc21		CHEMBL4075976	=	T1/2	hr	3.5	CHEMBL5464	Homo sapiens	t1/2	min	210.0
	18111163	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3C#N)C2=O)COc2ccccc21		CHEMBL4084681	=	T1/2	hr	3.0	CHEMBL5464	Homo sapiens	t1/2	min	180.0
	18111164	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3C(N)=O)C2=O)COc2ccccc21		CHEMBL4102622	=	T1/2	hr	2.5	CHEMBL5464	Homo sapiens	t1/2	min	150.0
	18111165	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Cl)C2=O)COc2ccc(C#N)cc21		CHEMBL4061975	=	T1/2	hr	3.5	CHEMBL5464	Homo sapiens	t1/2	min	210.0
	18111166	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Cl)C2=O)COc2cc(C#N)ccc21		CHEMBL4100398	=	T1/2	hr	3.5	CHEMBL5464	Homo sapiens	t1/2	min	210.0
	18111167	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CNC(=O)c1ccc2c(c1)OC[C@H](N1CCc3c(nn(Cc4ccccc4)c3Cl)C1=O)C(=O)N2C		CHEMBL4069537	=	T1/2	hr	3.833	CHEMBL5464	Homo sapiens	t1/2	min	230.0
	18111168	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN(C)C(=O)c1ccc2c(c1)OC[C@H](N1CCc3c(nn(Cc4ccccc4)c3Cl)C1=O)C(=O)N2C		CHEMBL4073321	=	T1/2	hr	2.5	CHEMBL5464	Homo sapiens	t1/2	min	150.0
	18111169	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4F)nc3C2=O)COc2cc(C#N)ccc21		CHEMBL4085728	=	T1/2	hr	2.5	CHEMBL5464	Homo sapiens	t1/2	min	150.0
	18111170	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4c(F)cccc4F)nc3C2=O)COc2cc(C#N)ccc21		CHEMBL4075705	=	T1/2	hr	3.333	CHEMBL5464	Homo sapiens	t1/2	min	200.0
	18111171	CHEMBL4023997	Inhibition of fluorescent-labeled 3-(3-((3-(4-amino-5-(4-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido)-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl)amino)-3-oxopropyl)-5,5-difluoro-7,9-dimethyl-5H-dipyrrolo[1,2-c:2',1'-f]-[1,3,2]diazaborinin-4-ium-5-uide binding to human N-terminal GST/His-tagged RIPK1 (1 to 375 residues) expressed in baculovirus expression system assessed as dissociation half life by TR-FRET assay	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	T1/2	hr	0.1333	CHEMBL5464	Homo sapiens	t1/2	min	8.0
	18111195	CHEMBL4024006	Inhibition of RIPK1 in human HT-29 cells assessed as decrease in TNFalpha/AT-406/zVAD-FMK-induced MLKL phosphorylation at S358 residue preincubated for 30 mins followed by TNFalpha/AT-406/zVAD-FMK addition measured after 6 hrs by WES assay	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Cl)C2=O)COc2cc(C#N)ccc21		CHEMBL4100398	=	IC50	nM	1.3	CHEMBL5464	Homo sapiens	IC50	nM	1.3
	18114831	CHEMBL4025361	Inhibition of wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL5464	Homo sapiens	Activity	%	100.0
	18203885	CHEMBL4044172	Inhibition of wild-type human partial length RIPK1 (M1 to K305 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL5464	Homo sapiens	Activity	%	100.0
	18224361	CHEMBL4048555	Binding affinity to RIPK1 (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	20.0	CHEMBL5464	Homo sapiens	Kd	nM	20.0
	18224652	CHEMBL4048565	Inhibition of human recombinant RIPK1 after 4 hrs by ADP-Glo assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	208.0	CHEMBL5464	Homo sapiens	IC50	uM	0.208
	18224653	CHEMBL4048565	Inhibition of human recombinant RIPK1 after 4 hrs by ADP-Glo assay	B	Cc1cc(Nc2cc(N3CCCCC3)nc(Nc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL4069729	=	IC50	nM	295.0	CHEMBL5464	Homo sapiens	IC50	uM	0.295
	18224654	CHEMBL4048565	Inhibition of human recombinant RIPK1 after 4 hrs by ADP-Glo assay	B	Cc1cc(Nc2cc(N3CCOCC3)nc(Nc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL4090723	=	IC50	nM	167.0	CHEMBL5464	Homo sapiens	IC50	uM	0.167
	18224655	CHEMBL4048565	Inhibition of human recombinant RIPK1 after 4 hrs by ADP-Glo assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL4105556	=	IC50	nM	178.0	CHEMBL5464	Homo sapiens	IC50	uM	0.178
	18224656	CHEMBL4048565	Inhibition of human recombinant RIPK1 after 4 hrs by ADP-Glo assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CCCCC4)cc3)nc(N3CCN(C)CC3)n2)n[nH]1		CHEMBL4064515	=	IC50	nM	2468.0	CHEMBL5464	Homo sapiens	IC50	uM	2.468
	18224657	CHEMBL4048565	Inhibition of human recombinant RIPK1 after 4 hrs by ADP-Glo assay	B	CN1C(=O)NC(Cc2c[nH]c3c(Cl)cccc23)C1=O		CHEMBL381230	=	IC50	nM	754.0	CHEMBL5464	Homo sapiens	IC50	uM	0.754
	18253628	CHEMBL4055098	Inhibition of wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	92.0	CHEMBL5464	Homo sapiens	Activity	%	92.0
	18253629	CHEMBL4055098	Inhibition of wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL5464	Homo sapiens	Activity	%	100.0
	18440427	CHEMBL4157251	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	90.0	CHEMBL5464	Homo sapiens	Activity	%	90.0
	18484383	CHEMBL4186030	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL5464	Homo sapiens	Activity	%	100.0
	18484867	CHEMBL4186030	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	86.0	CHEMBL5464	Homo sapiens	Activity	%	86.0
	18507625	CHEMBL4191167	Inhibition of recombinant human RIPK1 (8 to 322 residues) at 1 uM using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	18.0	CHEMBL5464	Homo sapiens	INH	%	18.0
	18655305	CHEMBL4230930	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	89.0	CHEMBL5464	Homo sapiens	Activity	%	89.0
	18697683	CHEMBL4254356	Inhibition of wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	62.0	CHEMBL5464	Homo sapiens	Activity	%	62.0
Dose-dependent effect	18737856	CHEMBL4261383	Inhibition of RIPK1 in human HT-29 cells with TNFalpha/Smac-mimetic/z-VAD-FMK induced necroptosis assessed as reduction in MLKL phosphorylation after 8 hrs by Western blot analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Dose-dependent effect	18737857	CHEMBL4261382	Inhibition of RIPK1 in human HT-29 cells with TNFalpha/Smac-mimetic/z-VAD-FMK induced necroptosis assessed as reduction in RIPK3 phosphorylation after 8 hrs by Western blot analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Dose-dependent effect	18737858	CHEMBL4261381	Inhibition of RIPK1 phosphorylation in human HT-29 cells with TNFalpha/Smac-mimetic/z-VAD-FMK induced necroptosis after 8 hrs by Western blot analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
	18737871	CHEMBL4261373	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system by Kinomescan method	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	Kd	nM	4.4	CHEMBL5464	Homo sapiens	Kd	nM	4.4
	18737872	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	COCCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4289311	=	IC50	nM	105.0	CHEMBL5464	Homo sapiens	IC50	uM	0.105
	18737873	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCCCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4290735	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	uM	0.01
	18737874	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4292726	=	IC50	nM	31.0	CHEMBL5464	Homo sapiens	IC50	uM	0.031
	18737875	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CC(C)n1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4292454	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	uM	0.01
	18737876	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	11.0	CHEMBL5464	Homo sapiens	IC50	uM	0.011
	18737877	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4290948	=	IC50	nM	13.0	CHEMBL5464	Homo sapiens	IC50	uM	0.013
	18737878	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2cncnc21		CHEMBL4280312	=	IC50	nM	468.0	CHEMBL5464	Homo sapiens	IC50	uM	0.468
	18737879	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2cncnc21		CHEMBL4294339	=	IC50	nM	634.0	CHEMBL5464	Homo sapiens	IC50	uM	0.634
	18737880	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc3c(c2)CCN3C(=O)Cc2ccc(Cl)c(C(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4283766	=	IC50	nM	28.0	CHEMBL5464	Homo sapiens	IC50	uM	0.028
	18737881	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc3c(c2)CCN3C(=O)Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4284148	=	IC50	nM	264.0	CHEMBL5464	Homo sapiens	IC50	uM	0.264
	18737882	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc3c(c2)CCN3C(=O)Cc2cc(F)cc(C(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4292027	=	IC50	nM	18.0	CHEMBL5464	Homo sapiens	IC50	uM	0.018
	18737883	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc3c(c2)CCN3C(=O)Cc2ccc(Br)cc2)c2c(N)ncnc21		CHEMBL4287519	=	IC50	nM	392.0	CHEMBL5464	Homo sapiens	IC50	uM	0.392
	18737884	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc3c(c2)CCN3C(=O)Cc2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL4276878	=	IC50	nM	704.0	CHEMBL5464	Homo sapiens	IC50	uM	0.704
	18737885	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc3c(c2)CCN3C(=O)Cc2ccc(C(F)(F)F)cc2)c2c(N)ncnc21		CHEMBL4290879	=	IC50	nM	128.0	CHEMBL5464	Homo sapiens	IC50	uM	0.128
	18737886	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C#N)c2)c2c(N)ncnc21		CHEMBL4283005	=	IC50	nM	190.0	CHEMBL5464	Homo sapiens	IC50	uM	0.19
	18737887	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	COc1cccc(CC(=O)N2CCc3cc(-c4nn(C)c5ncnc(N)c45)ccc32)c1		CHEMBL4282588	=	IC50	nM	116.0	CHEMBL5464	Homo sapiens	IC50	uM	0.116
	18737888	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cc1cccc(CC(=O)N2CCc3cc(-c4nn(C)c5ncnc(N)c45)ccc32)c1		CHEMBL4283246	=	IC50	nM	56.0	CHEMBL5464	Homo sapiens	IC50	uM	0.056
	18737889	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4279118	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	uM	0.01
	18737890	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(Br)c2)c2c(N)ncnc21		CHEMBL4289802	=	IC50	nM	26.0	CHEMBL5464	Homo sapiens	IC50	uM	0.026
	18737891	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(Cl)c2)c2c(N)ncnc21		CHEMBL4289381	=	IC50	nM	58.0	CHEMBL5464	Homo sapiens	IC50	uM	0.058
	18737892	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(F)c2)c2c(N)ncnc21		CHEMBL4281501	=	IC50	nM	61.0	CHEMBL5464	Homo sapiens	IC50	uM	0.061
	18737893	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc3c(c2)CCN3C(=O)CCc2cccc(C(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4285969	=	IC50	nM	17.0	CHEMBL5464	Homo sapiens	IC50	uM	0.017
	18737894	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc3c(c2)CCN3C(=O)Nc2cccc(C(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4278044	=	IC50	nM	49.0	CHEMBL5464	Homo sapiens	IC50	uM	0.049
	18737895	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	C[C@H](C(=O)N1CCc2cc(-c3nn(C)c4ncnc(N)c34)ccc21)c1ccccc1		CHEMBL4292771	=	IC50	nM	2994.0	CHEMBL5464	Homo sapiens	IC50	uM	2.994
	18737896	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	C[C@@H](C(=O)N1CCc2cc(-c3nn(C)c4ncnc(N)c34)ccc21)c1ccccc1		CHEMBL4282159	=	IC50	nM	3457.0	CHEMBL5464	Homo sapiens	IC50	uM	3.457
	18737897	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4289355	=	IC50	nM	14.0	CHEMBL5464	Homo sapiens	IC50	uM	0.014
	18737898	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CC(C)c1cc(-c2nn(C)c3ncnc(N)c23)ccc1NC(=O)Cc1cccc(C(F)(F)F)c1		CHEMBL4278688	=	IC50	nM	531.0	CHEMBL5464	Homo sapiens	IC50	uM	0.531
	18737899	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCc1cc(-c2nn(C)c3ncnc(N)c23)ccc1NC(=O)Cc1cccc(C(F)(F)F)c1		CHEMBL4285949	=	IC50	nM	107.0	CHEMBL5464	Homo sapiens	IC50	uM	0.107
	18737900	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	COc1cc(-c2nn(C)c3ncnc(N)c23)ccc1NC(=O)Cc1cccc(C(F)(F)F)c1		CHEMBL4293838	=	IC50	nM	424.0	CHEMBL5464	Homo sapiens	IC50	uM	0.424
	18737901	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cc1cc(-c2nn(C)c3ncnc(N)c23)ccc1NC(=O)Cc1cccc(C(F)(F)F)c1		CHEMBL4282562	=	IC50	nM	134.0	CHEMBL5464	Homo sapiens	IC50	uM	0.134
	18737902	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc(NC(=O)Cc3cccc(C(F)(F)F)c3)cc2F)c2c(N)ncnc21		CHEMBL4290430	=	IC50	nM	49.0	CHEMBL5464	Homo sapiens	IC50	uM	0.049
	18737903	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc(NC(=O)Cc3cccc(C(F)(F)F)c3)c(Cl)c2)c2c(N)ncnc21		CHEMBL4279092	=	IC50	nM	94.0	CHEMBL5464	Homo sapiens	IC50	uM	0.094
	18737904	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc(NC(=O)Cc3cccc(C(F)(F)F)c3)c(F)c2)c2c(N)ncnc21		CHEMBL4287016	=	IC50	nM	79.0	CHEMBL5464	Homo sapiens	IC50	uM	0.079
	18737905	CHEMBL4261372	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	Cn1nc(-c2ccc(NC(=O)Cc3cccc(C(F)(F)F)c3)cc2)c2c(N)ncnc21		CHEMBL4291229	=	IC50	nM	77.0	CHEMBL5464	Homo sapiens	IC50	uM	0.077
	18752182	CHEMBL4264519	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	79.0	CHEMBL5464	Homo sapiens	Activity	%	79.0
	18851454	CHEMBL4305908	Inhibition of pDEST8HisGSTTev-tagged human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells assessed as on-rate constant by stopped flow spectrometry	B	O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4452233	=	Ka	10'4/Ms	2.5	CHEMBL5464	Homo sapiens	Ka	10'4/Ms	2.5
	18851456	CHEMBL4305913	Inhibition of RIP1 in human neutrophils assessed as inhibition of TNF-alpha/QVD-Oph/RMT5265-stimulated MIP-1 beta cytokine overproduction measured at 21 hrs post stimulation by sandwich ELISA	B	O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4452233	=	IC50	nM	0.4	CHEMBL5464	Homo sapiens	IC50	nM	0.4
	18851457	CHEMBL4305912	Inhibition of RIP1 in human neutrophils assessed as inhibition of TNF-alpha/QVD-Oph/RMT5265-stimulated necroptosis by measuring LDH release measured at 21 hrs post stimulation by LDH assay	B	O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4452233	=	IC50	nM	0.5	CHEMBL5464	Homo sapiens	IC50	nM	0.5
	18851458	CHEMBL4305911	Inhibition of RIP1 in human neutrophils assessed as inhibition of TNF-alpha/QVD-Oph/RMT5265-stimulated necroptosis by measuring cellular ATP levels measured at 21 hrs post stimulation by cell-Titer Glo luminescent cell viability assay	B	O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4452233	=	IC50	nM	1.6	CHEMBL5464	Homo sapiens	IC50	nM	1.6
	18851460	CHEMBL4305904	Inhibition of pDEST8HisGSTTev-tagged human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated with enzyme for 1 hr followed by ATP addition and measured after 5 hrs by ADP-Glo kinase assay	B	O=C(N[C@H]1COc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3786293	=	IC50	nM	32.0	CHEMBL5464	Homo sapiens	IC50	nM	32.0
	18851461	CHEMBL4305910	Displacement of fluorescent ligand ((14-(2-([3-((2-([4-(cyanomethyl)phenyl]amino)-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl)amino)propyl]amino)-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2,3]indolizino[8,7:5,6]pyrano[3,2:3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate) from pDEST8HisGSTTev-tagged human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells assessed as half life for dissociation measured for 50 mins by fluorescence polarization competitive binding assay	B	O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4452233	=	T1/2	hr	1.65	CHEMBL5464	Homo sapiens	t1/2	min	99.0
	18851462	CHEMBL4305905	Inhibition of RIP1 in human U937 cells assessed as reduction in necroptosis incubated for 24 hrs by cell titer-glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4071864	=	IC50	nM	6.3	CHEMBL5464	Homo sapiens	IC50	nM	6.3
	18851463	CHEMBL4305904	Inhibition of pDEST8HisGSTTev-tagged human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated with enzyme for 1 hr followed by ATP addition and measured after 5 hrs by ADP-Glo kinase assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc21		CHEMBL3785703	=	IC50	nM	1.6	CHEMBL5464	Homo sapiens	IC50	nM	1.6
	18851465	CHEMBL4305905	Inhibition of RIP1 in human U937 cells assessed as reduction in necroptosis incubated for 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(N[C@H]1COc2ccccc2NC1=O)c1cc(Cc2ccccc2)on1		CHEMBL3786293	=	IC50	nM	200.0	CHEMBL5464	Homo sapiens	IC50	nM	200.0
	18851466	CHEMBL4305909	Displacement of fluorescent ligand ((14-(2-([3-((2-([4-(cyanomethyl)phenyl]amino)-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl)amino)propyl]amino)-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2,3]indolizino[8,7:5,6]pyrano[3,2:3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate) from pDEST8HisGSTTev-tagged human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells assessed as off-rate constant measured for 50 mins by fluorescence polarization competitive binding assay	B	O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4452233	=	Kdiss	10'-4/s	1.2	CHEMBL5464	Homo sapiens	Kdiss	10'-4/s	1.2
	18851472	CHEMBL4305905	Inhibition of RIP1 in human U937 cells assessed as reduction in necroptosis incubated for 24 hrs by cell titer-glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)CCc2cc(F)cc(F)c21		CHEMBL4453758	=	IC50	nM	6.3	CHEMBL5464	Homo sapiens	IC50	nM	6.3
	18851473	CHEMBL4305904	Inhibition of pDEST8HisGSTTev-tagged human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated with enzyme for 1 hr followed by ATP addition and measured after 5 hrs by ADP-Glo kinase assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)CCc2ccccc21		CHEMBL4554676	=	IC50	nM	5.0	CHEMBL5464	Homo sapiens	IC50	nM	5.0
	18851474	CHEMBL4305905	Inhibition of RIP1 in human U937 cells assessed as reduction in necroptosis incubated for 24 hrs by cell titer-glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)CCc2ccccc21		CHEMBL4554676	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	18851475	CHEMBL4305904	Inhibition of pDEST8HisGSTTev-tagged human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated with enzyme for 1 hr followed by ATP addition and measured after 5 hrs by ADP-Glo kinase assay	B	O=C(N[C@H]1COc2ccccc2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4068352	=	IC50	nM	32.0	CHEMBL5464	Homo sapiens	IC50	nM	32.0
	18851476	CHEMBL4305905	Inhibition of RIP1 in human U937 cells assessed as reduction in necroptosis incubated for 24 hrs by cell titer-glo luminescent cell viability assay	B	CN1C(=O)[C@@H](NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc21		CHEMBL3785703	=	IC50	nM	7.9	CHEMBL5464	Homo sapiens	IC50	nM	7.9
	18851479	CHEMBL4305904	Inhibition of pDEST8HisGSTTev-tagged human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated with enzyme for 1 hr followed by ATP addition and measured after 5 hrs by ADP-Glo kinase assay	B	O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4452233	=	IC50	nM	6.3	CHEMBL5464	Homo sapiens	IC50	nM	6.3
	18851481	CHEMBL4305904	Inhibition of pDEST8HisGSTTev-tagged human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated with enzyme for 1 hr followed by ATP addition and measured after 5 hrs by ADP-Glo kinase assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)CCc2cc(F)cc(F)c21		CHEMBL4453758	=	IC50	nM	6.3	CHEMBL5464	Homo sapiens	IC50	nM	6.3
	18851484	CHEMBL4305904	Inhibition of pDEST8HisGSTTev-tagged human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated with enzyme for 1 hr followed by ATP addition and measured after 5 hrs by ADP-Glo kinase assay	B	O=C(N[C@H]1CCc2ccccc2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4470945	=	IC50	nM	50.0	CHEMBL5464	Homo sapiens	IC50	nM	50.0
	18851486	CHEMBL4305905	Inhibition of RIP1 in human U937 cells assessed as reduction in necroptosis incubated for 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4452233	=	IC50	nM	6.3	CHEMBL5464	Homo sapiens	IC50	nM	6.3
	18851487	CHEMBL4305905	Inhibition of RIP1 in human U937 cells assessed as reduction in necroptosis incubated for 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(N[C@H]1CCc2ccccc2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4470945	=	IC50	nM	63.0	CHEMBL5464	Homo sapiens	IC50	nM	63.0
	18851488	CHEMBL4305905	Inhibition of RIP1 in human U937 cells assessed as reduction in necroptosis incubated for 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(N[C@H]1COc2ccccc2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4068352	=	IC50	nM	100.0	CHEMBL5464	Homo sapiens	IC50	nM	100.0
	18851489	CHEMBL4305904	Inhibition of pDEST8HisGSTTev-tagged human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells preincubated with enzyme for 1 hr followed by ATP addition and measured after 5 hrs by ADP-Glo kinase assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4071864	=	IC50	nM	1.0	CHEMBL5464	Homo sapiens	IC50	nM	1.0
Not Active	18851591	CHEMBL4306778	Inhibition of RIP1 in human PDOTS (spheroid derived from tumors from pancreatic, colorectal, breast, gastric cancer patients) assessed as TNFalpha expression at 0.5 nM incubated for 3 days	B	O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4452233		Activity			CHEMBL5464	Homo sapiens	Activity		
Not Active	18851757	CHEMBL4306777	Inhibition of RIP1 in human PDOTS (spheroid derived from tumors from pancreatic, colorectal, breast, gastric cancer patients) assessed as CD8+ cytolytic T cells at 0.5 nM incubated for 3 days by flow cytometry	B	O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4452233		Activity			CHEMBL5464	Homo sapiens	Activity		
Active	18851834	CHEMBL4306776	Inhibition of RIP1 in human PDOTS (spheroid derived from tumors from pancreatic, colorectal, breast, gastric cancer patients) assessed as increase in immunogenic IFNgamma+ CD4+ T cells at 0.5 nM incubated for 3 days by flow cytometry	B	O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4452233		Activity			CHEMBL5464	Homo sapiens	Activity		
Active	18851940	CHEMBL4306775	Inhibition of RIP1 in human PDOTS (spheroid derived from tumors from pancreatic, colorectal, breast, gastric cancer patients) assessed as increase in effector-memory CD44+ T cells at 0.5 nM incubated for 3 days by flow cytometry	B	O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4452233		Activity			CHEMBL5464	Homo sapiens	Activity		
	18852068	CHEMBL4306770	Inhibition of RIP1 in human whole blood assessed as inhibition of TNF-alpha/QVD-Oph/RMT5265-stimulated MIP-1 beta cytokine overproduction incubated for 6 hrs by sandwich ELISA	B	O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4452233	=	IC50	nM	5.0	CHEMBL5464	Homo sapiens	IC50	nM	5.0
Active	18852224	CHEMBL4306769	Competitive inhibition of pDEST8HisGSTTev-tagged human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells using ATP as substrate incubated for 5 hrs by ADP-Glo kinase assay	B	O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4452233		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
	18852345	CHEMBL4306768	Inhibition of RIP1 in human neutrophils assessed as inhibition of TNF-alpha/QVD-Oph/RMT5265-stimulated MIP-1 beta mRNA overexpression measured at 21 hrs post-stimulation	B	O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4452233	=	IC50	nM	0.4	CHEMBL5464	Homo sapiens	IC50	nM	0.4
	18858182	CHEMBL4308028	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	96.0	CHEMBL5464	Homo sapiens	Activity	%	96.0
	18892961	CHEMBL4314927	Inhibition of human RIPK1 (8 to 322 residues) using myelin basic protein as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	92.0	CHEMBL5464	Homo sapiens	Activity	%	92.0
	18945366	CHEMBL4329657	Binding affinity to RIP1 (unknown origin) by fluorescence polarization assay	B	N#Cc1cc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)ncn1		CHEMBL4514271	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	pIC50		8.0
	18945367	CHEMBL4329657	Binding affinity to RIP1 (unknown origin) by fluorescence polarization assay	B	O=C(N[C@H]1CCc2cc(F)cc(F)c2NC1=O)c1n[nH]c(Cc2ccccc2)n1		CHEMBL4452233	=	IC50	nM	19.95	CHEMBL5464	Homo sapiens	pIC50		7.7
	18945368	CHEMBL4329657	Binding affinity to RIP1 (unknown origin) by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2cc(F)cc(F)c21		CHEMBL4536697	=	IC50	nM	2.512	CHEMBL5464	Homo sapiens	pIC50		8.6
	18945369	CHEMBL4329657	Binding affinity to RIP1 (unknown origin) by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3F)n2)CNc2ccccc21		CHEMBL4461132	=	IC50	nM	39.81	CHEMBL5464	Homo sapiens	pIC50		7.4
	18945370	CHEMBL4329657	Binding affinity to RIP1 (unknown origin) by fluorescence polarization assay	B	O=C(N[C@H]1CNc2cc(Cl)ccc2NC1=O)c1nnc(Cc2ccccc2)[nH]1		CHEMBL4438217	=	IC50	nM	19.95	CHEMBL5464	Homo sapiens	pIC50		7.7
	18945371	CHEMBL4329657	Binding affinity to RIP1 (unknown origin) by fluorescence polarization assay	B	O=C(N[C@H]1CNc2cccc(F)c2NC1=O)c1nnc(Cc2ccccc2F)[nH]1		CHEMBL4522283	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	pIC50		8.0
	18958578	CHEMBL4333613	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL5464	Homo sapiens	Activity	%	100.0
	18964652	CHEMBL4335267	Inhibition of recombinant human RIPK1 (8 to 322 residues) assessed as residual activity at 1 uM using myelin basic protein as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	100.0	CHEMBL5464	Homo sapiens	Activity	%	100.0
	18964653	CHEMBL4335267	Inhibition of recombinant human RIPK1 (8 to 322 residues) assessed as residual activity at 1 uM using myelin basic protein as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	106.0	CHEMBL5464	Homo sapiens	Activity	%	106.0
	18972080	CHEMBL4337090	Inhibition of recombinant human RIPK1 (8 to 322 residues) assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	98.0	CHEMBL5464	Homo sapiens	Activity	%	98.0
	19008085	CHEMBL4344882	Displacement of fluorescein labeled probe from full length human GST-tagged RIPK1 expressed in Sf9 cells incubated for 60 mins by HTRF assay	A	Nc1ccc(C#Cc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2N)nc1		CHEMBL4470115	=	IC50	nM	310.0	CHEMBL5464	Homo sapiens	IC50	nM	310.0
	19008086	CHEMBL4344882	Displacement of fluorescein labeled probe from full length human GST-tagged RIPK1 expressed in Sf9 cells incubated for 60 mins by HTRF assay	A	Cc1ccc(COC(=O)Nc2cc(-c3cc4c([nH]3)CCNC4=O)ccn2)cc1		CHEMBL4434926	=	IC50	nM	17000.0	CHEMBL5464	Homo sapiens	IC50	nM	17000.0
	19008109	CHEMBL4344885	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK1 (unknown origin) incubated for 60 mins by HTRF assay	A	O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL509101	=	IC50	nM	1500.0	CHEMBL5464	Homo sapiens	IC50	uM	1.5
	19008110	CHEMBL4344885	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK1 (unknown origin) incubated for 60 mins by HTRF assay	A	O=C(Nc1ccc(Oc2ccnc(NC(=O)C3CC3)c2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4455682	=	IC50	nM	180.0	CHEMBL5464	Homo sapiens	IC50	uM	0.18
	19008111	CHEMBL4344885	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK1 (unknown origin) incubated for 60 mins by HTRF assay	A	O=C(Nc1ccc(Oc2ccncc2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4572309	>	IC50	nM	15000.0	CHEMBL5464	Homo sapiens	IC50	uM	15.0
	19008112	CHEMBL4344885	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK1 (unknown origin) incubated for 60 mins by HTRF assay	A	O=C(Nc1ccc(Oc2ccncc2)c(F)c1)c1cccc(-c2ccc(F)cc2)c1		CHEMBL4468222	>	IC50	nM	15000.0	CHEMBL5464	Homo sapiens	IC50	uM	15.0
	19008113	CHEMBL4344885	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK1 (unknown origin) incubated for 60 mins by HTRF assay	A	Cc1cc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc(C)c1Oc1ccncc1		CHEMBL4542026	>	IC50	nM	15000.0	CHEMBL5464	Homo sapiens	IC50	uM	15.0
	19008114	CHEMBL4344885	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK1 (unknown origin) incubated for 60 mins by HTRF assay	A	O=C(Nc1ccc(Oc2ccncc2)c2ccccc12)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4438939	>	IC50	nM	15000.0	CHEMBL5464	Homo sapiens	IC50	uM	15.0
	19008115	CHEMBL4344885	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK1 (unknown origin) incubated for 60 mins by HTRF assay	A	Cc1cc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)ccc1Oc1ccnc(NC(=O)C2CC2)c1		CHEMBL4476485	=	IC50	nM	200.0	CHEMBL5464	Homo sapiens	IC50	uM	0.2
	19008116	CHEMBL4344885	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK1 (unknown origin) incubated for 60 mins by HTRF assay	A	Cc1cc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc(C)c1Oc1ccnc(NC(=O)C2CC2)c1		CHEMBL4476076	=	IC50	nM	11000.0	CHEMBL5464	Homo sapiens	IC50	uM	11.0
	19008117	CHEMBL4344885	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK1 (unknown origin) incubated for 60 mins by HTRF assay	A	Cc1c(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)ccc(Oc2ccnc(NC(=O)C3CC3)c2)c1C		CHEMBL4551490	=	IC50	nM	5500.0	CHEMBL5464	Homo sapiens	IC50	uM	5.5
	19008130	CHEMBL4344887	Displacement of fluorescein labeled ATP probe from full length His/GST-tagged RIPK1 (unknown origin) incubated for 60 mins by HTRF assay	A	CC#Cc1c(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)ccnc1N		CHEMBL4552106	=	IC50	nM	600.0	CHEMBL5464	Homo sapiens	IC50	uM	0.6
	19008131	CHEMBL4344887	Displacement of fluorescein labeled ATP probe from full length His/GST-tagged RIPK1 (unknown origin) incubated for 60 mins by HTRF assay	A	Cc1c(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)ccc(Oc2ccncc2)c1C		CHEMBL4434881	>	IC50	nM	15000.0	CHEMBL5464	Homo sapiens	IC50	uM	15.0
	19008134	CHEMBL4344890	Time dependent inhibition of full length His/GST-tagged RIPK1 (unknown origin) measured every 5 mins for 60 mins in presence of fluorescein labeled probe by HTRF assay relative to control	A	Nc1ccc(C#Cc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2N)nc1		CHEMBL4470115	=	FC		6.0	CHEMBL5464	Homo sapiens	FC		6.0
Not Active	19040138	CHEMBL4352039	Inhibition of human RIPK1 (8 to 322 residues) using myelin basic protein as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
	19040493	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(Nc1cccc(Cl)c1)N1N=CCC1c1ccccc1		CHEMBL1580000	=	IC50	nM	126.0	CHEMBL5464	Homo sapiens	IC50	nM	126.0
	19040494	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1CCCC1c1ccccc1		CHEMBL4584741	=	IC50	nM	316.0	CHEMBL5464	Homo sapiens	IC50	nM	316.0
	19040495	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccccc1		CHEMBL4446915	=	IC50	nM	25.0	CHEMBL5464	Homo sapiens	IC50	nM	25.0
	19040496	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	nM	16.0
	19040497	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CC[C@@H]1c1ccccc1		CHEMBL4442060	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040498	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1CCCC1c1cccc(F)c1		CHEMBL4438495	=	IC50	nM	200.0	CHEMBL5464	Homo sapiens	IC50	nM	200.0
	19040499	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC1=NN(C(=O)C(C)(C)C)[C@H](c2ccccc2)C1		CHEMBL4545356	=	IC50	nM	126.0	CHEMBL5464	Homo sapiens	IC50	nM	126.0
	19040500	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	C[C@@H]1C=NN(C(=O)C(C)(C)C)[C@@H]1c1ccccc1		CHEMBL4437641	=	IC50	nM	200.0	CHEMBL5464	Homo sapiens	IC50	nM	200.0
	19040501	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)n1nccc1-c1ccccc1		CHEMBL4463613	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040502	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1CCCCC1c1ccccc1		CHEMBL4577829	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040503	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1CCOCC1c1ccccc1		CHEMBL4464244	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040504	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1CCNCC1c1ccccc1		CHEMBL4458681	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040505	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CN1CCN(C(=O)C(C)(C)C)C(c2ccccc2)C1		CHEMBL4555675	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040506	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1CCSC1c1ccccc1		CHEMBL4455695	=	IC50	nM	3980.0	CHEMBL5464	Homo sapiens	IC50	nM	3980.0
	19040507	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1CCC1c1ccccc1		CHEMBL4540090	=	IC50	nM	79.0	CHEMBL5464	Homo sapiens	IC50	nM	79.0
	19040508	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CCC1c1cccc(F)c1		CHEMBL4537171	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040509	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	Cc1ccc(C2CC=NN2C(=O)C(C)(C)C)cc1F		CHEMBL4514028	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040510	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CCC1c1cc(F)cc(F)c1		CHEMBL4593226	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040511	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	Cc1ccc(C2CC=NN2C(=O)C(C)(C)C)cc1		CHEMBL4436215	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040512	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccc(Cl)cc1		CHEMBL4576386	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040513	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CCC1c1cccc(Cl)c1		CHEMBL4556131	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040514	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccc(C(C)(C)C)cc1		CHEMBL4533161	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040515	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccc(S(C)(=O)=O)cc1		CHEMBL4436896	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040516	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccccn1		CHEMBL4544356	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040517	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CCC1c1cccnc1		CHEMBL4446523	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040518	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccncc1		CHEMBL4448908	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040519	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CCC1c1cc[nH]n1		CHEMBL4446758	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040520	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CCC1c1c[nH]cn1		CHEMBL4446928	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040521	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CCC1c1cocn1		CHEMBL4440532	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040522	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CCC1C1CCCCC1		CHEMBL4590117	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040523	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CCC1C1CCCC1		CHEMBL4467752	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040524	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(C)C(=O)N1N=CCC1C1CCOCC1		CHEMBL4472572	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040525	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CN1CCC(C2CC=NN2C(=O)C(C)(C)C)CC1		CHEMBL4452768	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040526	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)C(=O)N1N=CCC1c1ccccc1		CHEMBL4519627	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040527	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(CO)C(=O)N1N=CCC1c1ccccc1		CHEMBL4451628	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040528	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(C)(CN)C(=O)N1N=CCC1c1ccccc1		CHEMBL4437098	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040529	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(C1CCCC1)N1N=CCC1c1ccccc1		CHEMBL4457026	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040530	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(C1CCCCC1)N1N=CCC1c1ccccc1		CHEMBL4471642	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040531	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(C1CCC1)N1N=CCC1c1ccccc1		CHEMBL4436131	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040532	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(C1CCOCC1)N1N=CCC1c1ccccc1		CHEMBL4474301	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040533	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(C1CCOC1)N1N=CCC1c1ccccc1		CHEMBL4474937	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040534	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(c1ccccc1)N1N=CCC1c1ccccc1		CHEMBL4564157	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040535	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(c1ccncc1)N1N=CCC1c1ccccc1		CHEMBL4452678	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040536	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(c1cccnc1)N1N=CCC1c1ccccc1		CHEMBL4554458	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040537	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(c1ccccn1)N1N=CCC1c1ccccc1		CHEMBL4519892	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040538	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CN1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4527680	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040539	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(C1CCN(c2ccccc2)CC1)N1N=CCC1c1ccccc1		CHEMBL4565985	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040540	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(=O)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4553214	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040541	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CC(=O)N1CCC(C(=O)N2N=CC[C@H]2c2ccccc2)CC1		CHEMBL4474320	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040542	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(C1CCN(C(=O)C(F)(F)F)CC1)N1N=CCC1c1ccccc1		CHEMBL4463322	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040543	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	CCC(=O)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4526661	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040544	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(C1CCCCC1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4448942	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040545	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(c1ccccc1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4588685	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040546	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(c1cccnc1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4548719	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040547	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(c1ccccn1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4575848	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040548	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(c1cocn1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4584779	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040549	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(c1cnco1)N1CCC(C(=O)N2N=CC[C@H]2c2ccccc2)CC1		CHEMBL4548784	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040550	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(c1cc[nH]n1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4583157	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040551	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(c1cn[nH]c1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4524420	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040552	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(c1c[nH]nn1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4465743	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040553	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(c1cscn1)N1CCC(C(=O)N2N=CC[C@H]2c2ccccc2)CC1		CHEMBL4552893	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040554	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(C1CCN(c2ccccc2)CC1)N1N=CC[C@H]1c1ccccc1		CHEMBL4594130	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040555	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(C1CCN(c2ccccn2)CC1)N1N=CC[C@H]1c1ccccc1		CHEMBL4454462	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040556	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(C1CCN(c2ncccn2)CC1)N1N=CC[C@H]1c1ccccc1		CHEMBL4455042	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040557	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(C1CCN(c2ccncn2)CC1)N1N=CC[C@H]1c1ccccc1		CHEMBL4443534	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040558	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	O=C(C1CCN(c2cccnn2)CC1)N1N=CC[C@H]1c1ccccc1		CHEMBL4556751	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040559	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	Cc1nnc(N2CCC(C(=O)N3N=CC[C@H]3c3ccccc3)CC2)o1		CHEMBL4454881	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040560	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	N#Cc1ccc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)nn1		CHEMBL4561445	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040561	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	N#Cc1cnc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)cn1		CHEMBL4450890	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040562	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	N#Cc1nccc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)n1		CHEMBL4541955	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040563	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	N#Cc1cc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)ncn1		CHEMBL4514271	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040564	CHEMBL4352155	Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to human GST/His-tagged RIP1 (1 to 375) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay	B	Cc1nnc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)o1		CHEMBL4545939	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040565	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccccc1		CHEMBL4446915	=	IC50	nM	4.8	CHEMBL5464	Homo sapiens	IC50	nM	4.8
	19040566	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353	=	IC50	nM	1.6	CHEMBL5464	Homo sapiens	IC50	nM	1.6
	19040567	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CC[C@@H]1c1ccccc1		CHEMBL4442060	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040568	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CCC1c1cccc(F)c1		CHEMBL4537171	=	IC50	nM	0.5	CHEMBL5464	Homo sapiens	IC50	nM	0.5
	19040569	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	Cc1ccc(C2CC=NN2C(=O)C(C)(C)C)cc1F		CHEMBL4514028	=	IC50	nM	2.0	CHEMBL5464	Homo sapiens	IC50	nM	2.0
	19040570	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CCC1c1cc(F)cc(F)c1		CHEMBL4593226	=	IC50	nM	1.3	CHEMBL5464	Homo sapiens	IC50	nM	1.3
	19040571	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	Cc1ccc(C2CC=NN2C(=O)C(C)(C)C)cc1		CHEMBL4436215	=	IC50	nM	6.3	CHEMBL5464	Homo sapiens	IC50	nM	6.3
	19040572	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccc(Cl)cc1		CHEMBL4576386	=	IC50	nM	6.3	CHEMBL5464	Homo sapiens	IC50	nM	6.3
	19040573	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CCC1c1cccc(Cl)c1		CHEMBL4556131	=	IC50	nM	9.0	CHEMBL5464	Homo sapiens	IC50	nM	9.0
	19040574	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccc(C(C)(C)C)cc1		CHEMBL4533161	=	IC50	nM	3980.0	CHEMBL5464	Homo sapiens	IC50	nM	3980.0
	19040575	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccc(S(C)(=O)=O)cc1		CHEMBL4436896	=	IC50	nM	2000.0	CHEMBL5464	Homo sapiens	IC50	nM	2000.0
	19040576	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccccn1		CHEMBL4544356	=	IC50	nM	316.0	CHEMBL5464	Homo sapiens	IC50	nM	316.0
	19040577	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CCC1c1cccnc1		CHEMBL4446523	=	IC50	nM	159.0	CHEMBL5464	Homo sapiens	IC50	nM	159.0
	19040578	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccncc1		CHEMBL4448908	=	IC50	nM	5012.0	CHEMBL5464	Homo sapiens	IC50	nM	5012.0
	19040579	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CCC1c1cc[nH]n1		CHEMBL4446758	=	IC50	nM	3980.0	CHEMBL5464	Homo sapiens	IC50	nM	3980.0
	19040580	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CCC1c1c[nH]cn1		CHEMBL4446928	=	IC50	nM	3980.0	CHEMBL5464	Homo sapiens	IC50	nM	3980.0
	19040581	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CCC1c1cocn1		CHEMBL4440532	=	IC50	nM	794.0	CHEMBL5464	Homo sapiens	IC50	nM	794.0
	19040582	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CCC1C1CCCCC1		CHEMBL4590117	=	IC50	nM	126.0	CHEMBL5464	Homo sapiens	IC50	nM	126.0
	19040583	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CCC1C1CCCC1		CHEMBL4467752	=	IC50	nM	200.0	CHEMBL5464	Homo sapiens	IC50	nM	200.0
	19040584	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(C)C(=O)N1N=CCC1C1CCOCC1		CHEMBL4472572	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040585	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CN1CCC(C2CC=NN2C(=O)C(C)(C)C)CC1		CHEMBL4452768	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040586	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)C(=O)N1N=CCC1c1ccccc1		CHEMBL4519627	=	IC50	nM	80.0	CHEMBL5464	Homo sapiens	IC50	nM	80.0
	19040587	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(CO)C(=O)N1N=CCC1c1ccccc1		CHEMBL4451628	=	IC50	nM	631.0	CHEMBL5464	Homo sapiens	IC50	nM	631.0
	19040588	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(C)(CN)C(=O)N1N=CCC1c1ccccc1		CHEMBL4437098	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040589	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(C1CCCC1)N1N=CCC1c1ccccc1		CHEMBL4457026	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	nM	16.0
	19040590	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(C1CCCCC1)N1N=CCC1c1ccccc1		CHEMBL4471642	=	IC50	nM	1.6	CHEMBL5464	Homo sapiens	IC50	nM	1.6
	19040591	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(C1CCC1)N1N=CCC1c1ccccc1		CHEMBL4436131	=	IC50	nM	126.0	CHEMBL5464	Homo sapiens	IC50	nM	126.0
	19040592	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(C1CCOCC1)N1N=CCC1c1ccccc1		CHEMBL4474301	=	IC50	nM	316.0	CHEMBL5464	Homo sapiens	IC50	nM	316.0
	19040593	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(C1CCOC1)N1N=CCC1c1ccccc1		CHEMBL4474937	=	IC50	nM	1000.0	CHEMBL5464	Homo sapiens	IC50	nM	1000.0
	19040594	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(c1ccccc1)N1N=CCC1c1ccccc1		CHEMBL4564157	=	IC50	nM	398.0	CHEMBL5464	Homo sapiens	IC50	nM	398.0
	19040595	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(c1ccncc1)N1N=CCC1c1ccccc1		CHEMBL4452678	=	IC50	nM	2000.0	CHEMBL5464	Homo sapiens	IC50	nM	2000.0
	19040596	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(c1cccnc1)N1N=CCC1c1ccccc1		CHEMBL4554458	=	IC50	nM	2512.0	CHEMBL5464	Homo sapiens	IC50	nM	2512.0
	19040597	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(c1ccccn1)N1N=CCC1c1ccccc1		CHEMBL4519892	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040598	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CN1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4527680	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040599	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(C1CCN(c2ccccc2)CC1)N1N=CCC1c1ccccc1		CHEMBL4565985	=	IC50	nM	13.0	CHEMBL5464	Homo sapiens	IC50	nM	13.0
	19040600	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(=O)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4553214	=	IC50	nM	126.0	CHEMBL5464	Homo sapiens	IC50	nM	126.0
	19040601	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CC(=O)N1CCC(C(=O)N2N=CC[C@H]2c2ccccc2)CC1		CHEMBL4474320	=	IC50	nM	35.0	CHEMBL5464	Homo sapiens	IC50	nM	35.0
	19040602	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(C1CCN(C(=O)C(F)(F)F)CC1)N1N=CCC1c1ccccc1		CHEMBL4463322	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	nM	16.0
	19040603	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	CCC(=O)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4526661	=	IC50	nM	126.0	CHEMBL5464	Homo sapiens	IC50	nM	126.0
	19040604	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(C1CCCCC1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4448942	=	IC50	nM	794.0	CHEMBL5464	Homo sapiens	IC50	nM	794.0
	19040605	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(c1ccccc1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4588685	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040606	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(c1cccnc1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4548719	=	IC50	nM	159.0	CHEMBL5464	Homo sapiens	IC50	nM	159.0
	19040607	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(c1ccccn1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4575848	=	IC50	nM	2.5	CHEMBL5464	Homo sapiens	IC50	nM	2.5
	19040608	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(c1cocn1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4584779	=	IC50	nM	6.3	CHEMBL5464	Homo sapiens	IC50	nM	6.3
	19040609	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(c1cnco1)N1CCC(C(=O)N2N=CC[C@H]2c2ccccc2)CC1		CHEMBL4548784	=	IC50	nM	2.5	CHEMBL5464	Homo sapiens	IC50	nM	2.5
	19040610	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(c1cc[nH]n1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4583157	=	IC50	nM	25.0	CHEMBL5464	Homo sapiens	IC50	nM	25.0
	19040611	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(c1cn[nH]c1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4524420	=	IC50	nM	79.0	CHEMBL5464	Homo sapiens	IC50	nM	79.0
	19040612	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(c1c[nH]nn1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4465743	=	IC50	nM	32.0	CHEMBL5464	Homo sapiens	IC50	nM	32.0
	19040613	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(c1cscn1)N1CCC(C(=O)N2N=CC[C@H]2c2ccccc2)CC1		CHEMBL4552893	=	IC50	nM	20.0	CHEMBL5464	Homo sapiens	IC50	nM	20.0
	19040614	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(C1CCN(c2ccccc2)CC1)N1N=CC[C@H]1c1ccccc1		CHEMBL4594130	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	nM	16.0
	19040615	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(C1CCN(c2ccccn2)CC1)N1N=CC[C@H]1c1ccccc1		CHEMBL4454462	=	IC50	nM	2.5	CHEMBL5464	Homo sapiens	IC50	nM	2.5
	19040616	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(C1CCN(c2ncccn2)CC1)N1N=CC[C@H]1c1ccccc1		CHEMBL4455042	=	IC50	nM	1.6	CHEMBL5464	Homo sapiens	IC50	nM	1.6
	19040617	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(C1CCN(c2ccncn2)CC1)N1N=CC[C@H]1c1ccccc1		CHEMBL4443534	=	IC50	nM	5.0	CHEMBL5464	Homo sapiens	IC50	nM	5.0
	19040618	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	O=C(C1CCN(c2cccnn2)CC1)N1N=CC[C@H]1c1ccccc1		CHEMBL4556751	=	IC50	nM	20.0	CHEMBL5464	Homo sapiens	IC50	nM	20.0
	19040619	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	Cc1nnc(N2CCC(C(=O)N3N=CC[C@H]3c3ccccc3)CC2)o1		CHEMBL4454881	=	IC50	nM	50.0	CHEMBL5464	Homo sapiens	IC50	nM	50.0
	19040620	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	N#Cc1ccc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)nn1		CHEMBL4561445	=	IC50	nM	7.9	CHEMBL5464	Homo sapiens	IC50	nM	7.9
	19040621	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	N#Cc1cnc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)cn1		CHEMBL4450890	=	IC50	nM	2.0	CHEMBL5464	Homo sapiens	IC50	nM	2.0
	19040622	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	N#Cc1nccc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)n1		CHEMBL4541955	=	IC50	nM	2.5	CHEMBL5464	Homo sapiens	IC50	nM	2.5
	19040623	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	N#Cc1cc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)ncn1		CHEMBL4514271	=	IC50	nM	1.0	CHEMBL5464	Homo sapiens	IC50	nM	1.0
	19040624	CHEMBL4352156	Inhibition of human GST/His-tagged RIP1 (1 to 375 residues) expressed in baculovirus expression system assessed as reduction in autophosphorylation measured after 4 hrs in presence of ATP by ADP-Glo luminescence assay	B	Cc1nnc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)o1		CHEMBL4545939	=	IC50	nM	20.0	CHEMBL5464	Homo sapiens	IC50	nM	20.0
	19040625	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(Nc1cccc(Cl)c1)N1N=CCC1c1ccccc1		CHEMBL1580000	=	IC50	nM	398.0	CHEMBL5464	Homo sapiens	IC50	nM	398.0
	19040626	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1CCCC1c1ccccc1		CHEMBL4584741	=	IC50	nM	316.0	CHEMBL5464	Homo sapiens	IC50	nM	316.0
	19040627	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccccc1		CHEMBL4446915	=	IC50	nM	8.0	CHEMBL5464	Homo sapiens	IC50	nM	8.0
	19040628	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353	=	IC50	nM	4.0	CHEMBL5464	Homo sapiens	IC50	nM	4.0
	19040629	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CC[C@@H]1c1ccccc1		CHEMBL4442060	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040630	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1CCCC1c1cccc(F)c1		CHEMBL4438495	=	IC50	nM	79.0	CHEMBL5464	Homo sapiens	IC50	nM	79.0
	19040631	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC1=NN(C(=O)C(C)(C)C)[C@H](c2ccccc2)C1		CHEMBL4545356	=	IC50	nM	159.0	CHEMBL5464	Homo sapiens	IC50	nM	159.0
	19040632	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	C[C@@H]1C=NN(C(=O)C(C)(C)C)[C@@H]1c1ccccc1		CHEMBL4437641	=	IC50	nM	400.0	CHEMBL5464	Homo sapiens	IC50	nM	400.0
	19040633	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)n1nccc1-c1ccccc1		CHEMBL4463613	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040634	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1CCCCC1c1ccccc1		CHEMBL4577829	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040635	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1CCOCC1c1ccccc1		CHEMBL4464244	>	IC50	nM	1000.0	CHEMBL5464	Homo sapiens	IC50	nM	1000.0
	19040636	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1CCNCC1c1ccccc1		CHEMBL4458681	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040637	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CN1CCN(C(=O)C(C)(C)C)C(c2ccccc2)C1		CHEMBL4555675	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040638	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1CCSC1c1ccccc1		CHEMBL4455695	>	IC50	nM	1000.0	CHEMBL5464	Homo sapiens	IC50	nM	1000.0
	19040639	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1CCC1c1ccccc1		CHEMBL4540090	=	IC50	nM	126.0	CHEMBL5464	Homo sapiens	IC50	nM	126.0
	19040640	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CCC1c1cccc(F)c1		CHEMBL4537171	=	IC50	nM	4.0	CHEMBL5464	Homo sapiens	IC50	nM	4.0
	19040641	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	Cc1ccc(C2CC=NN2C(=O)C(C)(C)C)cc1F		CHEMBL4514028	=	IC50	nM	2.5	CHEMBL5464	Homo sapiens	IC50	nM	2.5
	19040642	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CCC1c1cc(F)cc(F)c1		CHEMBL4593226	=	IC50	nM	6.4	CHEMBL5464	Homo sapiens	IC50	nM	6.4
	19040643	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	Cc1ccc(C2CC=NN2C(=O)C(C)(C)C)cc1		CHEMBL4436215	=	IC50	nM	4.0	CHEMBL5464	Homo sapiens	IC50	nM	4.0
	19040644	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccc(Cl)cc1		CHEMBL4576386	=	IC50	nM	13.0	CHEMBL5464	Homo sapiens	IC50	nM	13.0
	19040645	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CCC1c1cccc(Cl)c1		CHEMBL4556131	=	IC50	nM	63.0	CHEMBL5464	Homo sapiens	IC50	nM	63.0
	19040646	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccc(C(C)(C)C)cc1		CHEMBL4533161	>	IC50	nM	1000.0	CHEMBL5464	Homo sapiens	IC50	nM	1000.0
	19040647	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccc(S(C)(=O)=O)cc1		CHEMBL4436896	>	IC50	nM	1000.0	CHEMBL5464	Homo sapiens	IC50	nM	1000.0
	19040648	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccccn1		CHEMBL4544356	=	IC50	nM	398.0	CHEMBL5464	Homo sapiens	IC50	nM	398.0
	19040649	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CCC1c1cccnc1		CHEMBL4446523	=	IC50	nM	126.0	CHEMBL5464	Homo sapiens	IC50	nM	126.0
	19040650	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CCC1c1ccncc1		CHEMBL4448908	>	IC50	nM	1000.0	CHEMBL5464	Homo sapiens	IC50	nM	1000.0
	19040651	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CCC1c1cc[nH]n1		CHEMBL4446758	>	IC50	nM	1000.0	CHEMBL5464	Homo sapiens	IC50	nM	1000.0
	19040652	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CCC1c1c[nH]cn1		CHEMBL4446928	=	IC50	nM	5012.0	CHEMBL5464	Homo sapiens	IC50	nM	5012.0
	19040653	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CCC1c1cocn1		CHEMBL4440532	=	IC50	nM	1000.0	CHEMBL5464	Homo sapiens	IC50	nM	1000.0
	19040654	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CCC1C1CCCCC1		CHEMBL4590117	=	IC50	nM	794.0	CHEMBL5464	Homo sapiens	IC50	nM	794.0
	19040655	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CCC1C1CCCC1		CHEMBL4467752	=	IC50	nM	794.0	CHEMBL5464	Homo sapiens	IC50	nM	794.0
	19040656	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(C)C(=O)N1N=CCC1C1CCOCC1		CHEMBL4472572	>	IC50	nM	1000.0	CHEMBL5464	Homo sapiens	IC50	nM	1000.0
	19040657	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CN1CCC(C2CC=NN2C(=O)C(C)(C)C)CC1		CHEMBL4452768	>	IC50	nM	1000.0	CHEMBL5464	Homo sapiens	IC50	nM	1000.0
	19040658	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)C(=O)N1N=CCC1c1ccccc1		CHEMBL4519627	=	IC50	nM	159.0	CHEMBL5464	Homo sapiens	IC50	nM	159.0
	19040659	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(CO)C(=O)N1N=CCC1c1ccccc1		CHEMBL4451628	=	IC50	nM	501.0	CHEMBL5464	Homo sapiens	IC50	nM	501.0
	19040660	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(C)(CN)C(=O)N1N=CCC1c1ccccc1		CHEMBL4437098	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040661	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(C1CCCC1)N1N=CCC1c1ccccc1		CHEMBL4457026	=	IC50	nM	63.0	CHEMBL5464	Homo sapiens	IC50	nM	63.0
	19040662	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(C1CCCCC1)N1N=CCC1c1ccccc1		CHEMBL4471642	=	IC50	nM	13.0	CHEMBL5464	Homo sapiens	IC50	nM	13.0
	19040663	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(C1CCC1)N1N=CCC1c1ccccc1		CHEMBL4436131	=	IC50	nM	200.0	CHEMBL5464	Homo sapiens	IC50	nM	200.0
	19040664	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(C1CCOCC1)N1N=CCC1c1ccccc1		CHEMBL4474301	=	IC50	nM	794.0	CHEMBL5464	Homo sapiens	IC50	nM	794.0
	19040665	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(C1CCOC1)N1N=CCC1c1ccccc1		CHEMBL4474937	>	IC50	nM	1000.0	CHEMBL5464	Homo sapiens	IC50	nM	1000.0
	19040666	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(c1ccccc1)N1N=CCC1c1ccccc1		CHEMBL4564157	=	IC50	nM	794.0	CHEMBL5464	Homo sapiens	IC50	nM	794.0
	19040667	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(c1ccncc1)N1N=CCC1c1ccccc1		CHEMBL4452678	=	IC50	nM	2000.0	CHEMBL5464	Homo sapiens	IC50	nM	2000.0
	19040668	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(c1cccnc1)N1N=CCC1c1ccccc1		CHEMBL4554458	=	IC50	nM	2000.0	CHEMBL5464	Homo sapiens	IC50	nM	2000.0
	19040669	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(c1ccccn1)N1N=CCC1c1ccccc1		CHEMBL4519892	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	19040670	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CN1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4527680	=	IC50	nM	7940.0	CHEMBL5464	Homo sapiens	IC50	nM	7940.0
	19040671	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(C1CCN(c2ccccc2)CC1)N1N=CCC1c1ccccc1		CHEMBL4565985	=	IC50	nM	79.0	CHEMBL5464	Homo sapiens	IC50	nM	79.0
	19040672	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(=O)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4553214	=	IC50	nM	501.0	CHEMBL5464	Homo sapiens	IC50	nM	501.0
	19040673	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CC(=O)N1CCC(C(=O)N2N=CC[C@H]2c2ccccc2)CC1		CHEMBL4474320	=	IC50	nM	126.0	CHEMBL5464	Homo sapiens	IC50	nM	126.0
	19040674	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(C1CCN(C(=O)C(F)(F)F)CC1)N1N=CCC1c1ccccc1		CHEMBL4463322	=	IC50	nM	160.0	CHEMBL5464	Homo sapiens	IC50	nM	160.0
	19040675	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	CCC(=O)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4526661	=	IC50	nM	316.0	CHEMBL5464	Homo sapiens	IC50	nM	316.0
	19040676	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(C1CCCCC1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4448942	=	IC50	nM	2511.0	CHEMBL5464	Homo sapiens	IC50	nM	2511.0
	19040677	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(c1ccccc1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4588685	=	IC50	nM	79.0	CHEMBL5464	Homo sapiens	IC50	nM	79.0
	19040678	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(c1cccnc1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4548719	=	IC50	nM	316.0	CHEMBL5464	Homo sapiens	IC50	nM	316.0
	19040679	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(c1ccccn1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4575848	=	IC50	nM	316.0	CHEMBL5464	Homo sapiens	IC50	nM	316.0
	19040680	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(c1cocn1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4584779	=	IC50	nM	7.9	CHEMBL5464	Homo sapiens	IC50	nM	7.9
	19040681	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(c1cnco1)N1CCC(C(=O)N2N=CC[C@H]2c2ccccc2)CC1		CHEMBL4548784	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040682	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(c1cc[nH]n1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4583157	=	IC50	nM	100.0	CHEMBL5464	Homo sapiens	IC50	nM	100.0
	19040683	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(c1cn[nH]c1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4524420	=	IC50	nM	251.0	CHEMBL5464	Homo sapiens	IC50	nM	251.0
	19040684	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(c1c[nH]nn1)N1CCC(C(=O)N2N=CCC2c2ccccc2)CC1		CHEMBL4465743	=	IC50	nM	159.0	CHEMBL5464	Homo sapiens	IC50	nM	159.0
	19040685	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(c1cscn1)N1CCC(C(=O)N2N=CC[C@H]2c2ccccc2)CC1		CHEMBL4552893	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	nM	16.0
	19040686	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(C1CCN(c2ccccc2)CC1)N1N=CC[C@H]1c1ccccc1		CHEMBL4594130	=	IC50	nM	25.0	CHEMBL5464	Homo sapiens	IC50	nM	25.0
	19040687	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(C1CCN(c2ccccn2)CC1)N1N=CC[C@H]1c1ccccc1		CHEMBL4454462	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	nM	16.0
	19040688	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(C1CCN(c2ncccn2)CC1)N1N=CC[C@H]1c1ccccc1		CHEMBL4455042	=	IC50	nM	10.0	CHEMBL5464	Homo sapiens	IC50	nM	10.0
	19040689	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(C1CCN(c2ccncn2)CC1)N1N=CC[C@H]1c1ccccc1		CHEMBL4443534	=	IC50	nM	32.0	CHEMBL5464	Homo sapiens	IC50	nM	32.0
	19040690	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	O=C(C1CCN(c2cccnn2)CC1)N1N=CC[C@H]1c1ccccc1		CHEMBL4556751	=	IC50	nM	50.0	CHEMBL5464	Homo sapiens	IC50	nM	50.0
	19040691	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	Cc1nnc(N2CCC(C(=O)N3N=CC[C@H]3c3ccccc3)CC2)o1		CHEMBL4454881	=	IC50	nM	126.0	CHEMBL5464	Homo sapiens	IC50	nM	126.0
	19040692	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	N#Cc1ccc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)nn1		CHEMBL4561445	=	IC50	nM	25.0	CHEMBL5464	Homo sapiens	IC50	nM	25.0
	19040693	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	N#Cc1cnc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)cn1		CHEMBL4450890	=	IC50	nM	7.9	CHEMBL5464	Homo sapiens	IC50	nM	7.9
	19040694	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	N#Cc1nccc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)n1		CHEMBL4541955	=	IC50	nM	2.0	CHEMBL5464	Homo sapiens	IC50	nM	2.0
	19040695	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	N#Cc1cc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)ncn1		CHEMBL4514271	=	IC50	nM	4.0	CHEMBL5464	Homo sapiens	IC50	nM	4.0
	19040696	CHEMBL4352157	Inhibition of RIP1 in human U937 cells assessed as reduction in TNFalpha/QVD-Oph-induced necroptosis measured after 24 hrs by cell titer-glo luminescent cell viability assay	B	Cc1nnc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)o1		CHEMBL4545939	=	IC50	nM	63.0	CHEMBL5464	Homo sapiens	IC50	nM	63.0
	19040979	CHEMBL4352240	Inhibition of RIP1 in human whole blood assessed as reduction in TNFalpha/zVAD-fmk/SMAC-induced MIP1alpha production measured after 6 hrs by ELISA	B	Cc1nnc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)o1		CHEMBL4545939	=	IC50	nM	8.5	CHEMBL5464	Homo sapiens	IC50	nM	8.5
	19059807	CHEMBL4358108	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL5464	Homo sapiens	Activity	%	100.0
	19090371	CHEMBL4365945	Inhibition of wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL5464	Homo sapiens	Activity	%	100.0
	19144827	CHEMBL4377843	Inhibition of human RIPK1 (8 to 322 residues) at 1 uM using myelin basic protein as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	37.0	CHEMBL5464	Homo sapiens	INH	%	37.0
	19146675	CHEMBL4378712	Inhibition of RIPK1 (1 to 312 residues) (unknown origin) preincubated for 15 mins followed by addition of [gamma32P] ATP and measured after 30 mins by SDS-PAGE based autoradiography	B	CN1C(=O)NC(Cc2c[nH]c3c(Cl)cccc23)C1=O		CHEMBL381230	=	IC50	nM	320.0	CHEMBL5464	Homo sapiens	IC50	uM	0.32
	19146679	CHEMBL4378715	Inhibition of human RIPK1	B	COc1ccc2c(c1)CC[C@H](NC(=O)c1nc3n(n1)[C@H](c1ccccc1)CC3)C(=O)N2C		CHEMBL4455611	=	Ki	nM	21.0	CHEMBL5464	Homo sapiens	Ki(app)	nM	21.0
	19146690	CHEMBL4378724	Inhibition of recombinant RIPK1 (unknown origin) using MBP as substrate preincubated for 15 mins followed by addition of MBP and measured after 120 min ADP-Glo kinase assay	B	CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(CC(=O)Cc4ccccc4)c3)cc2s1		CHEMBL4453780	=	IC50	nM	200.0	CHEMBL5464	Homo sapiens	IC50	nM	200.0
	19146691	CHEMBL4378724	Inhibition of recombinant RIPK1 (unknown origin) using MBP as substrate preincubated for 15 mins followed by addition of MBP and measured after 120 min ADP-Glo kinase assay	B	CC(=O)Nc1nc2ccc(-c3cnc(C)c(CC(=O)OC4CCCCC4)c3)cc2s1		CHEMBL4464023	=	IC50	nM	90.0	CHEMBL5464	Homo sapiens	IC50	nM	90.0
	19146697	CHEMBL4378729	Inhibition of recombinant GST-tagged RIPK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 4 hrs by ADP-Glo assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	12.0	CHEMBL5464	Homo sapiens	IC50	nM	12.0
	19146698	CHEMBL4378729	Inhibition of recombinant GST-tagged RIPK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 4 hrs by ADP-Glo assay	B	Cc1ccc(CCCCN2C(=O)N[C@H](Cc3c[nH]c4c(Cl)cccc34)C2=O)cc1C#Cc1cnc2cccnn12		CHEMBL4464634	=	IC50	nM	90.0	CHEMBL5464	Homo sapiens	IC50	nM	90.0
	19146707	CHEMBL4378734	Inhibition of RIPK1 in human HT-29 cells assessed as reduction in TNFalpha-induced necroptosis incubated for 14 to 24 hrs in presence of Smac mimetic and z-VAD-FMK by cell titer glo-based luminescence assay	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	873.0	CHEMBL5464	Homo sapiens	IC50	nM	873.0
	19146708	CHEMBL4378735	Inhibition of recombinant human GST-tagged RIPK1 (1 to 479 residues) incubated for 4 hrs by ADP-Glo assay	B	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21		CHEMBL2171124	=	IC50	nM	18.0	CHEMBL5464	Homo sapiens	IC50	nM	18.0
	19146709	CHEMBL4378735	Inhibition of recombinant human GST-tagged RIPK1 (1 to 479 residues) incubated for 4 hrs by ADP-Glo assay	B	Cn1cc(-c2ccc3c(c2F)CCN3C(=O)Cc2cccc(C(F)(F)F)n2)c2c(N)ncnc21		CHEMBL2441342	=	IC50	nM	69.0	CHEMBL5464	Homo sapiens	IC50	nM	69.0
	19146717	CHEMBL4378741	Inhibition of human full length GST-tagged RIPK1 expressed in baculovirus in Sf9 insect cells incubated for 10 mins in presence of [gamma32-ATP] by SDS-PAGE based topcount scintillation counting method	B	Oc1ccc(-c2cc3cccnc3[nH]2)cc1		CHEMBL4439426	=	IC50	nM	1030.0	CHEMBL5464	Homo sapiens	IC50	nM	1030.0
	19146718	CHEMBL4378742	Binding affinity to human RIPK1 by kinome scan based method	B	Oc1ccc(-c2cc3cccnc3[nH]2)cc1		CHEMBL4439426	=	Kd	nM	218.0	CHEMBL5464	Homo sapiens	Kd	nM	218.0
	19146719	CHEMBL4378742	Binding affinity to human RIPK1 by kinome scan based method	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	1300.0	CHEMBL5464	Homo sapiens	Kd	nM	1300.0
	19146720	CHEMBL4378742	Binding affinity to human RIPK1 by kinome scan based method	B	Nc1nccnc1C(=O)O[C@@H](C(=O)Nc1ccc(F)cc1)c1ccccc1		CHEMBL4440337	>	Kd	nM	30000.0	CHEMBL5464	Homo sapiens	Kd	nM	30000.0
	19146721	CHEMBL4378742	Binding affinity to human RIPK1 by kinome scan based method	B	COc1cc(O)c2c(c1)OC(O)(c1ccc(OCc3ccccc3)cc1)CC2=O		CHEMBL4534082	=	Kd	nM	130.0	CHEMBL5464	Homo sapiens	Kd	nM	130.0
	19146723	CHEMBL4378744	Inhibition of GSK657 binding to human RIPK1 (1 to 328) by fluorescence Polarization assay	B	CNC(=O)c1ccc2c(c1)ncn2-c1ccc(CC(=O)OC(C)(C)C)cc1		CHEMBL4439913	=	IC50	nM	0.9	CHEMBL5464	Homo sapiens	IC50	nM	0.9
	19146724	CHEMBL4378744	Inhibition of GSK657 binding to human RIPK1 (1 to 328) by fluorescence Polarization assay	B	Cc1cc(-c2cnc(N)c3c(-c4ccc5scnc5c4)csc23)n(C)n1		CHEMBL4441118	=	IC50	nM	8.6	CHEMBL5464	Homo sapiens	IC50	nM	8.6
	19146725	CHEMBL4378744	Inhibition of GSK657 binding to human RIPK1 (1 to 328) by fluorescence Polarization assay	B	CC(C)S(=O)(=O)c1ccc2nccc(Nc3ccc4ncsc4c3)c2c1		CHEMBL4469781	=	IC50	nM	1.8	CHEMBL5464	Homo sapiens	IC50	nM	1.8
	19146726	CHEMBL4378745	Inhibition of human RIPK1 by ADP-Glo assay	B	CNC(=O)c1ccc2c(c1)ncn2-c1ccc(CC(=O)OC(C)(C)C)cc1		CHEMBL4439913	=	IC50	nM	0.3	CHEMBL5464	Homo sapiens	IC50	nM	0.3
	19146727	CHEMBL4378745	Inhibition of human RIPK1 by ADP-Glo assay	B	Cc1cc(-c2cnc(N)c3c(-c4ccc5scnc5c4)csc23)n(C)n1		CHEMBL4441118	=	IC50	nM	6.5	CHEMBL5464	Homo sapiens	IC50	nM	6.5
	19146728	CHEMBL4378745	Inhibition of human RIPK1 by ADP-Glo assay	B	CC(C)S(=O)(=O)c1ccc2nccc(Nc3ccc4ncsc4c3)c2c1		CHEMBL4469781	=	IC50	nM	1.3	CHEMBL5464	Homo sapiens	IC50	nM	1.3
	19146729	CHEMBL4378746	Inhibition of RIPK1 (unknown origin)	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12		CHEMBL395358	=	IC50	nM	73.6	CHEMBL5464	Homo sapiens	IC50	nM	73.6
	19146730	CHEMBL4378746	Inhibition of RIPK1 (unknown origin)	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCCCC5)c4)ccc23)cc1		CHEMBL4474235	=	IC50	nM	20.8	CHEMBL5464	Homo sapiens	IC50	nM	20.8
	19146731	CHEMBL4378746	Inhibition of RIPK1 (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	1500.0	CHEMBL5464	Homo sapiens	IC50	nM	1500.0
	19146748	CHEMBL4378757	Binding affinity to RIPK1 (unknown origin) assessed as increase in thermal stabilization at 10 uM incubated for 30 mins by thermal shift dye based qPCR analysis	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Delta Tm	degrees C	0.75	CHEMBL5464	Homo sapiens	deltaTm	degrees C	0.75
	19146749	CHEMBL4378757	Binding affinity to RIPK1 (unknown origin) assessed as increase in thermal stabilization at 10 uM incubated for 30 mins by thermal shift dye based qPCR analysis	B	Nc1nccnc1C(=O)O[C@@H](C(=O)Nc1ccc(F)cc1)c1ccccc1		CHEMBL4440337	=	Delta Tm	degrees C	-0.15	CHEMBL5464	Homo sapiens	deltaTm	degrees C	-0.15
	19146756	CHEMBL4378759	Inhibition of human RIPK1 using MBP as substrate by [gamma33-ATP] based radiometric assay	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	IC50	nM	53200.0	CHEMBL5464	Homo sapiens	IC50	nM	53200.0
	19148022	CHEMBL4379418	Inhibition of recombinant human RIPK1 (8 to 322 residues) using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	uM	10.0
	19159635	CHEMBL4382739	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	82.0	CHEMBL5464	Homo sapiens	Activity	%	82.0
	19191372	CHEMBL4389458	Inhibition of wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL5464	Homo sapiens	INH	%	100.0
	19192121	CHEMBL4389935	Inhibition of wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL5464	Homo sapiens	INH	%	100.0
	19200377	CHEMBL4391561	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	3.3	CHEMBL5464	Homo sapiens	Activity	%	3.3
	19271932	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Cc1cccc(C(F)(F)F)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4540715	=	Kd	nM	97.0	CHEMBL5464	Homo sapiens	Kd	nM	97.0
Not Determined	19271933	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Cc1ccccc1C(F)(F)F)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4535384		Kd			CHEMBL5464	Homo sapiens	Kd		
	19271934	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Cc1cccc(C(F)(F)F)c1F)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4553409	=	Kd	nM	510.0	CHEMBL5464	Homo sapiens	Kd	nM	510.0
	19271935	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Cc1ccc(F)c(C(F)(F)F)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4438227	=	Kd	nM	590.0	CHEMBL5464	Homo sapiens	Kd	nM	590.0
Not Determined	19271936	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Cc1cccc(C(F)(F)F)c1Cl)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4538649		Kd			CHEMBL5464	Homo sapiens	Kd		
Not Determined	19271937	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4437431		Kd			CHEMBL5464	Homo sapiens	Kd		
	19271938	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	Cc1ccc(CC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)cc1C		CHEMBL4550952	=	Kd	nM	1200.0	CHEMBL5464	Homo sapiens	Kd	nM	1200.0
	19271939	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Cc1cccc([N+](=O)[O-])c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4590158	=	Kd	nM	770.0	CHEMBL5464	Homo sapiens	Kd	nM	770.0
	19271940	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	Cc1cccc(CC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)c1		CHEMBL4444744	=	Kd	nM	320.0	CHEMBL5464	Homo sapiens	Kd	nM	320.0
	19271941	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	COc1cccc(CC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)c1		CHEMBL4464579	=	Kd	nM	240.0	CHEMBL5464	Homo sapiens	Kd	nM	240.0
	19271942	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Cc1cccc(OC(F)(F)F)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4439346	=	Kd	nM	49.0	CHEMBL5464	Homo sapiens	Kd	nM	49.0
Not Determined	19271943	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Cc1cccc(O)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4548286		Kd			CHEMBL5464	Homo sapiens	Kd		
	19271944	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	N#Cc1cccc(CC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)c1		CHEMBL4573380	=	Kd	nM	780.0	CHEMBL5464	Homo sapiens	Kd	nM	780.0
	19271945	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Cc1cccc(C(F)(F)F)n1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4575736	=	Kd	nM	220.0	CHEMBL5464	Homo sapiens	Kd	nM	220.0
Not Determined	19271946	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Cc1ccccn1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4530209		Kd			CHEMBL5464	Homo sapiens	Kd		
	19271947	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Cc1ccc2c(c1)OCO2)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4469480	=	Kd	nM	1100.0	CHEMBL5464	Homo sapiens	Kd	nM	1100.0
	19271948	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	Cn1cc(CC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)c2ccccc21		CHEMBL4525593	=	Kd	nM	4800.0	CHEMBL5464	Homo sapiens	Kd	nM	4800.0
	19271949	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(CCc1cccc(C(F)(F)F)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4439279	=	Kd	nM	510.0	CHEMBL5464	Homo sapiens	Kd	nM	510.0
Not Determined	19271950	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Nc1nc2ccc(Oc3ccc(F)c(NC(=O)C4(c5cccc(C(F)(F)F)c5)CC4)c3)cc2s1)C1CC1		CHEMBL4563598		Kd			CHEMBL5464	Homo sapiens	Kd		
Not Determined	19271951	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Nc1nc2ccc(Oc3ccc(F)c(NS(=O)(=O)c4cccc(C(F)(F)F)c4)c3)cc2s1)C1CC1		CHEMBL4537807		Kd			CHEMBL5464	Homo sapiens	Kd		
Not Determined	19271952	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Nc1nc2ccc(Oc3ccc(F)c(NCc4ccc5c(c4)OCO5)c3)cc2s1)C1CC1		CHEMBL4561389		Kd			CHEMBL5464	Homo sapiens	Kd		
Not Determined	19271953	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Nc1nc2ccc(Oc3ccc(F)c(NCc4cccc(C(F)(F)F)c4)c3)cc2s1)C1CC1		CHEMBL4452724		Kd			CHEMBL5464	Homo sapiens	Kd		
	19271954	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	COc1cccc(NC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)c1		CHEMBL4594113	=	Kd	nM	3600.0	CHEMBL5464	Homo sapiens	Kd	nM	3600.0
	19271955	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	Cc1cccc(NC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)c1		CHEMBL4440432	=	Kd	nM	2200.0	CHEMBL5464	Homo sapiens	Kd	nM	2200.0
	19271956	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	CCOC(=O)c1cccc(NC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)c1		CHEMBL4454319	>	Kd	nM	5000.0	CHEMBL5464	Homo sapiens	Kd	nM	5000.0
	19271957	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	CC(=O)c1cccc(NC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)c1		CHEMBL4548552	>	Kd	nM	5000.0	CHEMBL5464	Homo sapiens	Kd	nM	5000.0
	19271958	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Nc1cccc(Br)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4465561	>	Kd	nM	5000.0	CHEMBL5464	Homo sapiens	Kd	nM	5000.0
Not Active	19272019	CHEMBL4406964	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system at 5 uM after 1 hr by quantitative PCR based KINOMEscan assay	A	O=C(Nc1cccc(Br)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4465561		Activity			CHEMBL5464	Homo sapiens	Activity		
Not Active	19272049	CHEMBL4406994	Inhibition of RIPK1 phosphorylation in TNFalpha/smac mimetic/Z-VAD-fmk stimulated human HT-29 cells at 1 uM treated prior to TNFalpha/smac mimetic/Z-VAD-fmk stimulation and measured after 2 to 4 hrs by SDS-PAGE based immunoblot assay	A	O=C(Nc1cccc(Br)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4465561		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
	19272073	CHEMBL4406960	Binding affinity to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	A	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3125890	=	Kd	nM	480.0	CHEMBL5464	Homo sapiens	Kd	nM	480.0
	19276111	CHEMBL4408114	Inhibition of recombinant human RIPK1 (8 to 322 residues) at 1 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	15.0	CHEMBL5464	Homo sapiens	INH	%	15.0
	20669017	CHEMBL4620273	Inhibition of biotinylated ligand binding to wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system at 50 nM measured after 1 hr by kinomescan assay relative to control	B	CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@H]3[C@@H]4CC=C(c5cncc(Cl)c5)[C@@]4(C)CC[C@@H]32)C1		CHEMBL4648955	>	Inhibition	%	80.0	CHEMBL5464	Homo sapiens	INH	%	80.0
	22391983	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2nnn3c2CC(C(F)(F)C(F)(F)F)CC3)COc2ccccc21		CHEMBL4756878	=	Ki	nM	24.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.024
	22391984	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2nnc3ccc(C(F)(F)F)nn23)COc2ccccc21		CHEMBL4790658	=	Ki	nM	570.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.57
	22391985	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)F)cc23)COc2ccccc21		CHEMBL4740099	=	Ki	nM	98.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.098
	22391986	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3c2CC(C)(C)CC3)COc2ccccc21		CHEMBL4783819	=	Ki	nM	42.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.042
	22391987	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	C[C@H]1CCc2[nH]nc(C(=O)N[C@H]3COc4ccccc4N(C)C3=O)c2C1		CHEMBL4761296	=	Ki	nM	100.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.1
	22391988	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3c2C2CC2CC3)COc2ccccc21		CHEMBL4742333	=	Ki	nM	1700.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	1.7
	22391989	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	C[C@@H]1CCc2[nH]nc(C(=O)N[C@H]3COc4ccccc4N(C)C3=O)c2C1		CHEMBL4788837	=	Ki	nM	16.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.016
	22391990	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CC(C)c1cnc2[nH]nc(C(=O)N[C@H]3COc4ccccc4N(C)C3=O)c2c1		CHEMBL4746817	=	Ki	nM	55.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.055
	22391991	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3c2CC(n2cccn2)CC3)COc2ccccc21		CHEMBL4758232	=	Ki	nM	750.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.75
	22391992	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3c2C[C@H](C(F)(F)F)CC3)COc2ccccc21		CHEMBL4790507	=	Ki	nM	7.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.006999999999999999
	22391993	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3c2CCC2(CC2)C3)COc2ccccc21		CHEMBL4749885	=	Ki	nM	6500.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	6.5
	22391994	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Ki	nM	6.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.006
	22391995	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ccc(C(F)(F)F)cc23)COc2ccccc21		CHEMBL4761749	=	Ki	nM	5.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.005
	22391996	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3c2CC(c2ccccc2)CC3)COc2ccccc21		CHEMBL4792456	=	Ki	nM	28.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.027999999999999997
	22391997	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2nnc3ccc(C(F)(F)C(F)(F)F)nn23)COc2ccccc21		CHEMBL4783919	=	Ki	nM	68.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.068
	22391998	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2ncn3ccc(C(F)(F)F)cc23)COc2ccccc21		CHEMBL4795841	=	Ki	nM	5.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.005
	22391999	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3c2C[C@H](C(C)(C)C)CC3)COc2ccccc21		CHEMBL4779136	=	Ki	nM	48.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.048
	22392000	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3c2CC2CC2C3)COc2ccccc21		CHEMBL4753759	=	Ki	nM	920.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.92
	22392001	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2nnc[nH]2)COc2ccccc21		CHEMBL4749893	>	Ki	nM	10000.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	10.0
	22392002	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2nnn3c2C[C@H](C(F)(F)F)CC3)COc2ccccc21		CHEMBL4764530	=	Ki	nM	64.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.064
	22392003	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2nn(C)c3c2C[C@H](C(F)(F)F)CC3)COc2ccccc21		CHEMBL4793776	=	Ki	nM	63.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	0.063
	22392004	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3c2CCCC3)COc2ccccc21		CHEMBL4747732	=	Ki	nM	3400.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	3.4
	22392005	CHEMBL4667100	Inhibition of recombinant human His/GST-tagged RIPK1 (2 to 257 residues) expressed in insect expression system incubated for 2 hrs by fluorescence polarization assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3c2CCC(C)(C)C3)COc2ccccc21		CHEMBL4764542	>	Ki	nM	10000.0	CHEMBL5464	Homo sapiens	Ki(app)	uM	10.0
	22926373	CHEMBL4737652	Inhibition of human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by kinome scan method relative to control	B	COc1ncc(-c2ccc3nccc(/C(C)=C/C(=O)N4CCN(C)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4739883	=	Activity	%	87.0	CHEMBL5464	Homo sapiens	Activity	%	87.0
	22977486	CHEMBL4772124	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as reduction in TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4776698	=	EC50	nM	1700.0	CHEMBL5464	Homo sapiens	EC50	uM	1.7
	22977487	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCNc1nc2ccc(-c3cccc(OC)c3)cc2[nH]1		CHEMBL4780741	=	Activity	%	-12.8	CHEMBL5464	Homo sapiens	Activity	%	-12.8
	22977488	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2cc(C(F)(F)F)cc(Br)c2[nH]1		CHEMBL4786704	=	Activity	%	23.7	CHEMBL5464	Homo sapiens	Activity	%	23.7
	22977489	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2ccc(C#N)cc2[nH]1		CHEMBL4783366	=	Activity	%	6.3	CHEMBL5464	Homo sapiens	Activity	%	6.3
	22977490	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2ccc(-n3cnnn3)cc2[nH]1		CHEMBL4778783	=	Activity	%	-1.32	CHEMBL5464	Homo sapiens	Activity	%	-1.32
	22977491	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2ccc(I)cc2[nH]1		CHEMBL4793066	=	Activity	%	-16.3	CHEMBL5464	Homo sapiens	Activity	%	-16.3
	22977492	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	Brc1ccc2nc(NC3CCCCC3)[nH]c2c1		CHEMBL4776373	=	Activity	%	43.7	CHEMBL5464	Homo sapiens	Activity	%	43.7
	22977493	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	Clc1ccc2nc(NC3CCCCC3)[nH]c2c1		CHEMBL4782744	=	Activity	%	38.2	CHEMBL5464	Homo sapiens	Activity	%	38.2
	22977494	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	Cc1ccc2nc(NC3CCCCC3)[nH]c2c1		CHEMBL4789725	=	Activity	%	7.0	CHEMBL5464	Homo sapiens	Activity	%	7.0
	22977495	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	O=[N+]([O-])c1cccc2nc(NCc3ccccc3)[nH]c12		CHEMBL4800642	=	Activity	%	5.1	CHEMBL5464	Homo sapiens	Activity	%	5.1
	22977496	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	O=[N+]([O-])c1cccc2nc(Nc3ccccc3)[nH]c12		CHEMBL4797562	=	Activity	%	0.0	CHEMBL5464	Homo sapiens	Activity	%	0.0
	22977497	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	O=[N+]([O-])c1cccc2nc(NC3CCCCC3)[nH]c12		CHEMBL4780457	=	Activity	%	13.0	CHEMBL5464	Homo sapiens	Activity	%	13.0
	22977498	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	COCCNc1nc2cccc([N+](=O)[O-])c2[nH]1		CHEMBL4779567	=	Activity	%	-2.3	CHEMBL5464	Homo sapiens	Activity	%	-2.3
	22977499	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2cccc([N+](=O)[O-])c2[nH]1		CHEMBL4791580	=	Activity	%	1.2	CHEMBL5464	Homo sapiens	Activity	%	1.2
	22977500	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CC(C)Nc1nc2cccc([N+](=O)[O-])c2[nH]1		CHEMBL4797401	=	Activity	%	1.0	CHEMBL5464	Homo sapiens	Activity	%	1.0
	22977501	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	COC(=O)c1cccc2nc(NC3CCCCC3)[nH]c12		CHEMBL4780623	=	Activity	%	21.7	CHEMBL5464	Homo sapiens	Activity	%	21.7
	22977502	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2cccc(C(=O)OC)c2[nH]1		CHEMBL4787708	=	Activity	%	29.2	CHEMBL5464	Homo sapiens	Activity	%	29.2
	22977503	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2ccc(C(=O)OC)cc2[nH]1		CHEMBL4790575	=	Activity	%	2.9	CHEMBL5464	Homo sapiens	Activity	%	2.9
	22977504	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2ccc(Br)cc2[nH]1		CHEMBL4776136	=	Activity	%	7.3	CHEMBL5464	Homo sapiens	Activity	%	7.3
	22977505	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCNc1nc2ccc(Br)cc2[nH]1		CHEMBL4790898	=	Activity	%	10.4	CHEMBL5464	Homo sapiens	Activity	%	10.4
	22977506	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCOC(=O)CNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4782322	=	Activity	%	15.3	CHEMBL5464	Homo sapiens	Activity	%	15.3
	22977507	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CN(C)c1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)cc1		CHEMBL4798221	=	Activity	%	14.0	CHEMBL5464	Homo sapiens	Activity	%	14.0
	22977508	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	O=[N+]([O-])c1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)cc1		CHEMBL4777700	=	Activity	%	3.6	CHEMBL5464	Homo sapiens	Activity	%	3.6
	22977509	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	O=[N+]([O-])c1ccc2nc(Nc3ccc(C(F)(F)F)cc3)[nH]c2c1		CHEMBL4800287	=	Activity	%	-30.8	CHEMBL5464	Homo sapiens	Activity	%	-30.8
	22977510	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	N#Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)cc1		CHEMBL4777400	=	Activity	%	-31.4	CHEMBL5464	Homo sapiens	Activity	%	-31.4
	22977511	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	O=[N+]([O-])c1ccc2nc(Nc3ccc(Br)cc3)[nH]c2c1		CHEMBL4786812	=	Activity	%	-6.1	CHEMBL5464	Homo sapiens	Activity	%	-6.1
	22977512	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	O=C(Nc1nc2ccc([N+](=O)[O-])cc2[nH]1)c1ccccc1		CHEMBL4782065	=	Activity	%	-21.3	CHEMBL5464	Homo sapiens	Activity	%	-21.3
	22977513	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	O=[N+]([O-])c1ccc2nc(NCc3ccccc3)[nH]c2c1		CHEMBL4789300	=	Activity	%	9.0	CHEMBL5464	Homo sapiens	Activity	%	9.0
	22977514	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	O=[N+]([O-])c1ccc2nc(Nc3ccccc3)[nH]c2c1		CHEMBL4785154	=	Activity	%	41.9	CHEMBL5464	Homo sapiens	Activity	%	41.9
	22977515	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	O=[N+]([O-])c1ccc2nc(NC3CCCCC3)[nH]c2c1		CHEMBL4784995	=	Activity	%	68.1	CHEMBL5464	Homo sapiens	Activity	%	68.1
	22977516	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	COCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4779992	=	Activity	%	5.6	CHEMBL5464	Homo sapiens	Activity	%	5.6
	22977517	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CC(C)CNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4797106	=	Activity	%	53.7	CHEMBL5464	Homo sapiens	Activity	%	53.7
	22977518	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	C#CCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4795439	=	Activity	%	3.4	CHEMBL5464	Homo sapiens	Activity	%	3.4
	22977519	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	C=CCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4781564	=	Activity	%	4.7	CHEMBL5464	Homo sapiens	Activity	%	4.7
	22977520	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CC(C)Nc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4778912	=	Activity	%	16.2	CHEMBL5464	Homo sapiens	Activity	%	16.2
	22977521	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCCCCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4779143	=	Activity	%	6.4	CHEMBL5464	Homo sapiens	Activity	%	6.4
	22977522	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4779037	=	Activity	%	23.6	CHEMBL5464	Homo sapiens	Activity	%	23.6
	22977523	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4799016	=	Activity	%	20.0	CHEMBL5464	Homo sapiens	Activity	%	20.0
	22977524	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4785519	=	Activity	%	6.4	CHEMBL5464	Homo sapiens	Activity	%	6.4
	22977525	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4776698	=	Activity	%	56.9	CHEMBL5464	Homo sapiens	Activity	%	56.9
	22977526	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCNc1nc2ccc(-c3cccc([N+](=O)[O-])c3)cc2[nH]1		CHEMBL4789763	=	Activity	%	-19.4	CHEMBL5464	Homo sapiens	Activity	%	-19.4
	22977527	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCNc1nc2ccc(-c3ccccc3Cl)cc2[nH]1		CHEMBL4794369	=	Activity	%	4.9	CHEMBL5464	Homo sapiens	Activity	%	4.9
	22977528	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2ccc(-c3cccc([N+](=O)[O-])c3)cc2[nH]1		CHEMBL4789137	=	Activity	%	-20.6	CHEMBL5464	Homo sapiens	Activity	%	-20.6
	22977529	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2ccc(-c3cccc(OC)c3)cc2[nH]1		CHEMBL4790757	=	Activity	%	-16.8	CHEMBL5464	Homo sapiens	Activity	%	-16.8
	22977530	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2ccc(-c3cccs3)cc2[nH]1		CHEMBL4779587	=	Activity	%	-20.5	CHEMBL5464	Homo sapiens	Activity	%	-20.5
	22977531	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2ccc(C#C[Si](C)(C)C)cc2[nH]1		CHEMBL4791757	=	Activity	%	-18.5	CHEMBL5464	Homo sapiens	Activity	%	-18.5
	22977532	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	C#Cc1ccc2nc(NCCCC)[nH]c2c1		CHEMBL4778299	=	Activity	%	-21.3	CHEMBL5464	Homo sapiens	Activity	%	-21.3
	22977533	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2ccc(-c3cn(Cc4ccccc4)nn3)cc2[nH]1		CHEMBL4796548	=	Activity	%	-10.5	CHEMBL5464	Homo sapiens	Activity	%	-10.5
	22977534	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCNC(=O)CNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4783184	=	Activity	%	1.9	CHEMBL5464	Homo sapiens	Activity	%	1.9
	22977535	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNC(=O)CNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4783694	=	Activity	%	4.6	CHEMBL5464	Homo sapiens	Activity	%	4.6
	22977536	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2ccc(C(=O)NCc3ccccc3)cc2[nH]1		CHEMBL4792729	=	Activity	%	5.0	CHEMBL5464	Homo sapiens	Activity	%	5.0
	22977537	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2ccc(C(=O)NCCc3ccccc3)cc2[nH]1		CHEMBL4783923	=	Activity	%	2.6	CHEMBL5464	Homo sapiens	Activity	%	2.6
	22977538	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2ccc(C(=O)NCCCc3ccccc3)cc2[nH]1		CHEMBL4785343	=	Activity	%	-3.6	CHEMBL5464	Homo sapiens	Activity	%	-3.6
	22977539	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	O=[N+]([O-])c1ccc2sc(Cl)nc2c1		CHEMBL4783056	=	Activity	%	0.1	CHEMBL5464	Homo sapiens	Activity	%	0.1
	22977540	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2ccc([N+](=O)[O-])cc2s1		CHEMBL4790129	=	Activity	%	28.0	CHEMBL5464	Homo sapiens	Activity	%	28.0
	22977541	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	CCCCNc1nc2cc([N+](=O)[O-])ccc2s1		CHEMBL4796622	=	Activity	%	56.1	CHEMBL5464	Homo sapiens	Activity	%	56.1
	22977542	CHEMBL4772125	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis by measuring remaining viable cells at 10 uM measured after 24 hrs by MTS assay relative to TNFalpha	B	Oc1ccc(-c2cc3cccnc3[nH]2)cc1		CHEMBL4439426	=	Activity	%	57.9	CHEMBL5464	Homo sapiens	Activity	%	57.9
Dose-dependent effect	22977543	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4776698		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
	22977544	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4776698	=	EC50	nM	1700.0	CHEMBL5464	Homo sapiens	EC50	uM	1.7
Not Determined	22977545	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4785519		EC50			CHEMBL5464	Homo sapiens	EC50		
	22977546	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4799016	=	EC50	nM	14400.0	CHEMBL5464	Homo sapiens	EC50	uM	14.4
Not Determined	22977547	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4779037		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977548	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCCCCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4779143		EC50			CHEMBL5464	Homo sapiens	EC50		
	22977549	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CC(C)Nc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4778912	>	EC50	nM	25000.0	CHEMBL5464	Homo sapiens	EC50	uM	25.0
Not Determined	22977550	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	C=CCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4781564		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977551	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	C#CCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4795439		EC50			CHEMBL5464	Homo sapiens	EC50		
	22977552	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CC(C)CNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4797106	=	EC50	nM	2200.0	CHEMBL5464	Homo sapiens	EC50	uM	2.2
Not Determined	22977553	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	COCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4779992		EC50			CHEMBL5464	Homo sapiens	EC50		
	22977554	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	O=[N+]([O-])c1ccc2nc(NC3CCCCC3)[nH]c2c1		CHEMBL4784995	=	EC50	nM	1040.0	CHEMBL5464	Homo sapiens	EC50	uM	1.04
	22977555	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	O=[N+]([O-])c1ccc2nc(Nc3ccccc3)[nH]c2c1		CHEMBL4785154	=	EC50	nM	2500.0	CHEMBL5464	Homo sapiens	EC50	uM	2.5
Not Determined	22977556	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	O=[N+]([O-])c1ccc2nc(NCc3ccccc3)[nH]c2c1		CHEMBL4789300		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977557	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	O=C(Nc1nc2ccc([N+](=O)[O-])cc2[nH]1)c1ccccc1		CHEMBL4782065		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977558	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	O=[N+]([O-])c1ccc2nc(Nc3ccc(Br)cc3)[nH]c2c1		CHEMBL4786812		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977559	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	N#Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)cc1		CHEMBL4777400		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977560	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	O=[N+]([O-])c1ccc2nc(Nc3ccc(C(F)(F)F)cc3)[nH]c2c1		CHEMBL4800287		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977561	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	O=[N+]([O-])c1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)cc1		CHEMBL4777700		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977562	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CN(C)c1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)cc1		CHEMBL4798221		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977563	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCOC(=O)CNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4782322		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977564	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCNc1nc2ccc(Br)cc2[nH]1		CHEMBL4790898		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977565	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2ccc(Br)cc2[nH]1		CHEMBL4776136		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977566	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2ccc(C(=O)OC)cc2[nH]1		CHEMBL4790575		EC50			CHEMBL5464	Homo sapiens	EC50		
	22977567	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2cccc(C(=O)OC)c2[nH]1		CHEMBL4787708	=	EC50	nM	18100.0	CHEMBL5464	Homo sapiens	EC50	uM	18.1
	22977568	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	COC(=O)c1cccc2nc(NC3CCCCC3)[nH]c12		CHEMBL4780623	=	EC50	nM	9000.0	CHEMBL5464	Homo sapiens	EC50	uM	9.0
Not Determined	22977569	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CC(C)Nc1nc2cccc([N+](=O)[O-])c2[nH]1		CHEMBL4797401		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977570	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2cccc([N+](=O)[O-])c2[nH]1		CHEMBL4791580		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977571	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	COCCNc1nc2cccc([N+](=O)[O-])c2[nH]1		CHEMBL4779567		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977572	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	O=[N+]([O-])c1cccc2nc(NC3CCCCC3)[nH]c12		CHEMBL4780457		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977573	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	O=[N+]([O-])c1cccc2nc(Nc3ccccc3)[nH]c12		CHEMBL4797562		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977574	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	O=[N+]([O-])c1cccc2nc(NCc3ccccc3)[nH]c12		CHEMBL4800642		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977575	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	Cc1ccc2nc(NC3CCCCC3)[nH]c2c1		CHEMBL4789725		EC50			CHEMBL5464	Homo sapiens	EC50		
	22977576	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	Clc1ccc2nc(NC3CCCCC3)[nH]c2c1		CHEMBL4782744	=	EC50	nM	4400.0	CHEMBL5464	Homo sapiens	EC50	uM	4.4
Not Determined	22977577	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	Brc1ccc2nc(NC3CCCCC3)[nH]c2c1		CHEMBL4776373		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977578	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2ccc(I)cc2[nH]1		CHEMBL4793066		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977579	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2ccc(-n3cnnn3)cc2[nH]1		CHEMBL4778783		EC50			CHEMBL5464	Homo sapiens	EC50		
	22977580	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2cc(C(F)(F)F)cc(Br)c2[nH]1		CHEMBL4786704	=	EC50	nM	8900.0	CHEMBL5464	Homo sapiens	EC50	uM	8.9
Not Determined	22977581	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCNc1nc2ccc(-c3ccccc3Cl)cc2[nH]1		CHEMBL4794369		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977582	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCNc1nc2ccc(-c3cccc([N+](=O)[O-])c3)cc2[nH]1		CHEMBL4789763		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977583	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCNc1nc2ccc(-c3cccc(OC)c3)cc2[nH]1		CHEMBL4780741		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977584	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2ccc(-c3cccc([N+](=O)[O-])c3)cc2[nH]1		CHEMBL4789137		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977585	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2ccc(-c3cccc(OC)c3)cc2[nH]1		CHEMBL4790757		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977586	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2ccc(-c3cccs3)cc2[nH]1		CHEMBL4779587		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977587	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2ccc(C#C[Si](C)(C)C)cc2[nH]1		CHEMBL4791757		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977588	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	C#Cc1ccc2nc(NCCCC)[nH]c2c1		CHEMBL4778299		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977589	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2ccc(-c3cn(Cc4ccccc4)nn3)cc2[nH]1		CHEMBL4796548		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977590	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCNC(=O)CNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4783184		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977591	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNC(=O)CNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4783694		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977592	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2ccc(C(=O)NCc3ccccc3)cc2[nH]1		CHEMBL4792729		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977593	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2ccc(C(=O)NCCc3ccccc3)cc2[nH]1		CHEMBL4783923		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977594	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2ccc(C(=O)NCCCc3ccccc3)cc2[nH]1		CHEMBL4785343		EC50			CHEMBL5464	Homo sapiens	EC50		
Not Determined	22977595	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	O=[N+]([O-])c1ccc2sc(Cl)nc2c1		CHEMBL4783056		EC50			CHEMBL5464	Homo sapiens	EC50		
	22977596	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2ccc([N+](=O)[O-])cc2s1		CHEMBL4790129	=	EC50	nM	6900.0	CHEMBL5464	Homo sapiens	EC50	uM	6.9
	22977597	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2cc([N+](=O)[O-])ccc2s1		CHEMBL4796622	=	EC50	nM	4700.0	CHEMBL5464	Homo sapiens	EC50	uM	4.7
	22977598	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	Oc1ccc(-c2cc3cccnc3[nH]2)cc1		CHEMBL4439426	=	EC50	nM	1100.0	CHEMBL5464	Homo sapiens	EC50	uM	1.1
Dose-dependent effect	22977599	CHEMBL4772126	Inhibition of RIPK1 in human FADD-deficient Jurkat I 2.1 cells assessed as protection against TNFalpha-induced necroptosis measured after 24 hrs by MTS assay	B	CCCCNc1nc2cc([N+](=O)[O-])ccc2s1		CHEMBL4796622		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
	22977609	CHEMBL4772131	Inhibition of recombinant human RIPK1 kinase domain (8 to 322 residues) using myelin basic protein as substrate measured after 120 mins by [gamma-32P]ATP based scintillation counting method	B	CCCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4776698	=	IC50	nM	12120.0	CHEMBL5464	Homo sapiens	IC50	uM	12.12
	22977610	CHEMBL4772131	Inhibition of recombinant human RIPK1 kinase domain (8 to 322 residues) using myelin basic protein as substrate measured after 120 mins by [gamma-32P]ATP based scintillation counting method	B	CCCCNc1nc2cc([N+](=O)[O-])ccc2s1		CHEMBL4796622	=	IC50	nM	2890.0	CHEMBL5464	Homo sapiens	IC50	uM	2.89
Dose-dependent effect	22977611	CHEMBL4772131	Inhibition of recombinant human RIPK1 kinase domain (8 to 322 residues) using myelin basic protein as substrate measured after 120 mins by [gamma-32P]ATP based scintillation counting method	B	CCCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4776698		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Dose-dependent effect	22977612	CHEMBL4772131	Inhibition of recombinant human RIPK1 kinase domain (8 to 322 residues) using myelin basic protein as substrate measured after 120 mins by [gamma-32P]ATP based scintillation counting method	B	CCCCNc1nc2cc([N+](=O)[O-])ccc2s1		CHEMBL4796622		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
	23122792	CHEMBL4805143	Inhibition of human RIPK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL5464	Homo sapiens	Activity	%	100.0
	23123487	CHEMBL4805731	Inhibition of human RIPK1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	87.0	CHEMBL5464	Homo sapiens	Activity	%	87.0
	23123942	CHEMBL4806186	Inhibition of DNA-tagged human RIPK1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	95.0	CHEMBL5464	Homo sapiens	Activity	%	95.0
	23125064	CHEMBL4806748	Inhibition of human RIPK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	99.0	CHEMBL5464	Homo sapiens	Activity	%	99.0
	23125065	CHEMBL4806748	Inhibition of human RIPK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5464	Homo sapiens	Activity	%	100.0
	23183195	CHEMBL4817023	Binding affinity to human wild type RIPK1 (M1/K305) expressed in bacterial expression system by Kinomescan method	B	O=S1(=O)CC2(OCCO2)c2cc3nccc(Nc4ccc5scnc5c4)c3cc21		CHEMBL4861646	=	Kd	nM	5950.0	CHEMBL5464	Homo sapiens	Kd	nM	5950.0
Not Active	23183197	CHEMBL4817025	Inhibition of human RIPK1 using ATP and substrate at 10 uM incubated for 120 mins by ADP-glo based luminescence assay	B	O=S1(=O)CC2(OCCO2)c2cc3nccc(Nc4ccc5scnc5c4)c3cc21		CHEMBL4861646		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
	23208889	CHEMBL4822246	Inhibition of wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	CCc1cc(NC(=O)[C@H](O)c2cc(F)cc(F)c2)ccc1-c1cnc(N)c(C(=O)NC(C)C)c1		CHEMBL4857782	=	Activity	%	100.0	CHEMBL5464	Homo sapiens	Activity	%	100.0
	23208890	CHEMBL4822246	Inhibition of wild-type human partial length RIPK1 (M1 to K305 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Cc1cccc(CC(=O)N2CCc3c2ccc(-c2cn(C)c4ncnc(N)c24)c3F)n1		CHEMBL2441340	=	Activity	%	0.0	CHEMBL5464	Homo sapiens	Activity	%	0.0
	23211155	CHEMBL4822733	Inhibition of human wild type RIPK1 (M1 to K305) expressed in bacterial system by kinomescan assay	B	CC1(C)CC1C(=O)Nc1nc2ccc(Oc3ccc(F)c(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)cc2s1		CHEMBL4860842	=	Kd	nM	480.0	CHEMBL5464	Homo sapiens	Kd	nM	480.0
	23211156	CHEMBL4822733	Inhibition of human wild type RIPK1 (M1 to K305) expressed in bacterial system by kinomescan assay	B	CC1(C)C[C@H]1C(=O)Nc1nc2ccc(Oc3ccc(F)c(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)cc2s1		CHEMBL4869920	=	Kd	nM	1700.0	CHEMBL5464	Homo sapiens	Kd	nM	1700.0
	23211157	CHEMBL4822733	Inhibition of human wild type RIPK1 (M1 to K305) expressed in bacterial system by kinomescan assay	B	CC1(C)C[C@@H]1C(=O)Nc1nc2ccc(Oc3ccc(F)c(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)cc2s1		CHEMBL4850219	=	Kd	nM	430.0	CHEMBL5464	Homo sapiens	Kd	nM	430.0
	23211158	CHEMBL4822733	Inhibition of human wild type RIPK1 (M1 to K305) expressed in bacterial system by kinomescan assay	B	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3125890	=	Kd	nM	480.0	CHEMBL5464	Homo sapiens	Kd	nM	480.0
	23211159	CHEMBL4822733	Inhibition of human wild type RIPK1 (M1 to K305) expressed in bacterial system by kinomescan assay	B	O=C(Cc1cccc(C(F)(F)F)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4540715	=	Kd	nM	97.0	CHEMBL5464	Homo sapiens	Kd	nM	97.0
Active	23211165	CHEMBL4822735	Inhibition of RIPK1 in human HT-29 cells assessed as inhibition of TSZ-induced RIPK1 phosphorylation at 1 uM measured upto 4 hrs by Western blot analysis	B	CC1(C)CC1C(=O)Nc1nc2ccc(Oc3ccc(F)c(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)cc2s1		CHEMBL4860842		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	23211166	CHEMBL4822735	Inhibition of RIPK1 in human HT-29 cells assessed as inhibition of TSZ-induced RIPK1 phosphorylation at 1 uM measured upto 4 hrs by Western blot analysis	B	CC1(C)C[C@H]1C(=O)Nc1nc2ccc(Oc3ccc(F)c(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)cc2s1		CHEMBL4869920		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	23211167	CHEMBL4822735	Inhibition of RIPK1 in human HT-29 cells assessed as inhibition of TSZ-induced RIPK1 phosphorylation at 1 uM measured upto 4 hrs by Western blot analysis	B	CC1(C)C[C@@H]1C(=O)Nc1nc2ccc(Oc3ccc(F)c(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)cc2s1		CHEMBL4850219		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	23211168	CHEMBL4822736	Inhibition of RIPK1 in human HT-29 cells assessed as inhibition of TSZ-induced RIPK3 phosphorylation at 1 uM measured upto 4 hrs by Western blot analysis	B	CC1(C)CC1C(=O)Nc1nc2ccc(Oc3ccc(F)c(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)cc2s1		CHEMBL4860842		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	23211169	CHEMBL4822736	Inhibition of RIPK1 in human HT-29 cells assessed as inhibition of TSZ-induced RIPK3 phosphorylation at 1 uM measured upto 4 hrs by Western blot analysis	B	CC1(C)C[C@H]1C(=O)Nc1nc2ccc(Oc3ccc(F)c(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)cc2s1		CHEMBL4869920		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	23211170	CHEMBL4822736	Inhibition of RIPK1 in human HT-29 cells assessed as inhibition of TSZ-induced RIPK3 phosphorylation at 1 uM measured upto 4 hrs by Western blot analysis	B	CC1(C)C[C@@H]1C(=O)Nc1nc2ccc(Oc3ccc(F)c(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)cc2s1		CHEMBL4850219		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	23211171	CHEMBL4822737	Inhibition of RIPK1 in human HT-29 cells assessed as inhibition of TSZ-induced MLKL phosphorylation at 1 uM measured upto 4 hrs by Western blot analysis	B	CC1(C)CC1C(=O)Nc1nc2ccc(Oc3ccc(F)c(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)cc2s1		CHEMBL4860842		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	23211172	CHEMBL4822737	Inhibition of RIPK1 in human HT-29 cells assessed as inhibition of TSZ-induced MLKL phosphorylation at 1 uM measured upto 4 hrs by Western blot analysis	B	CC1(C)C[C@H]1C(=O)Nc1nc2ccc(Oc3ccc(F)c(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)cc2s1		CHEMBL4869920		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	23211173	CHEMBL4822737	Inhibition of RIPK1 in human HT-29 cells assessed as inhibition of TSZ-induced MLKL phosphorylation at 1 uM measured upto 4 hrs by Western blot analysis	B	CC1(C)C[C@@H]1C(=O)Nc1nc2ccc(Oc3ccc(F)c(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)cc2s1		CHEMBL4850219		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
	23211188	CHEMBL4822744	Inhibition of GST-tagged RIPK1 (1 to 375) (unknown origin) by fluorescent polarization based binding assay	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353	=	IC50	nM	16.0	CHEMBL5464	Homo sapiens	IC50	nM	16.0
	23211189	CHEMBL4822744	Inhibition of GST-tagged RIPK1 (1 to 375) (unknown origin) by fluorescent polarization based binding assay	B	CC(C)(C)C(=O)N1N=CC[C@@H]1c1ccccc1		CHEMBL4442060	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
	23211190	CHEMBL4822745	Inhibition of GST-tagged RIPK1 (1 to 375) (unknown origin) incubated for 4 hrs by ADP-Glo kinase assay	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353	=	IC50	nM	1.6	CHEMBL5464	Homo sapiens	IC50	nM	1.6
	23211191	CHEMBL4822745	Inhibition of GST-tagged RIPK1 (1 to 375) (unknown origin) incubated for 4 hrs by ADP-Glo kinase assay	B	CC(C)(C)C(=O)N1N=CC[C@@H]1c1ccccc1		CHEMBL4442060	>	IC50	nM	10000.0	CHEMBL5464	Homo sapiens	IC50	nM	10000.0
Active	23303824	CHEMBL4842518	Inhibition of RIPK1 phosphorylation in Z-VAD-fmk (TSZ)-induced human HT-29 cells at 1 uM measured up to 4 hrs by immunoblotting analysis	B	CN1C(=S)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4871408		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	23303825	CHEMBL4842518	Inhibition of RIPK1 phosphorylation in Z-VAD-fmk (TSZ)-induced human HT-29 cells at 1 uM measured up to 4 hrs by immunoblotting analysis	B	CN1C(=S)[C@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4872011		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Dose-Dependent Effect	23303830	CHEMBL4842521	Inhibition of RIPK1 phosphorylation in Z-VAD-fmk (TSZ)-induced human HT-29 cells measured at 4 hrs by immunoblotting analysis	B	CN1C(=S)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4871408		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Dose-Dependent Effect	23303831	CHEMBL4842521	Inhibition of RIPK1 phosphorylation in Z-VAD-fmk (TSZ)-induced human HT-29 cells measured at 4 hrs by immunoblotting analysis	B	CN1C(=S)[C@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4872011		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	23303836	CHEMBL4842524	Inhibition of RIPK1 in Z-VAD-fmk (TSZ)-induced human HT-29 cells assessed as reduction in RIPK1-RIPK3 necrosome formation at 1 uM measured after 6 hrs by Western blot analysis	B	CN1C(=S)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4871408		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Active	23303837	CHEMBL4842524	Inhibition of RIPK1 in Z-VAD-fmk (TSZ)-induced human HT-29 cells assessed as reduction in RIPK1-RIPK3 necrosome formation at 1 uM measured after 6 hrs by Western blot analysis	B	CN1C(=S)[C@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4872011		Inhibition	%		CHEMBL5464	Homo sapiens	INH		
Not Active	23317628	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	82.0	CHEMBL5464	Homo sapiens	% Control	%	82.0
Not Active	23318096	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23318762	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	79.0	CHEMBL5464	Homo sapiens	% Control	%	79.0
Not Active	23319246	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	90.0	CHEMBL5464	Homo sapiens	% Control	%	90.0
Not Active	23319883	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23320358	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23321036	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23321504	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23322134	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	88.0	CHEMBL5464	Homo sapiens	% Control	%	88.0
Not Active	23322602	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	55.0	CHEMBL5464	Homo sapiens	% Control	%	55.0
Not Active	23323291	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	93.0	CHEMBL5464	Homo sapiens	% Control	%	93.0
Not Active	23323759	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23324613	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	94.6	CHEMBL5464	Homo sapiens	% Control	%	94.6
Not Active	23325248	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	84.0	CHEMBL5464	Homo sapiens	% Control	%	84.0
Not Active	23325716	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23326363	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	81.0	CHEMBL5464	Homo sapiens	% Control	%	81.0
Not Active	23326831	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	93.0	CHEMBL5464	Homo sapiens	% Control	%	93.0
Not Active	23327531	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Slightly Active	23327999	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	30.0	CHEMBL5464	Homo sapiens	% Control	%	30.0
Not Active	23328586	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23329054	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23329508	CHEMBL4881215	RIPK1(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	100.0	CHEMBL5464	Homo sapiens	% residual kinase activity	%	100.0
Not Active	23330000	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23330468	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	98.0	CHEMBL5464	Homo sapiens	% Control	%	98.0
Not Active	23331224	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23331692	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23332279	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	91.5	CHEMBL5464	Homo sapiens	% Control	%	91.5
Not Active	23332745	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	80.7	CHEMBL5464	Homo sapiens	% Control	%	80.7
Not Active	23333463	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	85.8	CHEMBL5464	Homo sapiens	% Control	%	85.8
Not Active	23334102	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	97.0	CHEMBL5464	Homo sapiens	% Control	%	97.0
Not Active	23334570	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23335549	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23336017	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23336644	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	89.0	CHEMBL5464	Homo sapiens	% Control	%	89.0
Not Active	23337112	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	86.0	CHEMBL5464	Homo sapiens	% Control	%	86.0
Not Active	23338193	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	82.0	CHEMBL5464	Homo sapiens	% Control	%	82.0
Not Active	23338661	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	89.0	CHEMBL5464	Homo sapiens	% Control	%	89.0
Not Active	23339273	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23339741	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	92.0	CHEMBL5464	Homo sapiens	% Control	%	92.0
Not Active	23340378	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23340846	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	99.0	CHEMBL5464	Homo sapiens	% Control	%	99.0
Not Active	23341503	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23341971	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23342587	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23343055	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23343685	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23344153	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23344791	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	88.0	CHEMBL5464	Homo sapiens	% Control	%	88.0
Not Active	23345364	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23345832	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	88.0	CHEMBL5464	Homo sapiens	% Control	%	88.0
Not Active	23346409	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	87.1	CHEMBL5464	Homo sapiens	% Control	%	87.1
Not Active	23346877	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	95.9	CHEMBL5464	Homo sapiens	% Control	%	95.9
Not Active	23347479	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23347969	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23348548	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23349016	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	97.0	CHEMBL5464	Homo sapiens	% Control	%	97.0
Not Active	23349603	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23350221	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23350689	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23351294	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23351762	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	93.0	CHEMBL5464	Homo sapiens	% Control	%	93.0
Not Active	23352786	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23353254	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	98.0	CHEMBL5464	Homo sapiens	% Control	%	98.0
Not Active	23354136	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23354604	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23355336	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23355804	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23356440	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23356908	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23357517	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23358164	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	97.0	CHEMBL5464	Homo sapiens	% Control	%	97.0
Not Active	23358632	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23359218	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	97.4	CHEMBL5464	Homo sapiens	% Control	%	97.4
Not Active	23359816	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23360284	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23360869	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23361337	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	92.0	CHEMBL5464	Homo sapiens	% Control	%	92.0
Not Active	23361910	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23362446	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	90.0	CHEMBL5464	Homo sapiens	% Control	%	90.0
Not Active	23362914	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	91.0	CHEMBL5464	Homo sapiens	% Control	%	91.0
Not Active	23364556	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	77.0	CHEMBL5464	Homo sapiens	% Control	%	77.0
Not Active	23365024	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	99.0	CHEMBL5464	Homo sapiens	% Control	%	99.0
Not Active	23365763	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	92.0	CHEMBL5464	Homo sapiens	% Control	%	92.0
Not Active	23366306	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	86.0	CHEMBL5464	Homo sapiens	% Control	%	86.0
Not Active	23366896	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23367364	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	89.0	CHEMBL5464	Homo sapiens	% Control	%	89.0
Not Active	23368242	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	99.0	CHEMBL5464	Homo sapiens	% Control	%	99.0
Not Active	23368710	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23369309	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	95.0	CHEMBL5464	Homo sapiens	% Control	%	95.0
Not Active	23369777	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	93.0	CHEMBL5464	Homo sapiens	% Control	%	93.0
Not Active	23370745	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23371213	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23372022	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	88.0	CHEMBL5464	Homo sapiens	% Control	%	88.0
Not Active	23372490	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	94.0	CHEMBL5464	Homo sapiens	% Control	%	94.0
Active	23372647	CHEMBL4884600	TR-FRET (human RIPK1)	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		Ki	nM	3.9	CHEMBL5464	Homo sapiens	Ki	nM	3.9
	23372876	CHEMBL4884841	RIPK1(RIP1PGN1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	21.88	CHEMBL5464	Homo sapiens	pIC50		7.66
Active	23373056	CHEMBL4884600	TR-FRET (human RIPK1)	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		Ki	nM	0.43	CHEMBL5464	Homo sapiens	Ki	nM	0.43
	23373285	CHEMBL4885132	RIPK1(RIP1PGN1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	10.0	CHEMBL5464	Homo sapiens	pIC50		8.0
Not Active	23373418	CHEMBL4884600	TR-FRET (human RIPK1)	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		Ki	nM	6900.0	CHEMBL5464	Homo sapiens	Ki	nM	6900.0
	23373641	CHEMBL4885418	RIPK1(RIP1PGN1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5464	Homo sapiens	pIC50		6.0
Not Active	23375917	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23376385	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23376962	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	83.0	CHEMBL5464	Homo sapiens	% Control	%	83.0
Not Active	23377430	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	81.0	CHEMBL5464	Homo sapiens	% Control	%	81.0
Not Active	23378290	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23378758	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	93.0	CHEMBL5464	Homo sapiens	% Control	%	93.0
Not Active	23379925	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23380393	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23381087	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23381735	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23382203	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23382827	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23383295	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL5464	Homo sapiens	% Control	%	100.0
Not Active	23384445	CHEMBL4888040	RIPK1(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	21.25	CHEMBL5464	Homo sapiens	% inhibition	%	21.25
Not Active	23385210	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	91.0	CHEMBL5464	Homo sapiens	% Control	%	91.0
Not Active	23385677	CHEMBL4879934	KinomeScan assay: inhibition of RIPK1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	84.0	CHEMBL5464	Homo sapiens	% Control	%	84.0
